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Abstract
Transcranial magnetic stimulation (TMS) is a non-invasive technique for stim-
ulating the brain. A brief electric current passing through a magnetic coil produces
a brief, high-intensity magnetic ﬁeld which stimulates the brain. Repetitive TMS,
application of many magnetic pulses, is able to induce relatively long-lasting ex-
citability changes and nowadays is being developed for various therapeutic and sci-
entiﬁc purposes. The after-eﬀects of rTMS over motor cortex are well documented
in healthy individuals, however less is known about the stimulation of dorso-lateral
prefrontal cortex (DLPFC).
The aim of this PhD thesis was to compare diﬀerent rTMS protocols in healthy
subjects and to ﬁnd neurophysiological EEG biomarkers characteristic for response
or not to rTMS therapy in major and bipolar depression. The main originality of
presented method is within-subject comparison of between-protocols eﬀects. Addi-
tionally, source localisation was performed in both analyses.
Here, we studied in 20 healthy subjects how cortical oscillations are modulated
by four diﬀerent active rTMS protocols (1 Hz, 10 Hz, cTBS and iTBS) of the left
DLPFC, and by a sham-1Hz protocol used as a control condition, by comparing the
spectral power of pre- and post-rTMS electroencephalographic (EEG) recordings of
15 minutes duration. EEG spectrum was estimated with the Fast Fourier transform
(FFT) and partitioned using the common physiological frequency.
We found for every active protocol a signiﬁcant decrease of delta and theta
power on left prefrontal electrodes, mainly localised in the left DLPFC. In higher
frequency bands (beta and gamma), the decrease of power in the DLPFC was also
observed additionally in the contralateral DLFPC and depended on the stimulation
protocol. Because large delta and theta activity is usually associated with cortical
inhibition, these results suggest that rTMS of DLPFC transiently decreases local
cortical inhibition. Furthermore, fast EEG oscillations are associated to cortical
xi
excitability and it can be concluded that observed decreases in fast activity, unspe-
ciﬁc to protocol, localised in the DLPFC also suggest reduced cortical excitability,
which accompanies a decrease in cortical inhibition.
In the second experiment we worked on two subgroups of patients, with major
depressive disorder (MDD) and bipolar disorder (BP). In this open study we aimed
to examine whether there are EEG diﬀerences in resting brain activity between BP
and MADD patients, and between responders and non-responders to 10 Hz repeti-
tive transcranial magnetic stimulation (rTMS) by studying EEG biomarkers.Eight
MDD (6 females) and 10 BP patients (6 females) were included. The 10 Hz rTMS
protocol was the same for MDD and BP. The diﬀerent patterns of EEG activity
in both depressive disorders were studied, by comparing spectral power of pre- and
post-rTMS EEG recordings throughout the therapeutic sessions in responders and
non-responders.
The most important ﬁnding is that it is possible to distinguish responders from
non-responders to the rTMS treatment. Responders showed signiﬁcantly higher
power of low frequencies. Therefore, an increase of alpha power was observed in
ventral cingulate cortex in both groups. The comparison of MDD and BP disorders
revealed signiﬁcantly higher activity in theta and beta bands power in BP patients,
mainly localised in prefrontal cortex.
The results of multiple regression analysis revealed that alpha band power on
the left fronto-temporal regions was signiﬁcantly and negatively correlated with
∆MADRS. Additionally, we found positive correlation of ∆MADRS and theta band
power in the posterior midline areas. We can suggest that both EEG features could
be used as biomarkers to predict rTMS outcome.
Keywords:
rTMS, EEG, prefrontal cortex, depression
Re´sume´
La stimulation magne´tique transcranienne (SMT) est une technique non inva-
sive qui permet de stimuler le cerveau. Les SMT re´pe´titives (SMTr), c’est-a`-dire
l’application de nombreuses impulsions magne´tiques, sont capable d’induire des
modiﬁcations de longue dure´e de l’excitabilite´ neuronale. La SMT s’est de´veloppe´e
dans un but the´rapeutique et scientiﬁque. Les eﬀets apre`s la SMTr sur le cortex
moteur sont bien documente´s chez les individus sains, mais on en sait moins sur la
stimulation du cortex pre´frontal dorso-late´ral (DLPFC).
L’objectif de cette the`se e´tait de comparer diﬀe´rents protocoles SMTr sur des
sujets sains et de trouver des marqueurs e´lectroence´phalograpiques (EEG) de la
re´ponse ou pas a` la the´rapie SMTr dans la de´pression majeure et bipolaire. La
principale originalite´ de la me´thode pre´sente´e est la comparaison intra-sujet d’eﬀets
entre-protocoles et le de´veloppement de techniques de localisation de sources.
Nous avons e´tudie´ chez 20 sujets sains comment les oscillations corticales sont
module´es suite a` quatre protocoles SMTr actifs diﬀe´rents, et a` un protocole sham
utilise´ comme controˆle, du DLPFC gauche et en comparant la puissance spectrale
d’EEG avant et apre`s SMTr de dure´e de 15 minutes. Le spectre EEG a e´te´ estime´
graˆce a` la transforme´e de Fourier rapide (FFT) et partitionne´ en bandes de fre´quence
selon la classiﬁcation commune.
Nous avons trouve´ pour chaque protocole actif une diminution signiﬁcative de
puissance delta et theta sur les e´lectrodes pre´frontales gauches, principalement lo-
calise´es dans le DLPFC gauche. Dans des bandes de fre´quences plus hautes, la
diminution de puissance dans le DLPFC a e´te´ de plus observe´e dans le DLFPC
controlate´ral et de´pend du protocole de stimulation. Parce que les activite´s delta
et theta sont ge´ne´ralement associe´es a` l’inhibition corticale, ces re´sultats sugge`rent
que la SMTr du DLPFC diminue transitoirement l’inhibition corticale locale. Aussi,
les oscillations d’EEG rapides sont associe´es a` l’excitabilite´ corticale et on peut con-
clure que des diminutions observe´es non spe´ciﬁques dans l’activite´ rapide localise´e
dans le DLPFC sugge`rent e´galement une re´duction de l’excitabilite´ corticale.
xiii
Dans la deuxie`me expe´rience, nous avons travaille´ sur groupe de patients, souf-
frant de trouble de´pressif majeur (MDD) et de trouble bipolaire (BP). Dans cette
e´tude ouverte, nous avons cherche´ a` de´terminer s’il existe des diﬀe´rences d’EEG de
repos dans l’activite´ ce´re´brale entre patients BP et MDD, et entre les re´pondeurs
et non-re´pondeurs a` la SMTr a` 10 Hz en e´tudiant des biomarqueurs d’EEG. Le
protocole SMTr a` 10 Hz e´taient le meˆme entre patients MDD et BP. Les pro-
prie´te´s EEG dans les deux troubles de´pressifs ont e´te´ e´tudie´es, en comparant la
puissance spectrale des enregistrements pre´- et post-SMTr EEG au cours des ses-
sions the´rapeutiques chez les patients re´pondeurs et non-re´pondeurs.
La conclusion est qu’il est possible de distinguer les re´pondeurs des non-re´pondeurs
au traitement SMTr. Les re´pondeurs avaient une puissance en basse fre´quence plus
importante. Une augmentation de puissance alpha a aussi e´te´ observe´e au niveau
du cortex cingulaire ventral dans les deux groupes. La comparaison des MDD et
BP a re´ve´le´ une activite´ signiﬁcativement plus e´leve´e dans la puissance des bandes
theˆta et beˆta chez les patients BP, principalement localise´e dans le cortex pre´frontal.
Les re´sultats de l’analyse de re´gression ont re´ve´le´ que la puissance de la bande al-
pha sur les re´gions fronto-temporales gauches e´tait signiﬁcativement et ne´gativement
corre´le´e avec le score clinique de de´pression (MADRS). En outre, nous avons trouve´
une corre´lation positive du score MADRS et de la puissance de la bande theˆta
dans les zones me´dianes poste´rieures. Nous pouvons sugge´rer que les deux car-
acte´ristiques EEG pourraient eˆtre utilise´s comme marqueurs pour pre´dire les re´sultats
SMTr.
Les mots cle´s:
EEG, rTMS, cortex pre´frontal dorso-late´ral (DLPFC), la depression
Introduction
Nowadays, transcranial magnetic stimulation (TMS) is a very popular tool
widely used to stimulate the brain non-invasively. The application of many
pulses (repetitive TMS, rTMS) can modulate brain’s activity during peri-
ods that outlast the stimulation time and additionally has a therapeutic po-
tential in treating neurological and psychiatric disorders such as depression
[Dell’Osso 2009, George 2010, Richieri 2011], schizophrenia with auditory halluci-
nations [Hasan 2013, Homan 2012], migraines [Brigo 2012, Magis 2012] or stroke
[Hummel 2008, Jung 2012, Hummel 2012]. Depending on the stimulation param-
eters, it has diﬀerent inﬂuence on the brain. The main stimulation parame-
ters are the frequency of stimulation and the temporal structure of the pulses,
i.e. whether the series of pulses are applied continuously or not [Classen 2008].
The easiest way to estimate the inﬂuence of the TMS on the neuronal activ-
ity is to stimulate over the motor cortex. Then, it is possible to record the
response as motor evoked potentials (MEPs) on peripheral muscles. Numerous
studies of electromyographic (EMG) recordings showed that in most cases low-
frequency stimulation (≤ 1 Hz) produces lasting decrease in motor cortex ex-
citability, whereas high-frequency stimulation (≥ 5 Hz) induces facilitatory eﬀects
[Romero 2002, Hayashi 2004, Houdayer 2008, Di Lazzaro 2011, Noh 2012]. Regard-
ing theta burst stimulation (TBS, burst of three 50 Hz pulses repeated every 200
ms), it is also possible to obtain two opposite results, where the after-eﬀects depend
on bursts application. If stimulation is delivered continuously (cTBS) it has an in-
hibitory eﬀect, whereas when delivered as an intermittent TBS (iTBS) the eﬀect is
excitatory [Huang 2005, Hoogendam 2010].
Although the rTMS-eﬀects over the motor cortex are well documented, less is
known about the stimulation over the dorso-lateral prefrontal cortex (DLPFC).
In this case, the rTMS pulses do not spread through the cortico-spinal pathways
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and must be measured with other technique, electroencephalography (EEG). Using
EEG, it is possible to measure directly from the scalp the rTMS after-eﬀects and to
investigate how rTMS pulses propagate in the brain network. Additionally, EEG
brought important information about depression and various studies have found
that typically 20% to 40% of depressed patients have EEG abnormalities, with
several characteristics and controversial patterns [Coburn 2006]. Moreover, up to
80% of psychiatric patients present various quantitative EEG (qEEG) abnormalities
on contrary to only 10% of healthy subjects [Begic 2011, Coburn 2006].
Generally, there are two main types of depression, major depressive disorder
(MDD) and bipolar disorder (BP). Although a physiopathology of these two types
of depression is due to distinct neuropathologies, the clinical symptoms are some-
times diﬃcult to distinguish between depressive symptoms. In this perspective, the
possibility to predict treatment response in mental health disorders with biomark-
ers became very important clinical issue. Diﬀerent pre-treatment EEG parameters
were tested as possible biomarkers, and alpha and theta bands were reported as the
most valuable indices to diﬀerentiate responders from non-responders.
There are two main aspects of this work. First, concurrent EEG-rTMS were
recorded on healthy subjects maintained at rest and awake, and the aim was to
investigate how cortical oscillations are modulated by four diﬀerent active rTMS
protocols (1 Hz, 10 Hz, cTBS and iTBS) of the left DLPFC, and by a sham protocol
used as a control condition. Spectral power of pre- and post-rTMS EEG recordings
was compared on the scalp and cortical sources levels.
The second part is devoted to research on patients. Here, the aim was to examine
whether it is possible to distinguish BP from MDD patients, and responders from
non-responders to 10 Hz repetitive transcranial magnetic stimulation by studying
EEG biomarkers of resting state brain activity. This was also done at both scalp
and cortical sources levels.
The thesis is organized as follows:
– The ﬁrst chapter introduces the general informations about depression. Clas-
siﬁcation of depression and its neurobiological basis with neurotransmitters’
pathways are described.
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– Second chapter gives a detailed description of EEG technique. The neural
activity and cortical cytoarchitecture are brieﬂy discussed. Next, EEG brain
waves and source localisation method which are used in this thesis are ad-
dressed.
– The main technique used in this study, repetitive transcranial magnetic stim-
ulation, is described in the third chapter. There is a description of physical
principles of magnetic stimulation and of physiology of elicited brain activity
changes, followed by long-term depression and potentiation deﬁnitions. Next,
rTMS protocols which has been used in this work are discussed. Functional
connectivity and cortical excitability with neuronavigation technique are ad-
ditionally described. Also, an overview of current use of rTMS in the clinical
applications is presented.
– The fourth chapter brings together the EEG-rTMS co-registration. The chal-
lenges of EEG-rTMS co-registration and the overview of EEG changes cor-
related with mood disorders are presented. There is also a comparison of
diﬀerences in brain oscillations between healthy and depressed individuals.
Finally, EEG is presented as a plausible predictor of depression treatment.
– Chapter ﬁve describes the experimental design and the data processing used
in this thesis.
– The results are presented in chapter six. There are short introductions and
manuscripts of two articles submitted to NeuroImage. The ﬁrst paper is in re-
vision and the second one is about to be submitted. Presented papers describe
results for EEG-rTMS co-registration on healthy and depressed patients, sep-
arately.
– The last chapter, the seventh one, includes a discussion of presented results
and gives an introduction to the next steps of this project.
Re´sume´ du Chapitre 1
Dans le chapitre suivant, je pre´senterai la classiﬁcation de la de´pression ainsi que
l’un de ses mode`les. Je de´crirai e´galement la neurobiologie de la de´pression ainsi
que le roˆle de certains neurotransmetteurs tels que la dopamine, la nore´pine´phrine,
la se´rotonine, le glutamate et l’acide gamma-aminobutyrique. Je terminerai en
pre´sentant le lien entre l’absence ou le dysfonctionnement de certains neurotrans-
metteurs et les symptoˆmes caracte´ristiques de la de´pression.
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1.1 Introduction
Brain disorders, including depression and bipolar disorder, are among the lead-
ing causes of disability worldwide. Underlying pathophysiological mechanisms are
still largely unknown and they are among the most mysterious of brain diseases.
One of these aﬀective disorders is depression. Depression is deﬁned as a state of
sadness, low mood accompanied by low self-esteem, loss of interest in activities that
once were pleasurable and reduced capabilities to concentrate or decide. It is also
characterised by altered emotional and cognitive functioning [APA 2000]. Depressed
mood is not necessarily a psychiatric disorder. It is related to a normal reaction to
certain life events, a symptom of some medical conditions, and a side eﬀect of some
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medical treatments. But, depressed mood is also a primary or associated feature of
certain psychiatric syndromes such as clinical depression. Classic severe states of
depression, however, often have no dramatic external causes.
Depression classiﬁcation includes:
– major depressive disorder (MDD), also referred to as major depression,
unipolar depression or clinical depression. In this case a person has one or
more major depressive episodes.
– bipolar (BP) depression, also known as “maniac depression”, is described
by alternating periods of depression and mania. Depending on how rapidly
the mood changes occur, the episodes of bipolar disorder can also be classiﬁed
as rapid cycling, mixed or with psychotic symptoms. This type of disorder
has been subdivided into:
– Bipolar I requires the presence or history of at least one manic episode with
or without major depressive episodes.
– Bipolar II consists alternating episodes of major depression and hypoma-
nia. In this type of disorder, the “manic” moods never reach full mania.
The less-intense elevated moods in bipolar II disorder are called hypomanic
episodes, or hypomania.
– Cyclothymia is a mild-form of bipolar disorder, consisting of less severe
mood swings. Episodes alternate between hypomania and mild depression,
but no full manic episodes or full major depressive episodes.
– Mixed episode is the simultaneous presence of elements of the manic line
and clinical elements of depressive line during a single episode.
1.2 Neurobiology of depression
The pathophysiology of depression has not been clearly understood, but so-
cial, psychological, and biological factors all play an important role in depression
[Goldman 1999]. Previous studies point out evidences that there is an association
of speciﬁc symptoms and features of depression and dysfunction or deﬁcit of cer-
tain neurotransmitters [Nutt 2008]. One of the oldest hypothesis, the monoamine
4 Chapter 1. Depression
hypothesis, suggests disturbances in serotonin (5-HT), norepinephrine (NE), and
dopamine (DA) neurotransmission in the central nervous system [Belmaker 2008,
Krishnan 2008]. Hence, reduced NE neurotransmission is associated with low en-
ergy, decreased alertness, problems with concentration and cognitive ability. Lack-
oﬀ 5-HT is related to anxiety, obsessions and compulsions, while increased 5-HT
activity can be associated with certain symptoms such as fatigue [Marin 2005]. Dys-
functional DA activity is linked with problems of motivation, reward, psychomo-
tor speed, concentration and the ability to experience pleasure and interest in life
[Cowen 2008]. The role of NE [Delgado 2000, Nutt 2008] and DA [Dunlop 2007,
Montgomery 2008] has been less extensively studied, than 5-HT role.
This suggests that speciﬁc antidepressant drugs can target symptom-speciﬁc
neurotransmitters, because speciﬁc symptoms of depression could be assigned to
speciﬁc neurochemical mechanisms. Nowadays, all available antidepressants act on
one or more of the following mechanisms: antagonism of inhibitory presynaptic 5-
HT or NE receptors, or inhibition of monoamine oxidase, or inhibition of reuptake
of DA and 5-HT or NE. All of these mechanisms result in an enhanced neuro-
transmission of 5-HT and/or NE. However, most antidepressant treatments do not
directly enhance DA neurotransmission.
Abnormal metabolism in limbic and paralimbic structures of the prefrontal cor-
tex is associated with major depression. Patients with MDD have diﬀerent symp-
toms of depression, which implies that they may all have diﬀerent malfunctioning
circuits. According to Stahl [Stahl 2003b, Stahl 2003a, Stahl 2003c, Stahl 2004],
it is interesting to look at the brain neuroanatomy in terms of speciﬁc functional
centers. The “emotional” and “somatic” networks receive input from both, NE and
5-HT, as well as DA systems. On the other hand, the “cognitive” centers receive in-
formation only from NE, DA and histaminergic pathways, but not 5-HT projections
(Table 1.1).
1.2.1 Dopaminergic pathways
In the brain, dopamine plays an important role in the regulation of reward
and movement. Dopaminergic neurons are organized into four major DA pathways
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Table 1.1: Neurological projections of DA, NE and 5-HT to different brain regions [Drevets 2002].
Emotional systems
NE projections from the locus coeruleus to the hypothalamus
NE projections from the locus coeruleus to the amygdala and prefrontal cortex
5-HT projections from the midbrain raphe to the hypothalamus
5-HT projections from the midbrain raphe to the amygdala and prefrontal cortex
DA projections from the ventral tegmentum to the nucleus accumbens
Somatic systems
NE projections from the locus coeruleus to the hypothalamus
NE projections from the locus coeruleus to the cerebellum
NE projections from the locus coeruleus to the spinal cord
5-HT projections from the midbrain raphe to the hypothalamus
5-HT projections from the midbrain raphe to the striatum
5-HT projections from the midbrain raphe to the spinal cord
DA projections from the substantia nigra to the striatum
Cognitive systems
NE projections from the locus coeruleus to the dorsolateral prefrontal cortex
DA projections from the ventral tegmentum to the dorsolateral prefrontal cortex
Histamine projections from the hypothalamus to the dorsolateral prefrontal cortex
depicted in Figure 1.1 [Dunlop 2007, Schatzberg 2004]:
1. The nigrostriatal system, which is linked with regulation of movement, origi-
nates in substantia nigra pars compacta and projects to the dorsal striatum
(putamen and caudate).
2. The mesocortical system is important for concentration and executive func-
tions such as working memory. This DA pathway originates in the VTA and
its ﬁbers arise to the frontal and temporal cortices, particularly the entorhinal,
prefrontal and anterior cingulate cortices.
3. The mesolimbic system is particularly important for motivation, the experi-
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ence of pleasure and reward. It also arises in VTA, but release dopamine into
the ventral striatum, nucleus accumbens, bed nucleus of the stria terminalis,
hippocampus, amygdala and septum.
4. The tuberoinfundibular system regulates the secretion of prolactin from the
anterior pituitary. It originates in the arcuate nucleus of the mediobasal
hypothalamus that projects to the median eminence.
Figure 1.1: Major dopaminergic pathways in the human brain [Dunlop 2007, Schatzberg 2004]
1.2.2 Norepinephrine pathways
The recent studies [Cowen 2008, Moret 2011] on depression and neuronal path-
ways indicated the speciﬁc role of the norepinephrine in the depressive disorders.
Norepinephrine (NE) implicates the regularization of emotions and regulates such
executive function as cognition, motivation, and intellect, which are fundamen-
tal in social relationships. Norepinephrine is produced in the cell bodies of the
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locus coeruleus (LC) and reaches to a variety of diﬀerent structures, such as cere-
bral cortex, thalamus, cerebellar cortex, hippocampus, hypothalamus and amygdala
[Moret 2011]. Components of the limbic system (hippocampus, hypothalamus and
amygdala) are aﬀected in a number of functions which are modiﬁed in depression
such as emotion and cognition, response to pain, level of pleasure, appetite, sex-
ual satisfaction and aggressive behaviour [Drevets 2002]. Figure 1.2 illustrates the
noradrenergic projections throughout the brain.
Figure 1.2: The noradrenergic pathways in the human brain [Moret 2011, Schatzberg 2004]
1.2.3 Serotonin pathways
Serotonin (5-HT) is a neurotransmitter derived enzymatically from tryptophan
and produced in neurons of the rostral and caudal raphe nuclei. Projections aris-
ing from the raphe nuclei are widespread and stimulate many of forebrain struc-
tures including the hypothalamus, amygdala, basal ganglia, thalamus, hippocam-
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pus, cingulate cortex and prefrontal cortex. The serotoninergic system controls
numerous physiological and behavioural functions. It also modulates mood, emo-
tions, sleep, appetite, memory and learning, temperature regulation and some so-
cial behaviors. The 5-HT hypothesis of depression proposes that decreased sero-
toninergic neurotransmission plays a key role in the pathophysiology of depres-
sion. The concentration of synaptic serotonin is controlled directly by its reuptake
into the pre-synaptic terminal and, thus, drugs blocking serotonin transport have
been successfully used for the treatment of depression [Coppen 1967, Cowen 2008,
Schatzberg 2004, Schloss 1998]. Figure 1.3 illustrates the major serotonin-producing
structures.
Figure 1.3: The serotonergic pathways in the human brain [Schatzberg 2004]
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1.2.4 Glutamate pathways
The most popular monoamine theory of the pathophysiology of major depres-
sion and bipolar illness has involved abnormalities in NE and 5-HT and contributed
greatly to our understanding of mood disorders and their treatment. Neverthe-
less, this theory does not fully explain the fact that >40% patients fail to achieve
full remission following treatment with conventional antidepressants, raising the
possibility that other neurotransmitter systems may also contribute to the patho-
physiology of mood disorders and the mechanism of antidepressant action. Recent
studies have provided strong evidence that glutamate and other amino acid neuro-
transmitters are involved in the pathophysiology and treatment of mood disorders
[Kugaya 2005].
The end of this section reviews studies suggesting that the glutamatergic and
gamma-aminobutyric acid (GABA)-ergic systems are altered in mood disorders
and contribute to the mechanism of antidepressant action for several treatment
modalities.
Glutamate is the major excitatory neurotransmitter which plays a key role in
synaptic plasticity, learning and memory. Eﬀects of action are mediated by a large
variety of glutamate receptor subtypes which include three major groups of excita-
tory ionotropic receptors: N-methyl-D-aspartate (NMDA) receptor, the α-amino-
-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor, and the kainate
receptor.
Alterations of the glutamatergic system in mood regulation has been investi-
gated for several years. Early studies measuring plasma or serum glutamate lev-
els in depressed patients yielded interesting but inconsistent results. Increased
serum glutamate concentrations in medicated patients was ﬁrst reported in the
research of Kim and colleagues [Kim 1982]. Then, Altamura obtained the same
results, but this group was later unable to replicate this ﬁnding in unmedicated pa-
tients [Altamura 1993]. Next, Maes and colleagues [Maes 1998] also showed elevated
plasma and platelet glutamate levels in depressed subjects. However, in contrast
to the previous studies, they found no baseline abnormality in serum glutamate
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levels, but did report that glutamate levels were reduced after antidepressant treat-
ment. Other studies revealed no signiﬁcant diﬀerence in frontal cortex glutamate
levels of antemortem glutamate in neurosurgical samples from depressed subjects
[Francis 1989].
A recent study by Sanacora and colleagues [Sanacora 2004] showed glutamate
levels in the occipital cortex to be signiﬁcantly elevated, in medication-free pa-
tients with MDD, as compared with healthy controls. Another interesting point of
this study is that the glutamate levels were signiﬁcantly increased in patients with
melancholic depression subtype than those with no subtype as compared with con-
trols. However, patients with atypical depression did not have signiﬁcantly diﬀerent
glutamate levels than controls. The glutamate levels were inversely correlated with
GABA levels in studied occipital cortex.
1.2.5 Gamma-aminobutyric acid pathways
Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter
in the central nervous system (CNS). In recent decades alteration of GABAergic
neurotransmission in mood disorders has been widely studied.
In 1980 Gold et al. [Gold 1980] revealed that GABA concentrations in lumbar
cerebrospinal ﬂuid (CSF) in depressed patients were signiﬁcantly decreased compar-
ing to nondepressed control group, and since then the results have been replicated in
several studies. Petty and coworkers [Petty 1981, Petty 1984] showed that GABA
plasma concentrations were reduced in depressed patients as well. Moreover, Honig
et al. [Honig 1988] reported that GABA concentrations in brain tissue from pa-
tients undergoing cingulotomy for intractable depression were inversely correlated
with severity of depression.
More recent studies employing magnetic resonance spectroscopy also suggest
that unipolar, but not bipolar, depression is associated with reductions in cortical
GABA levels. Sanacora and colleagues [Sanacora 1999, Sanacora 2004], addition-
ally, found reduction in cortical GABA levels in patients with melancholic subtype
of depression, with the ratio of glutamate to GABA signiﬁcantly higher in the pa-
tients than the controls. This ﬁnding suggests a potential alteration in the common
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metabolic pathway that couples the two systems of glutamate and GABA.
1.3 Neurocognitive models of depression
In the following sections I will describe recent studies on the functional and
structural neurobiological mechanisms associated with depression.
1.3.1 Neural mechanisms of biased attention for emotional stimuli
The main point of the cognitive model of depression is the inability to allocate
attention to appropriate emotional cues [Disner 2011]. Attention towards positive
and negative stimuli is diﬀerent between healthy and depressed subjects. On con-
trary to healthy individuals whose attention is generally biased towards positive
stimuli, depressed patients show an attentional bias for negative thoughts.
The intraparietal sulcus, precentral sulcus, superior temporal sulcus, prefrontal
cortex (PFC) and areas which control shifts in gaze are associated with attention in
healthy individuals. These areas help to select competing visual stimuli represented
in the visual cortex and healthy subjects are able to switch attention from one to
another stimuli. As functional magnetic resonance imaging (fMRI) studies revealed
the act of attentional disengagement requires top-down connection from high-order
cortical structures such as dorsolateral prefrontal cortex (DLPFC) (related to exec-
utive functions), ventrolateral prefrontal cortex (VLPFC) (related to control over
stimulus selection) and superior parietal cortex (SPC) (associated with shifts in
gaze) [Fales 2008, Passarotti 2009, Beevers 2010]. Increased attention for negative
stimuli in people with depression may stem from an impaired ability to inhibit at-
tention for negative stimuli, which is related to decreased activity in right VLPFC,
DLPFC and SPC. Functional MRI results indicated that inhibitory processing is
associated with activity in the rostral anterior cingulate cortex (rACC) [Bush 2000,
Shafritz 2006]. Healthy subjects showed higher rACC activity inhibiting attention
to positive stimuli, whereas depressed patients showed greater activation inhibiting
negative thoughts [Disner 2011, Elliott 2002, Eugene 2010, Mitterschiﬀthaler 2008].
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1.3.2 Neural mechanisms of biased processing of emotional stimuli
The amygdala is known to be involved in the processing of emotions and in
the interpretation of the emotional aspect of stimuli. According to Davidson and
Drevets [Davidson 2000, Drevets 2001] it is controlled partially by indirect inhibitory
connection from the left DLPFC (Figure 1.4). In depressed patients hyperactivity of
left amygdala and putamen is associated with faster processing of negative stimuli.
This reactivity creates a bottom-up connection which distorts stimulus processing
in higher cortical areas.
Recent neuroimaging studies identiﬁed functional abnormalities also in the
DLPFC. Compared with nondepressed human being, patients with depression
have decreased left prefrontal gray matter volume [Li 2010, Lopez-Larson 2002,
Adler 2005], lower resting-state activity and reduced reactivity for positive and
negative stimuli [Gotlib 2008]. Moreover, altered function in the DLPFC is cor-
related with decreased cognitive control [Disner 2011, Gotlib 2008, Hooley 2005,
Schaefer 2006, Siegle 2002]. Abnormalities in negative emotional information pro-
cessing are caused, in addition, by abnormalities in the thalamocortical pathway,
which is responsible for processing and organizing external stimuli [LeDoux 1996,
Greicius 2007]. This pathway is composed of the thalamus, involved in transmit-
ting the aﬀerent signals [Guillery 1995, Sherman 2002], the dorsal anterior cingu-
late cortex (ACC), an area that sends top-down cognitive control to the DLPFC
[Ochsner 2005], and the subgenual cingulate cortex, a region that integrates emo-
tional feedback from the limbic system and projects to higher-order cognitive struc-
tures (Figure 1.4) [Greicius 2007].
Discussed researches indicated that people with depression experience a positive
blockage, which means that the capacity to process positive thoughts is decreased,
whereas it is increased for negative ones. Moreover, it was shown in previous stud-
ies [Arco 2008, Kim 2007, Wager 2008] that in healthy individuals the PFC regu-
lates the activity of the nucleus accumbens (NAc) and amygdala, and in particular
the release of dopamine in this area of the brain. In depressed patients, reduced
NAc responses to rewards are associated with diminished volume and activity in
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the caudate nucleus. This suggests that rewarding properties associated with a
stimulus may not be accurately classiﬁed [Disner 2011, Epstein 2006, Heller 2009,
Pizzagalli 2009]. As a result, positive stimuli may fail to activate reinforcement
mechanisms, which could reduce the ability of depressed patients to pursue re-
warding behaviours [Disner 2011]. Based on this evidence, Disner and colleagues
[Disner 2011] suggested, that the inability of depressed human being to adaptively
alter reward-seeking behaviour is associated with reduced reward sensitivity of the
NAc due to decreased PFC activity.
To conclude, there are several mechanisms which increase the projection of nega-
tive thoughts and decrease the positive or rewarding stimuli (Figure 1.4). They are:
amygdala hyperactivity, hypoactivity in the DLPFC and attenuated NAc response.
Figure 1.4: Hypothetical cognitive neurobiological model of biased processing of negative stimuli
in depressed human beings. Negative input stimulus induce hyperactivity (orange) in the thalamus,
from the thalamus to the amygdala and onto the subgenual cingulate cortex, which transmits limbic
activity to higher cortical regions such as the PFC. Concurrently, hypoactivity (blue) in the DLPFC
is associated with attenuated cognitive control, which impairs the ability of the dACC to adaptively
regulate the lower regions. As result, awareness and conscious processing of negative stimuli in the
environment is increased. Solid arrows (which show intact associations) and dashed arrows (which
show attenuated associations) are intended to represent functional connections, not necessarily
direct anatomical connections. Thicker arrows show increased information flow. [Disner 2011]
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Figure 1.5: Summary of an integrated cognitive neurobiological model of depression. (ACC -
anterior cingulate cortex; DLPFC - dorsolateral prefrontal cortex; MPFC - medial prefrontal cortex;
NAc - nucleus accumbens; PFC - prefrontal cortex; SPC - superior parietal cortex) [Disner 2011].
1.3.3 Integrated neurocognitive model
Neurobiological processes that initiate cognitive bias and attenuated cognitive
control, also underly cognitive biases in depression. Figure 1.5 presents the ﬂowchart
of the sequence of events that are proposed to be involved in the development of
depression, beginning with depression vulnerability factors and environmental stres-
sors, and resulting in depressive symptoms. Figure 1.5 outlines the neurobiological
events that are associated with each step of the cognitive model: schema activa-
tion, biased attention, biased processing, and biased memory and rumination. The
brain regions in this ﬂowchart are divided into two groups: regions associated with
bottom-up, limbic system inﬂuences (shown by the blue boxes), and regions that
maintain bottom-up inﬂuences through altered top-down cognitive control (shown
by the grey boxes). Note that all elements contribute directly to depressive symp-
toms, and that depressive symptoms also feed back into the system, thus exacer-
bating schema activation [Disner 2011].
Re´sume´ du Chapitre 2
Le chapitre suivant repre´sente une introduction a` l’e´lectroence´phalographie,
c’est-a`-dire a` une description ge´ne´rale de l’activite´ neuronale, de la ge´ne´ration des
signaux e´lectriques dans le cerveau ainsi que de la mesure des signaux EEG. Je
de´ﬁnirai e´galement les diﬀe´rentes ondes ce´re´brales, qui sont un concept important
de l’analyse EEG. Enﬁn, des me´thodes plus avance´es telles que l’EEG quantita-
tive et la localisation de la source ainsi qu’une description ge´ne´rale des proble`mes
forward et inverse seront pre´sente´es.
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2.1 Introduction
In 1875, Richard Caton discovered brain electrical activity in the animals, but
the history of human electroencephalography (EEG) began only in the late 1920s,
when the ﬁrst EEG recordings from the human scalp were obtained by the German
psychiatrist Hans Berger [Berger 1929]. Berger recorded mostly from his children,
showing that human brain normally produces near-sinusoidal voltage oscillations
(alpha rhythms) in awake, relaxed subjects with eyes closed. Strong reduction in
alpha amplitude during eyes opening or performing mental calculation has been
veriﬁed by modern studies. Unfortunately, Berger’s research waited more than 10
years to be accepted by the scientiﬁc community as validated brain signals. By
the 1950s, EEG technology was viewed as a genuine technique, with important
applications in neurosurgery, neurology, and cognitive science.
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2.2 Neural activity
The electrical signals generated by the brain represent a part of its physiologi-
cal activities. The neural activity of the human brain starts around the 17th and
23rd week of prenatal development [Sanei 2007]. Understanding of neurophysiolog-
ical properties of the brain with mechanisms underlying the generation of electrical
signals and their recording is crucial for signal detection. The CNS contains a net-
work of specialized cells called neurons that coordinate the actions of a subject and
transmit signals between diﬀerent parts of its body. A typical neuron is composed
of an axon, dendrites and synapses. Its morphology is presented in Figure 2.1.
Figure 2.1: Diagram of a typical myelinated neuron [Wikipedia 2012].
To fully understand what EEG measures, I will explain some general deﬁnitions:
– A synapse is a structure that permits a neuron to pass an electrical or chemical
signal to another neuron.
– Neurotransmitters are chemical molecules that transmit signals from the presy-
naptic neuron to a postsynaptic target cell across a synapse.
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– Postsynaptic neuron is the target neuron of the opposite side of the synapse.
– An action potential (AP) is a discharge of the neuron that is associated with
fast (around millisecond) opening and closing of Na+ and K+ ion channels
in the neuronal membrane of the axon. The discharge takes place if depolar-
ization of the membrane reaches a ﬁring threshold. The action potential is
considered as the simplest event of information processing in neuronal net-
works associated with transfer of information from one neuron to others.
– Postsynaptic potential (PSP) is a change in the membrane potential of the
postsynaptic neuron induced by a presynaptic AP. When the opening of ion
channel causes a positive charge across the membrane, the membrane is said
to be depolarized, as the potential comes closer to zero. This is an excitatory
postsynaptic potential (EPSP), as it brings the neuron’s potential closer to
its ﬁring threshold, about -50 mV. On the other hand, if the opening of the
ion channel builds negative charge, this moves the potential further from zero
and is referred to as hyperpolarization. This is an inhibitory postsynaptic
potential (IPSP), as it changes the charge across the membrane to be further
from the ﬁring threshold.
2.2.1 Cortical cytoarchitecture
The neocortex is described as a six-layer structure [DeFelipe 2002]. Smooth and
spiny neurons (pyramidal cells and spiny stellate cells) are the two major groups
of cortical neurons. The pyramidal cells are the majority of cortical neurons that
can be found in layers II and VI. Most spiny stellate cells are interneurons that are
localized in the middle cortical layers. Smooth neurons are substantially GABAergic
interneurons allocated in all layers. In general, it is believed that neocortical neurons
are organized into multiple, small repeating microcircuits, based around pyramidal
cells and their input-output connections. Despite of the cortical heterogeneity, a
common basic microcircuit has evolved. The pyramidal cells form its skeleton.
They receive excitatory inputs originate from extrinsic aﬀerent systems and spiny
cells. Inhibitory inputs originate mostly from GABAergic interneurons. These
micro-anatomical characteristics have been found in all cortical areas and can be
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considered as the fundamental aspects of cortical organisation [DeFelipe 2002].
2.3 EEG Generation
The EEG signal is a sum of the collective electrical behaviour of vertically ori-
ented pyramidal neurons located mainly in cortical layers III, V, and VI (Figure
2.2). Layers of cortical neurons are the main source of the EEG. Diﬀerences of
electrical potentials are caused by summed postsynaptic graded potentials from
pyramidal cells that create electrical dipoles between the soma (body of a neuron)
and apical dendrites, which branch from neurons (Figure 2.3). The dipoles are
induced by local currents that are associated with excitatory and inhibitory post-
synaptic potentials. Generally, EEG can be modelled as being generated by small
current dipoles, located in the grey matter [Friston 2007].
2.3.1 EEG
EEG is a very important clinical tool to study brain activity, in normal or patho-
logical conditions like: mental diseases and retardation, epilepsy, brain tumors,
strokes, infectious diseases, severe head injury, drug overdose, sleep and metabolic
disorders, and ultimately brain death.
EEG measures the electrical activity along the scalp, that is voltage ﬂuctuations
resulting from ionic current ﬂows within the neurons of the brain. Scalp electrodes
are more sensitive to the activation of cortical sources, close to scalp electrodes,
while the activation of deep sources is attenuated by layers including the scalp,
skull, brain and many other thin layers in between. Furthermore, the waveforms
that are recorded from the scalp represent summed activity from large populations
of neurons. This is because the electric ﬁeld of each active source of the brain
spreads in all directions and is registered in every electrode. Thus, EEG has lim-
ited anatomical speciﬁcity (spatial resolution) when compared with other functional
brain imaging techniques such as fMRI. However, EEG is still a very good tool to
explore brain activity. First of all, time resolution is much higher than in other
methods, such as fMRI or positron emission tomography (PET), and reaches mil-
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Figure 2.2: Organization of the neocortex in 6 layers [Pernet 2012].
liseconds. Additionally, EEG is one of the few methods (with magnetoencephalog-
raphy (MEG) or voltage-sensitive dye imaging (VSDI)) able to measure the electric
activity of the brain. Other methods for exploring functions in the brain rely on
blood ﬂow, blood volume or metabolism which may be decoupled from the brain
electric activity. Some researches combine EEG or MEG with fMRI or PET to get
high temporal and spatial resolution. Another huge advantage of EEG is its low
price.
The recordings can be varied so that the potential diﬀerence is measured either
between pairs of electrodes (bipolar derivation) or between individual electrodes and
a common reference point (referential montage). Because the amplitude of electrical
signal of the brain is very weak (up to 100 µV), the signal must be ampliﬁed before
being displayed. The scheme of electrodes position in the International 10-20 System
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Figure 2.3: Micro current sources due to synaptic and action potentials [Nunez 2006].
is depicted in Figure 2.4. The more detailed technical and practical aspects of EEG
techniques are beyond the scope of this work. It can be found in numerous literature
[Nunez 2006, Sanei 2007, Tatum 2008].
A lot of brain dysfunctions are diagnosed by visual inspection of EEG signals. In
healthy adults, the frequencies and amplitudes of brain waves change from one state
to another, such as wakefulness and sleep. Moreover, it can slightly diﬀer between
two human beings in the same state of mind. Moreover, the characteristics of brain
oscillations also change with the age. Nevertheless, brain oscillations have been
divided into ﬁve major brain waves distinguished by their diﬀerent frequency range,
as follows: delta (δ, 0.5-4 Hz), theta (θ, 4-7 Hz), alpha (α, 8-13 Hz), beta (β, 13-30
Hz) and gamma (γ, above 30 Hz). The alpha and beta waves were introduced by
Berger in 1929 [Berger 1929]. In 1938 Jasper and Andrews used for the ﬁrst time the
“gamma” to refer to the waves above 30 Hz [Jasper 1958]. Walter introduced delta
range in 1936 to describe all frequencies below alpha rhythm [Walter 1964]. The
notion of a theta wave was introduced by Wolter and Dovey in 1944 [Sterman 1974].
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Figure 2.4: Typical scalp EEG electrodes’ placement in the 10-20 system [Augustyniak 2001].
2.3.2 Brain waves
Delta waves
Delta waves (0.5-4 Hz) can be presented in the awake state, but they are pri-
marily associated with deep sleep. It is very easy to confuse the genuine delta with
artefact signals caused by large groups of muscles of the neck and jaw, or by eye-
movement. However, by applying signal analysis (such as independent component
analysis (ICA)), it is possible to distinguish the origin of the signal [Sanei 2007].
Theta waves
Theta waves (4-7 Hz) were ﬁrst presumed to have a thalamic origin and the
term “theta” might refer to it. Theta oscillations appear when wakefulness slips
towards drowsiness and is also related to the level of arousal. Moreover, these
waves are associated with states of rapid eye movement (REM) sleep, hypnosis,
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lucid dreaming, creative inspiration and deep meditation. Cortical theta is observed
frequently in young children. In older children and adults, large contingents of theta
waves in awake and during the deepest stages of sleep are caused by several brain
pathologies [Sanei 2007].
Alpha waves
Alpha waves (8-13 Hz) can be detected bilaterally in all posterior lobes. It is
usually found over the occipital part of the brain, where the amplitude is higher
than in other regions and is normally less than 50 µV. Alpha waves indicate wake-
ful relaxation with closed eyes, but they are suppressed by eye opening, visual
stimuli and visual scanning, drowsiness and sleep. This type of alpha oscillations
normally appears at age 4 months, initially with 4 waves per second. With the
brain development alpha reaches 10 Hz, and is established around age 3 years
[Kolev 1994, Niedermeyer 1997]. There are also other alpha variants, like: fast-
alpha or alpha-delta (slow-wave, SWS) state spreading across the brain in an
anterior-posterior gradient [Pivik 1995].
Interestingly, according to a recent study, alpha oscillations are enhanced during
internal tasks, such as mental calculation and working memory [Palva 2007]. Recent
research of alpha-amplitude and phase dynamic suggested a direct and active role for
alpha-frequency band rhythmicity in the mechanisms of attention and consciousness
[Palva 2007].
Mu waves
Mu waves (encompassed in the alpha range 8-12 Hz) can be found in primary
sensory or motor cortical areas when they are not processing sensory information or
producing motor output. It is strongly suppressed during the execution of contra-
lateral motor acts, the thought of a movement, or tactile stimulation [Cochin 1998,
Pfurtscheller 2006]. Mu rhythm is thought to be produced by interactions between
the thalamus and the cortex. Additionally, mu wave is most often asymmetric and
asynchronous between the 2 sides and may be also unilateral [McFarland 2000]. It
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has low to medium amplitude and comparable to that of the alpha rhythm. In
contrary to alpha wave, it does not react to eye opening and closing.
Beta waves
Beta waves (13-30 Hz) are detected mostly over the frontal and central regions
of the brain in normal adults. It appears during waking state and is associated
with active thinking and attention, concentration or solving certain problem. Im-
portantly, a central beta rhythm is related to the rolandic mu wave and can be
blocked by motor activity or tactile stimulation. The amplitude of beta rhythm
is normally under 30 µV. Interestingly, the beta wave may be enhanced around
tumoural regions [Sanei 2007].
Gamma waves
Theoretical and experimental work suggests that gamma waves (30-100 Hz) are
related with sensory processing [Jensen 2007]. They also have an important role in
attention and both working and long-term memory. In recent years, intracranial and
high-density EEG and MEG recordings allowed to study gamma band synchroniza-
tion during various cognitive functions in humans [Kaiser 2003, Herrmann 2004] and
in relation to psychiatric and neurological dysfunctions [Quyen 2006, Uhlhaas 2006].
The gamma oscillations, which have a crucial role in synaptic plasticity and neuronal
communication, allow to develop models of the neuronal processing in local and dis-
tributed cortical networks engaged in complex cognitive functions [Jensen 2007].
2.4 Source localisation
For many years, researchers have been interested in the source reconstruction
of M/EEG recordings. In this section I will focus on forward models which relate
electrical measurements M to neural activity J.
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2.4.1 Forward problem
The ﬁrst step of source localisation entails modelling of the brain electrical
activity (in case of EEG signal) and head volume conduction. This step is called
Forward Problem and its output is called the gain matrix. Each column of
the gain matrix represents a surface potential, linking the scalp recordings with the
cortical source corresponding to the column. To be able to do that, it is necessary to
model the conductivity and the geometry of the head, which is further explained in
section 2.4.1.1. The main assumption of the source model is that the neighbouring
pyramidal cells (current sources) which are parallel to each other and perpendicular
to the cortical surface, are the EEG generators [David 2002].
Given the three spatial coordinates (x,y,z), orientation angles (θ, φ) and strength
(d) of N sources, T time samples of EEG data measured with S electrodes the model
for distributed sources is described by the following linear equation:
M = GJ + E (2.1)
where M is a S × T matrix of measured EEG signal, G is a S × N gain matrix
representing a scalp potential, J is a N × T matrix representing an activity of
cortical sources, and E is a S × T matrix representing noise [David 2002].
To solve the forward model, ﬁrst, it is necessary to understand the nature of
neuronal activity and cerebral anatomy, and that lead to the head model. The
generation of neural activity has already been described in section 2.3, so further I
will focus on the head models.
2.4.1.1 Head models
The forward problem is to solve Maxwell’s equations describing the electromag-
netic ﬁeld produced by neural activity. The diﬃculty of forward model computation
lies in modelling the volume conductor, a human head, and the sources, the neuronal
activity of the brain. The structure of the head and the brain is very complicated.
The brain is surrounded by meninges and the CSF. The head comprises various
organs and tissues (skull, scalp, eyes, vessels, nerves, CSF, etc.). The brain tis-
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sues have highly anisotropic electrical conductivity. For example the conductivity
of white matter is 10 times greater along an axon ﬁbre than in the transverse di-
rection [Malmivuo 1995], whereas skull’s conductivity is 15 times lower than skin’s
or cortex’ [Oostendorp 2000]. [Haueisen 1995] studied the inﬂuence of volume cur-
rents on the magnetic ﬁeld and found that “the computed magnetic ﬁeld of radial
sources varied signiﬁcantly with the conductivities of the surrounding tissues where
the dipole was located”. For this reason, the complications are generally ignored
and the head model often assumes that the head consists of concentric homogeneous
shells: the brain (comprising the white and grey matter), the CSF, the skull and
the scalp.
The standard spherical model was the ﬁrst and simplest model used in forward
model computations. The head is modelled as a set of concentric homogeneous and
spherical volume conductors: the brain, skull and scalp. Sphere-shaped models are
very fast in forward model estimation. They can be expressed in simple analytic
form, however it is a crude approximation of real geometry.
Boundary element method (BEM), ﬁnite-element method (FEM) and ﬁnite dif-
ference method (FDM) algorithms allowed for more detailed and accurate for-
ward models. These algorithms reconstruct the realistic geometry of the head
and the brain, with all anatomical structures, using individual or standarized MRI
scans. The boundary element method BEM estimates the surface potential gen-
erated by current sources located in homogeneous tissues [Meijs 1987, Meijs 1989,
Hallez 2007]. The shape of the diﬀerent compartments of a volume conductor is
modeled by closed triangle meshes [Fuchs 2007]. In comparison to standard spheri-
cal models, the volume currents are more precisely taken into account [Vatta 2010].
Although, it uses only isotropic conductivities and lacks the capacity to accurately
represent the cortical structures (such as sulci and gyri) it remains to be widely used
because of its low computational needs [Hallez 2007]. Even better accuracy is pos-
sible when FDM or ﬁve or eleven tissue-type FEM models are used [Ramon 2006].
The summary of diﬀerent head models is presented on Figure 2.5. However I will
not focus on mathematical diﬀerences between all models, because it is beyond the
scope of this thesis.
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Figure 2.5: Summary of different head models. (A) The standard spherical model. (B) Real-
istic model with homogeneous layers computed with boundary element method (BEM). (C) Non
homogeneous realistic model estimated with finite elements methods (FEM) or finite differences
methods (FDM).
Once the forward problem is solved the inverse problem can be estimated from
acquired EEG signals. The Inverse Problem describes the opposite situation:
having the electric ﬁeld at the scalp and the gain matrix, the aim is to estimate the
time course of the sources. Figure 2.6 depicts a schematic representation of forward
and inverse problems.
Figure 2.6: Schematic representation of forward and inverse problems.
2.4.2 Inverse problem
The inverse problem is an estimation Jˆ of sources J that generate the measured
EEG (or MEG) data M. This model can be described by the following equation:
Jˆ = f(G,M) (2.2)
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where J is a matrix of estimated current density obtained from measured data M
and G is the gain matrix. In other words, the aim is to reconstruct the under-
lying current distribution in the cortex using potential diﬀerences which are mea-
sured non-invasively from the head surface [Wolters 2004]. Unfortunately, EEG
source localisation is an ill-posed inverse problem, because the number of esti-
mated sources (>>1000) is higher than the number of electrodes (<300), and in
the absence of constraints, the solution is non-unique and unstable. Although the
number of parameters can be reduced, if some constraints are placed on the sources
[Phillips 2001, Friston 2007, Grech 2008]. Many diﬀerent sources conﬁgurations can
still generate the same distribution of potentials (or magnetic ﬁelds in MEG) on
the scalp [Helmholtz 1853, Fender 1987].
Over the years, a number of various techniques have been developed to solve
the inverse model for EEG source localisation. These approaches can be divided
into two categories: parametric and non parametric. Non parametric methods are
also named as Distributed Source Models, distributed inverse solutions (DIS) or
imaging methods.
The parametric technique estimates the dipole parameters of an a priori de-
termined number of dipoles, whereas in the non parametric several dipole sources
with ﬁxed locations and possibly ﬁxed orientations are distributed in the brain vol-
ume or cortical surface [Grech 2008]. As it must be assumed that cortical pyrami-
dal neurons are normally oriented to the cortical surface, ﬁxed orientation dipoles
are set to be perpendicularly aligned. Then, the amplitudes of current sources
are estimated. Since the dipole location is not assessed, these methods present
a linear problem which can be solved by various methods, including: minimum
norm estimator (MNE) [Ha¨ma¨la¨inen 1994], low resolution electrical tomography
(LORETA) [Pascual-Marqui 1994], standardized low resolution brain electromag-
netic tomography (sLORETA) [Pascual-Marqui 2002], multiple sparse priors (MSP)
[Friston 2008], local autoregressive average (LAURA) [Menendez 2004] and many
others [Grech 2008]. However, the aim of this project was not to describe all pos-
sible source localisation methods, so in next paragraphs I will focus only on MNE
used in this work.
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Minimum Norm Estimates
According to Ha¨ma¨la¨inen and Ilmoniemi [Ha¨ma¨la¨inen 1994], minimum norm
estimators (MNE) are the best estimates for the currents in the absence of any
a priori information. MN estimates are generally based on the assumption that
the current distribution should have minimum overall power (the smallest L2-
norm). The estimate JˆM of J can be then written as [Dale 1993, Ha¨ma¨la¨inen 1994,
Pascual-Marqui 1999, Michel 2004]:
JˆM = GT (GGT + λI)−1M (2.3)
where I is the identity matrix. The relative weight of the prior term are modu-
lated by the positive hyperparameter λ. On the one hand, this method gives unique
solution, where only one combination of current sources can exactly ﬁt the data and
have the lowest overall intensity. But on the other, it is considered to produce quite
poor estimation of the true source locations [Michel 2004, Grech 2008]. However it
remains the most used approach.
In the following section 5.1.5 the independent and identically distributed (IID)
model (corresponds to the MNE) from SPM8 toolbox was used to solve the inverse
problem.
Re´sume´ du Chapitre 3
Dans ce chapitre, je pre´senterai la stimulation magne´tique transcranienne.
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3.1 Introduction
Transcranial magnetic stimulation (TMS) is a non-invasive technique for stim-
ulating the brain. A brief electric current passing through a magnetic coil produces
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a brief, high-intensity magnetic ﬁeld which stimulates the brain. The ﬁeld can ex-
cite or inhibit a small brain area below the coil. Although the stimulation can be
applied over any part of the brain, most of the studies focused on the motor cortex
where a focal muscle twitch can be produced, associated with a motor evoked po-
tential (MEP). The ﬁrst successful TMS study was performed in 1985 by Anthony
Barker and colleagues [Barker 1985]. Its earliest application investigated nervous
propagation along the cortico-spinal tract, spinal roots, and peripheral muscles in
humans [Rossini 2007]. In addition, TMS can be used to map brain function and
explore the excitability of diﬀerent regions. Repetitive TMS, application of many
magnetic pulses, which is able to induce relatively long-lasting excitability changes,
is being developed for various therapeutic purposes.
3.2 Principles of magnetic stimulation
TMS follows the fundamental physical principles of electromagnetic induction.
A brief, high-intensity electrical pulse is produced in a coil and placed tangentially
to the scalp (see Figure 3.1). According to Lenz’s law, the ﬂow of the induced
current is parallel but in opposite direction to the current in the coil, whereas the
magnetic ﬁeld passes perpendicularly to the coil. The magnetic ﬁeld can reach up
to about 2 Tesla and typically lasts for about 100 ms. The electric ﬁeld can excite
neurons, but more important are the induced currents [Hallett 2000, Hallett 2007].
In a homogeneous medium, in this case the brain, changes of the electric ﬁeld
cause the current to ﬂow in loops parallel to the plane of the coil. The loops
with the strongest current are near the circumference of the coil. The current loops
become weak near the centre until disappearance at the centre of the coil. Neuronal
elements are activated by the induced electric ﬁeld. If the ﬁeld is parallel to the
neuronal element, then the ﬁeld is most eﬀective where the intensity changes as a
function of distance [Hallett 2000, Hallett 2007].
Magnetic coils may have diﬀerent shapes. A ﬁgure-of-eight, or butterﬂy coil,
can stimulate a relatively focal area, producing maximal current at the intersection
of the two round components (Figure 3.2 A), whereas the circular coil produces
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Figure 3.1: Illustration of direction of current flows in a TMS coil and the induced current in
the brain [Hallett 2000].
more diﬀuse magnetic ﬁeld (like it is shown on Figure 3.2 B).
Figure 3.2: Magnetic field generated by the different coils: (a) magnetic field by a figure-of-eight
coil and (b) magnetic field by a circular coil [Giordano 2012].
The ﬁgure-of-eight coil with the two components at an angle, called the cone-
shaped coil, increases the power at the intersection. Another conﬁguration is called
the H-coil (Figure 3.3), with complex windings that permit a slower fall-oﬀ of the
intensity of the magnetic ﬁeld with depth [Zangen 2005]. In another coil, called
iron-coil (Figure 3.4), the windings of the coil are around an iron core rather than
around the air. This focuses the ﬁeld and allows greater strength and depth of
penetration [Epstein 2002].
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Figure 3.3: Sketch of the H-coil version used in this study of Zangen and coworkers [Zangen 2005]
placed on a human head.
Recently Bijsterbosch and coworkers [Bijsterbosch 2012] additionally modeled
the TMS-induced electric ﬁeld for some common cortical and cerebellar targets.
Using an anatomically detailed and realistic head model, they were able to construct
the ﬁrst numerical and graphical atlas of TMS-induced electric ﬁelds for various coil
positions. Figure 3.5 depicts example of the TMS-induced electric ﬁeld distribution
on the gray matter surface in the right DLPFC.
Figure 3.4: Three-dimensional view
of the iron core and coil windings. Con-
centric ovals above the coil represent
isopotential contour lines for magnitude
of the induced electrical field in the
model head at a depth of 2 cm. The
peak field above the center point is 1.2
V/cm. From the outside in, contour
lines represent 0.6, 0.8, 0.9, 1.0, and 1.1
V/cm. Direction of the induced electri-
cal field is into the page [Epstein 2002].
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Figure 3.5: TMS-induced electric fields in the right DLPFC. The induced electric field strength is
shown on a rendered view of the gray matter surface in the full range (a) 0-100% of 804 V/m, and
in the threshold range (b) 50-100% of 804 V/m. The view is presented looking down the central
axis of the coil. The green concentric circles represent the geometry of individual coil turns that
were modelled. Note that some darkening of the cortical structure occurs at the centre of each coil
wing in a and b. This darkening is caused by local minima in the electric field results, which have
been used to illuminate and thus reveal the cortical structure. c, d Voxels with supra-threshold
electric field intensity induced in grey matter (in red) are shown on coronal slices through the peak
electric field (c) and through the local maximum of the cluster with the next highest electric field
strength (d). Grey matter is shown in grey and CSF is shown in cyan. The coordinates shown
are those of the peak electric field voxels in the relevant cluster (the coordinates and the units on
the axes are in Talairach space). We have chosen to show the figures such that they include the
whole head in order to facilitate localization and interpretation of the results. However, the high
resolution of the figures allows further inspection of finer details [Bijsterbosch 2012].
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3.3 Targeting rTMS and neuronavigation
Precise and consistent position and orientation of the TMS coil is crucial to
obtain reliable and reproducible results of stimulation [Mills 1992]. In 2001, Her-
wig with coworkers questioned previous method of coil placement [Herwig 2001a].
According to [Herwig 2001a] “to place the coil above Brodman area (BA) 9 and
46 as functionally relevant parts of the DLPFC, George et al. [George 1995] and
Pascual-Leone et al. [Pascual-Leone 1996] proposed a standard procedure, which
was then applied by nearly all investigators in this ﬁeld. First, the motor cortex
was localized by evoking a response of contralateral hand muscles, for instance,
the abductor pollicis brevis (APB) muscle. Then the coil was moved 5 cm ros-
trally, presumably targeting the DLPFC. The measure of 5 cm was derived from
the Talairach atlas [Talairach 1988, George 1995]”. Although this method is easy
and cheap to perform, it does not take into account any individual variations in
the brain size and anatomy, which changes the distance between motor areas and
the DLPFC. Based on their results, they introduced a neuronavigation system to
ensure consistency of coil placement. To date, most neuronavigation systems work
in cooperation with anatomical magneting resonanse imaging (MRI) to identify tar-
get areas and guide positioning of the TMS coil relative to anatomical or functional
landmarks [Sparing 2008, Julkunen 2009, Fleming 2012].
In general, the neuronavigation system allows the visualisation of the coil lo-
cation in relation to the brain in real time on a computer screen. The system
is based on frameless stereotaxy, thereby avoiding head ﬁxation [Herwig 2001a,
Herwig 2001b]. Coil and subject’s head are tracked by a high-resolution optical
tracking system build with CCD cameras and infrared transmitters (Figure 3.6 A).
The CCD camera can detect the position and orientation of reference markers in 3D
space. Three passive reﬂecting spheres are mounted on these markers on the sub-
ject’s head and on the magnetic coil (Figure 3.6 B and C). The reﬂections of infrared
beams are captured by the CCD camera, and the computer uses them to determine
the position of the markers in space. A referencing procedure using anatomic land-
marks is performed to coregister the head and the coil in the coordinate system of
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the MRI of the brain (Figure 3.6 D).
Figure 3.6: Neuronavigation system includes: A) CCD camera; B) Reflecting spheres placed on
reference markers which are mounted on the coil C) and the head; D) Scene representation in the
Localite Premium software used in this thesis.
3.4 Physiology of TMS-induced changes
Depending on the stimulation parameters, TMS is able to excitate or inhibit
brain activity. Stimulation can be delivered in single TMS pulse, in pairs of stimuli
separated by a variable interval (paired pulse - ppTMS), or in trains (repetitive
TMS - rTMS) [Rossi 2009]. Single pulse TMS is mostly used to map motor corti-
cal outputs and to study central motor conduction time with causal chronometry
in brain-behavior relations. When a single TMS pulse is applied over the motor
cortex at suﬃcient intensity, a peripheral MEP is elicited. The amplitude and
latencie of the MEP reﬂect the excitability of the stimulated area [Hallett 2007].
Paired pulse TMS can be delivered with one coil to a single cortical target or
to two diﬀerent brain regions using two diﬀerent and synchronised coils. Using
ppTMS it is possible to measure the intracortical facilitation and inhibition. rTMS
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is able to modulate and change activity beyond the stimulation time. Its thera-
peutic properties in patients with psychiatric and neurological disorders have been
shown [Robertson 2003, Hallett 2007, Ridding 2007]. However, by which mecha-
nisms rTMS inﬂuences the brain, causing these long-lasting eﬀects, remains un-
clear. A common hypothesis of these after-eﬀects implicates changes in synaptic
plasticity such as long-term depression (LTD)- or long-term potentiation (LTP)-like
[Hoogendam 2010].
3.4.1 Synaptic plasticity
According to Butler and Wolf, plasticity is the ability of the brain to reorganise
itself, enabling short- and long-term remodeling of neural communication that out-
lasts an experimental manipulation or period of training [Butler 2007]. Plasticity
occurs at various levels of brain organisation, from synaptic to structural modiﬁ-
cations. At ﬁrst, I describe the synaptic level, because the long-lasting eﬀects of
rTMS seem to arise from synaptic plasticity [Hallett 2000, Hallett 2007].
Long-term potentiation (LTP) of chemical synaptic transmission and the con-
verse process of long-term depression (LTD) have been the focus of an enormous
amount of investigation and are widely studied in a variety of species [Cooke 2006,
Hoogendam 2010]. Long-term potentiation is an increase in the synaptic strength
that could last for hours in vitro and for weeks or months in vivo. LTP can be in-
duced in experimental conditions as a result of brief high-frequency stimulation. In
the complementary process of LTD the eﬃcacy of synaptic transmission is reduced
[Duﬀau 2006].
LTP and LTD can be exploited to treat disorder and disease in the human CNS.
A variety of neurological conditions arise from lost or excessive synaptic drive due
to sensory deprivation during childhood, brain damage or disease. Manipulation of
synaptic strength using various stimulations may provide a means of normalising
synaptic strength and thereby ameliorating plasticity-related disorders of the CNS
[Bliss 2011].
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3.4.2 LTD and LTP
LTP
In 1973, Bliss and Gardner-Medwin observed an occurrence of LTP in vivo in
the hippocampus of anesthetised rabbits [Bliss 1973]. They described that high-
frequency stimuli trains (tetani) delivered to the axons of pyramidal cells in the
hippocampus led to a long-lasting increase in the amplitude of excitatory post-
synaptic potentials (EPSP). Crucial for the induction of LTP are the coincidence
between pre- and post-synaptic activity and a speciﬁc temporal relationship be-
tween these activities [Cooke 2006].
N-methyl-D-aspartate (NMDA) receptor, which is placed post-synaptically, seems
to be the cellular basis of synaptic potentiation. This receptor has an intrinsic cation
channel, which is blocked by magnesium ions when the cell is at its normal resting
membrane potential. The Mg2+ blockade can be released and the channel of the
NMDA receptor can be opened only when the post-synaptic neuron is suﬃciently
depolarized. As the result, LTP is induced by Ca2+ entering into the post-synaptic
cell [Cooke 2006, Hoogendam 2010]. This mechanism explains several features of
LTP, among which cooperativity and associativity.
Cooperativity can be observed when a crucial number of pre-synaptic neurons
must be simultaneously activated to elicit LTP. This suggests the presence of some
threshold for LTP induction, depending on the number of pulses, stimulus intensity
and the pattern of stimulation. Another key characteristic of LTP is associativity
closely related to cooperativity. Associativity ensures that a weak tetanus, which is
not by itself capable of initiating LTP, can become potentiated through association
with a strong tetanus [McNaughton 1978, Levy 1979, Barrionuevo 1983]. This can
be explained by the fact that weak stimulation means that the postsynaptic neuron
is not enough depolarized to expel Mg2+ from the NMDA receptor. In contrast,
strong activation in another pathway is able to depolarize this postsynaptic neuron
nevertheless, to open the NMDA receptor, and to induce LTP in both pathways
[Malenka 2003, Hoogendam 2010].
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LTD
The phenomenon opposite to LTP is LTD, in which synaptic strength is reduced
for a long period. In vitro, LTD is induced by low-frequency stimulation (1 Hz)
with long periods of stimulation (600-900 impulses). LTD can also be activated
when the stimulation of post-synaptic neuron is followed by the stimulation of the
pre-synaptic neuron within a speciﬁc window of tens of milliseconds [Bi 1998].
Like in LTP induction, NMDA receptors are also responsible for LTD induction.
The activation of the NMDA receptor leads to a rise of the postsynaptic Ca2+
concentration. The nature of the Ca2+ signal is crucial for determining whether
LTP or LTD arises. Small and slow rises in the calcium ion concentration induce
LTD, whereas large and fast lead to LTP [Hoogendam 2010].
STDP
In 1983, Levy and Steward activated weak and strong input together, and they
observed that the temporal order of the pre- and post-synaptic spiking determined
whether LTP or LTD was induced and that timing of pre- and post-synaptic action
potentials (spikes) determines the polarity of synaptic change [Levy 1983, Bi 1998].
This was called spike timing-dependent plasticity (STDP). Repeated activation
of a pre-synaptic spike followed by post-synaptic spike, within a brief time win-
dow of approximately 50 ms, leads to LTP, while the reverse order leads to LTD
[Markram 1997, Bi 1998]. Additionally, independent stimulation of two aﬀerent
pathways has revealed that neighbouring synapses can be independently potenti-
ated or depressed. This property of input specificity is an important characteristic
of Hebbian LTP and LTD [Barrionuevo 1983, Markram 1997, Martin 2000].
3.5 rTMS protocols
There are several rTMS protocols with diﬀerent lasting eﬀects and purposes.
Parameters inﬂuencing the after-eﬀects of stimulation are stimulus intensity and
frequency, total number of delivered impulses, the duration of the application pe-
riod, and the shape of the magnetic pulse [Arai 2005, Taylor 2007a, Classen 2008].
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Moreover, 3D position and orientation of the TMS coil, which means the orientation
of the induced currents and the anatomy of the underlying gyri, also play a cru-
cial role in the eﬀects of rTMS [Thielscher 2010]. However, the exact mechanisms
of rTMS on neural activity remain partly unknown and not fully understood. In
fact, TMS in humans is relatively non-focal stimulation and one can suggest that
it activates a mixture of interacting neuronal systems which makes the after-eﬀects
diﬃcult to predict.
Previous studies have shown that rTMS of human motor cortex can produce
long-lasting changes in the excitability of excitatory and inhibitory neuronal net-
works. Low-frequency stimulation (≤ 1 Hz) produces lasting decrease in motor
cortex excitability, whereas high-frequency stimulus (≥ 5 Hz) induces facilitatory
eﬀects [Romero 2002, Hayashi 2004, Houdayer 2008, Di Lazzaro 2011, Noh 2012].
Furthermore, it was shown that longer stimulation period produced longer dura-
tion of after-eﬀects [Robertson 2003]. Moreover, it appeared that the structure
of the pulse train has an important inﬂuence on the eﬀects of rTMS protocol
[Classen 2008]. In basic protocols, individual stimuli are separated by identical
inter-stimulus intervals (ISIs), whereas in patterned protocols, diﬀerent ISIs are
used [Hoogendam 2010]. On the top panel of Figure 3.7, there are two protocols:
1) a low-frequency protocol - 1 Hz stimulation, 2) a high-frequency protocol - 5
Hz stimulation. Patterned protocols are shown on bottom panel and, as it can be
found on the ﬁgure, they are characterised by diﬀerent ISIs. In theta burst stim-
ulation (TBS), which is able to induce LTP and LTD, a pattern has three pulses
of stimulation given at 50 Hz (ISI 20 ms), repeated every 200 ms (5 Hz). There
are two main types of theta burst paradigm. In continuous theta burst stimulation
(cTBS), a 40-second train of uninterrupted TBS is delivered. In intermittent theta
burst stimulation (iTBS), a 2-second train of TBS is repeated every 10 seconds for
a total of 600 pulses (190 seconds) [Hoogendam 2010].
Table 3.1 and Table 3.2 present a summary of the studies using diﬀerent rTMS
protocols. In described studies, the intensity of the stimulation was deﬁned as
the percentage of the individual motor threshold (MT), resting motor threshold
(RMT) or active motor threshold (AMT). The MT is the lowest intensity of stim-
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Figure 3.7: Overview of rTMS protocols [Hoogendam 2010].
ulation applied to the primary motor cortex that induces a muscle response in
the contralateral hand, at least in 5 of 10 trials. RMT is measured during com-
plete relaxation, whereas the AMT is determined in a voluntary contracted muscle
[Hoogendam 2010]. The researches summarised in Tables 3.1 and 3.2 investigated
the eﬀects of rTMS by measuring the amplitude of MEPs.
In this section I will focus on recent papers describing 1 Hz, 10 Hz stimulation
and thetaburst protocols, cTBS and iTBS. This choice is based on the further
section 5.1.2 where these paradigms are used in my experimental protocols.
3.5.1 1 Hz rTMS
1 Hz stimulation is the most widely used protocol to stimulate motor cortex, as
well as other brain areas. It allows the structure-function relationships in the brain
to be investigated. In the literature, there are a lot of studies investigating the
eﬀects of 1 Hz rTMS on motor excitability, but they vary in the stimulus intensity
and in the number of pulses (see Table 3.1). Variations in the results can be found
in the eﬀects of stimulation, inhibitory in most cases, with large interindividual
variability, with some subjects even showing facilitatory eﬀects [Daskalakis 2006].
The duration of the after-eﬀects also vary, which can be explained by the technical
diﬀerences (number of pulses, used waveform [Taylor 2007a]) and interindividual
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Table 3.1: Low-frequency rTMS protocol (1 Hz): sign and duration of MEP ampli-
tude modulation [Hoogendam 2010].
Protocol Study n Intensity Imp. MEP Duration Note
1 Hz
Bagnato 9 90% RMT 900 ↔ NA High interindividual
variability
Chouinard 7 90% RMT 900 ↓ 10 min
Daskalakis 12 90% RMT 900 ↔ NA High interindividual
variability
Heide 11 115% RMT 900 ↓ 2 min MEP size of nonstim-
ulated motor cortex
increased (up to 30
min)
Lang 9 90% RMT 1200 ↓ 4 min Decrease in MEP
more pronounced
after pretreatment
with D1/D2 receptor
agonist
Modugno 14 90% RMT 900 ↔ NA
O’Shea 5 90% AMT 900 ↓ >15 min
Pal 13 115% RMT 900 ↔ NA
Rizzo 8 90% AMT 1500 ↓ NI
Suppa 15 90% AMT 1500 ↓ 30 min
Taylor 12 90% RMT 900 ↓ 5 min Monophasic wave-
form: significant
effect at 5 min after
rTMS. Biphasic at
20 min after rTMS
Zafar 9 90% RMT 900 ↓ NI
AMT - active motor threshold; RMT - resting motor threshold; NA - not applicable; NI - not
investigated; ↓ : decrease; ↑ : increase; ↔ : no significant change.
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Table 3.2: High-frequency rTMS protocols (10 Hz): sign and duration of MEP
amplitude modulation [Hoogendam 2010].
Protocol Study n Intensity Imp. MEP Duration Note
10 Hz
Arai 11 90% AMT 1000 ↔ NA Only monophasic
waveform induces
significant effect
Arai 11 90% RMT 1000 ↑ 10 min
Daskalakis 12 90% RMT 900 ↔ NA High interindividual
variability
Jung 20 80% RMT 300 ↑ up to 120 min Trains of 1.5 s
Jung 20 80% RMT 1000 ↓ up to 90 min Trains of 5.0 s
AMT - active motor threshold; RMT - resting motor threshold; NA - not applicable; ↓ : decrease;
↑ : increase; ↔ : no significant change.
variability.
3.5.2 10 Hz rTMS
In contrast to 1 Hz, high frequency stimulation (HFS) (i.e. 10 Hz) tends to
increase cortical excitability (see Table 3.2). As it was reported in papers of Mod-
ugno et al., Quartarone et al. and Arai et al. [Modugno 2001, Quartarone 2005,
Arai 2007], the after-eﬀects of HFS highly depend on the intensity of stimulation.
With low intensities of HFS, they reported a decrease in excitability, whereas an
increase was observed after HFS at higher intensities (see Table 3.2). Moreover,
Quartarone et al. and Arai et al. [Quartarone 2005, Arai 2007] reported diﬀerences
in the eﬀects between HFS at 90% of the AMT and RMT. At 90% of AMT they
did not ﬁnd any eﬀect, whereas they found the eﬀect of rTMS at 90% of RMT. The
resting threshold is, however, higher than AMT, which may indicate that if one
refers to the active threshold, the energy delivered is higher, the current induced
deeper and therefore the neurons involved in the response are not the same, the
results are therefore not comparable.
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3.5.3 Theta burst stimulation
In 1978, Hill observed that when an animal explores a new environment, pyra-
midal cells in the hippocampus ﬁre in short (approximately 30 milliseconds) bursts
and at a frequency of approximately 5 to 7 Hz [Hill 1978]. In 2005, Huang with
coworkers [Huang 2005] introduced a new type of rTMS, theta burst stimulation
where pulses are applied in bursts of three, delivered at a frequency of 50 Hz and an
interburst interval of 200 ms (5 Hz). The parameters of TBS paradigm were based
on these observations and additionally, on animal studies indicating that theta
rhythms are associated with LTP [Hill 1978, Larson 1986, Davies 1991, Hess 1996].
The goal of TBS is thus to maximise the probability to produce LTD/LTP.
Two diﬀerent modes of TBS have been tested showing opposite eﬀects on mo-
tor cortex excitability. If the stimulation is given intermittently (iTBS), say 2 s
of stimulation every 8 s, it leads to prolonged LTP-like increase of motor cortex
excitability, in the contrary to continuous theta burst (cTBS) which produces a
prolonged LTD-like decrease of motor cortex excitability [Huang 2005]. The main
diﬀerence between TBS paradigm and conventional rTMS protocols is that even
brief periods of stimulation (between 20 and 190 s) cause changes in cortical ex-
citability that outlast the time of stimulation for at least 20-30 min (see Table 3.3)
[Cardenas-Morales 2010].
Since its ﬁrst description, TBS has started to be used not only in motor cor-
tex stimulation, but also in other brain regions. However, little is known about
the modulatory eﬀects of cTBS and iTBS over non-motor regions. Recent studies
combining TBS and EEG or fMRI have observed the after-eﬀects of TBS on PFC
and the frontal eye ﬁeld, showing heterogeneous results [Hubl 2008, Schindler 2008,
Grossheinrich 2009]. Additionally, the abilities of TBS to induce long-lasting after-
eﬀects led to therapeutic implications for neuropsychiatric disorders. However, the
neurobiological mechanisms of TBS are not fully understood at present. As Huang
suggested, it may involve LTD- and LTP-like processes [Huang 2005], as well as in-
hibitory mechanisms modulated by GABA-ergic activity [Cardenas-Morales 2010].
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Table 3.3: TBS: eﬀects and eﬀect-durations on MEPs size [Hoogendam 2010].
Protocol Study n Intensity Imp. MEP Duration Note
cTBS
Cheeran 18 80% AMT 300 ↓ >30 min Influence of genotype: only
in individuals with Val/Val
group significant change of
MEP
Di Lazzaro 4* 80% AMT 300 ↓ 8 min
Huang 9 80% AMT 600 ↓ 60 min
Huang 6 80% AMT 600 ↓ NI No change in MEP
size after pretreatment
with NMDA receptor-
antagonist
Huang 9 80% AMT 300 ↓ 20 min No change in MEP size if
stimulation was given dur-
ing contraction FDI
Iezzi 10 80% AMT 300 ↓ 30 min Increase in MEP size if
finger-movements preceded
cTBS
Martin 8 80% AMT 600 ↓ 35 min
Murakami 6 80% AMT 600 ↓ 35 min
Zafar 9 80% AMT 600 ↓ 30 min Effects independent of cur-
rent direction or pulse con-
figuration
iTBS
Cheeran 18 80% AMT 600 ↑ 30 min Influence of genotype: only
in individuals with Val/Val
group significant change of
MEP
Di Lazzaro 3* 80% AMT 600 ↑ 6 min In one subject increase not
significant; just one mea-
surement after rTMS
Di Lazzaro 18 80% AMT 600 ↑ 6 min High interindividual vari-
ability; just one measure-
ment after rTMS
Huang 9 80% AMT 600 ↑ 15 min
Huang 6 80% AMT 600 ↑ NI No change in MEP size
after pretreatment with
NMDA receptor antagonist
Huang 7 80% AMT 600 ↑ 20 min No change in MEP size if
stimulation was given dur-
ing contraction FDI
Iezzi 10 80% AMT 600 ↑ 30 min Decrease in MEP size if
finger-movements preceded
iTBS
Murakami 6 80% AMT 600 ↑ 15 min
Teo 6 80% AMT 600 ↑ 20 min
Zafar 9 80% AMT 600 ↑ 30 min Effects independent of cur-
rent direction or pulse con-
figuration
AMT - active motor threshold; cTBS - continuous theta burst stimulation; FDI - first dorsal interosseus
muscle; iTBS - intermittent theta burst stimulation; NA - not applicable; NI - not investigated; RMT -
resting motor threshold; ↓ : decrease; ↑ : increase; ↔ : no significant change. * Patient with epidural
electrode.
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3.6 Functional connectivity and cortical excitability
It is well know that TMS changes brain activity as an independent variable.
It temporarily elicits “virtual lesions”, stimulate neuronal networks, increase or
decrease cortical excitability. But, without any additional neuroimaging measure
the localisation of eﬀects remains unknown. As it was already mentioned, single or
ppTMS are used to study the excitability of motor circuits. A TMS pulse spreads
along the corticospinal pathway and induces electromyographic (EMG) responses.
Although EMG is a good technique to measure TMS-evoked responses of the motor
cortex, it does not allow to directly measure the cortical reactivity and connectivity
of other brain areas. Combining TMS with EEG is a solution to enable direct
measurements of these parameters [Ilmoniemi 1997].
In recent study, Ferreri and coworkers combined ppTMS with EEG and EMG
recordings. They conﬁrmed that ppTMS modulates early and late ERPs and MEPs
[Paus 2001, Ferreri 2011]. Additionally, their ﬁndings revealed that “for some TMS-
induced EEG peaks, the measures of short intracortical inhibition (SICI) and intra-
cortical facilitation (ICF) are somewhat related to the same mechanisms mediating
EMG measures of SICI and ICF”. Most importantly, these results indicate that
with EEG it is possible to directly evaluate intracortical inhibition and facilitation
induced by ppTMS in each cortical area.
Subsequently, in a very interesting study, Rosanova and coworkers investigated
direct perturbation of diﬀerent regions of the human cortico-thalamic system to
measure their “natural frequencies”. This group stimulated three cortical sites
(middle or superior occipital gyrus, superior parietal gyrus, and middle or caudal
portion of the superior frontal gyrus) with a focal TMS bipulse. They used TMS-
compatible 60-channel ampliﬁer to record TMS-evoked potentials. Their ﬁndings
revealed that stimulating the cortex at diﬀerent sites results in various responses.
TMS evoked dominant alpha oscillations in the occipital cortex, beta oscillations in
the parietal cortex, and beta/gamma oscilations (21-50 Hz) in the frontal cortex.
Furthermore, they found that “each cortical area tended to preserve its own natural
frequency also when indirectly engaged by TMS through brain connections and
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when stimulated at diﬀerent intensities, indicating that the observed oscillations
reﬂect local physiological mechanisms” [Rosanova 2009]. These ﬁndings suggest
that in healthy subjects each corticothalamic system is tuned to oscillate at its own
characteristic frequency.
Next, recent TMS-neuroimaging studies have shown that the neural conse-
quences of rTMS are not restricted to the brain areas directly under the stimulating
coil, but they spread to remote and interconnected regions [Sack 2006, Taylor 2007b,
Leuchter 2013, Peters 2013]. It was shown that even a short train of high-frequency
rTMS is able to modulate activity of distant interconnected sites and in the con-
tralateral regions [Bestmann 2003, Sack 2007]. Moreover, Zandbelt and colleagues
[Zandbelt 2009] detected with fMRI that primed 1-Hz rTMS over the prefrontal
cortex increased resting-state activity locally for at least 45 minutes.
Knowing that a TMS pulse eﬀectively inserts the energy into the neuronal net-
works, which then spreads throughout the anatomical and functional connections,
these results are not surprising. The question is then not “whether” but “how”
rTMS pulses propagate in the brain system.
3.7 TMS in the treatment
3.7.1 TMS in the treatment of MDD
Major depressive disorder is a chronic disorder that leads the patient to sociolog-
ical disability and functional impairment [Murray 1996]. Treatment is often diﬃcult
and challenging. Moreover, an estimated 20-40% of patients do not respond to the
standard trials of medication and psychotherapy, resulting in a need for alternative
options of treatment [Greden 2001, Rush 2006, Trivedi 2006]. As a result of inciden-
tal observation that a number of subjects reported mood changes after TMS stimu-
lation, studies of TMS as a potential alternative to electroconvulsive therapy (ECT)
treatment for depression were initiated [Bickford 1987, Wassermann 2008]. In 1993,
repeated daily left prefrontal TMS was ﬁrst proposed as an alternative treatment
for mood disorders [George 2010]. Since then, researchers repeatedly demonstrated
that rTMS on the left and right DLPFC has antidepressant eﬀects, and that these
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after-eﬀects are clinically signiﬁcant [George 1995, Pascual-Leone 1996, Klein 1999,
O’Reardon 2007, Padberg 2009, Fitzgerald 2009b, George 2010].
The initial clinical trials of rTMS were driven by functional imaging evi-
dence that depressed patients have reduced activity in the left prefrontal cortex
[Cummings 1993, Hirono 1998]. The ﬁrst studies used HFS to excite the aﬀected
area and to obtain a long-lasting after-eﬀects by applying rTMS during several
daily sessions. Another idea was that an imbalance in the activity of the frontal
lobes, with hypo-function in the left frontal lobe was caused by excess inhibition
from the right frontal lobe [Ridding 2007]. This led to an alternative suppressive
low-frequency stimulation of the right DLPFC [Klein 1999]. The study of Speer et
al. [Speer 2000] conﬁrmed that daily high-frequency rTMS applied during a 2-week
period over left DLPFC induce increases in regional cerebral blood ﬂow (rCBF) in
bilateral frontal, limbic, and paralimbic regions implicated in depression, whereas
low-frequency rTMS produced more focal decrease of rCBF (Figure 3.8 and 3.9).
It suggested frequency-dependent rTMS-after-eﬀects on local and distant regional
brain activity and, additionally, indicated that higher stimulation frequencies lead
to more widespread changes in cerebral activity.
In most cases, TMS studies has conﬁrmed that rTMS has antidepressant prop-
erties when delivered to the left or right DLPFC, at high- and low-frequency, respec-
tively [George 1995, Pascual-Leone 1996, Klein 1999, George 2000, Fitzgerald 2003,
Avery 2006, O’Reardon 2007, Ahn 2013]. Although there is no evidence that rTMS
makes depression worse, a number of authors suggested that rTMS has very little
advantage over sham stimulation [Martin 2003, Couturier 2005]. In Miniussi et al.
study [Miniussi 2005], we can ﬁnd that “depressed patients beneﬁt from rTMS treat-
ment, but this beneﬁt is not strictly and clearly related to the real eﬀect of TMS
itself. In fact, it is not possible to say whether the improvement in the clinical out-
come is attributable to real or “placebo” TMS. However, it is worth of mentioning
that the power of the eﬀect is modest probably due to methodological limitations
of the trials: lack of precision in the location of the target, quality of the placebo
procedure or heterogeneity of recruited patients, often resistant to pharmacological
treatment. Now it is known, that the more severe depression the worst is the re-
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sponse to rTMS treatment. In another paper by Loo et al. [Loo 1999], the results
indicate that “the groups receiving real and sham rTMS improved in mood signiﬁ-
cantly over the 2-week double-blind period, but there was no signiﬁcant diﬀerence
between groups”. What is important, in this paper the placebo was performed with
a coil placed at 45o to the scalp. In a paper by Lisanby et al. [Lisanby 2000] it was
shown that this type of sham procedure produces a biological eﬀect, in this case
collection of MEPs, so it is diﬃcult to show diﬀerent eﬀects.
Figure 3.8: Significant increases in absolute rCBF 72 hours after 2 weeks of 20 Hz rTMS over
the left prefrontal cortex in the group of 10 depressed patients. A statistical parametric map shows
voxels that occur within significant clusters and is color coded according to their raw p value.
Increases in rCBF are displayed with a red - orange - yellow color scale, and there were no areas of
decreases in rCBF displayed with a darklight blue color scale. Nonsignificant values are displayed
as gray on the positron emission tomography template. The number in the top right corner of
each horizontal section (top two rows) indicates its position in mm with respect to the anterior
commissure / posterior commissure plane. 20 Hz rTMS resulted in widespread increases in rCBF
in the following regions: prefrontal cortex (L > R), cingulate gyrus (L >> R), bilateral insula,
basal ganglia, uncus, hippocampus, parahippocampus, thalamus, cerebellum, and left amygdala.
Note the distal effects in bilateral cortical and subcortical structures following stimulation over the
left prefrontal cortex. Coronal sections (middle, bottom row) are displayed at the AC and 4 mm
behind it to maximize visualization of the amygdala. Increases in the left amygdala but not the
right are best viewed in horizontal sections at -20, -16, and -12 mm, however. Sagittal sections are
4 mm to the left and right of midline to illustrate the greater increases in the left cingulate gyrus
relative to the right. L, “left” side of image. [Speer 2000].
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Figure 3.9: Significant decreases in absolute rCBF 72 hours after 2 weeks of 1-Hz rTMS over
the left prefrontal cortex in the same group of 10 depressed patients. Horizontal, sagittal, and
coronal images are illustrated as in Figure 3.8. Focal decreases in rCBF were present in the right
prefrontal cortex (horizontal sections -4 to 32 mm), left medial temporal cortex (-20 to -12 mm),
left basal ganglia (14 to 8 mm), and left amygdala (-12 to -8 mm). Note the opposite effect of rTMS
frequency on rCBF in the left amygdala (horizontal section = -12 mm) in Figure 3.8 [Speer 2000].
Table 3.4 presents a summary of meta-analysis of rTMS-after-eﬀects studies in
the treatment of major depressive depression.
To quote Ridding et al. “rTMS is unlikely to restore function to specific sets
of synaptic connections that are affected by disease or injury because TMS is too
non-specific in its action on populations of neurons, both at the site of stimulation
and at a distance. However, it might interact with some natural process and lead
to restoration of normality in malfunctioning neural circuits. In this model, rTMS
increases the ability of the brain to undergo compensatory changes that improve
behaviours” [Ridding 2007].
However, a very recent study by [Leuchter 2013] suggested how rTMS may
act in mood disorders. In most cases, patients with MDD show a high syn-
chronisation of theta and alpha activity over most brain regions (Figure 3.10 A).
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Table 3.4: The review of meta-analysis investigating the effects of rTMS on MDD [Ridding 2007].
Meta-analysis Nr of
studies
rTMS approach Outcome
measure
Analysis conclusion
[Couturier 2005] 6 Randomized sham-
controlled trials
using Left DLPFC
rTMS
Change in
HDRS
Suggests rTMS no better
than sham
[Martin 2003] 14 Most (13 out of
14 studies) used
high frequency Left
DLPFC and sham
control
Change in
HDRS
Real rTMS significantly
greater effect than sham
on HDRS when applied for
2 weeks (but not 1 week).
No significant difference for
BDI
[Kozel 2002] 12 Randomized sham-
controlled trials in-
volving Left DLPFC
rTMS
Change in
HDRS
Real rTMS led to small
but significantly greater ef-
fect than sham
[Burt 2002] 16 Randomized con-
trolled (sham or
other control) trials
predominantly in-
volving Left/Right
DLPFC
Change in
HDRS
Real rTMS significantly
better than sham. Im-
provement in HAM-D of
20%. Doubtful clinical
significance
[Holtzheimer 2001] 12 Most (11/12) used
Left DLPFC and
sham control
Change in
HDRS
Real rTMS significantly bet-
ter than sham. However,
clinical significance consid-
ered only modest
BDI - Beck depression inventory; DLPFC - dorsolateral prefrontal cortex; HDRS - Hamilton Rating
Scale for Depression.
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Leuchter and coworkers proposed the hypothesis that repetitive magnetic pulses
entrain oscillation at the frequency of the stimuli, thereby reset cortical and
thalamo-cortical oscillators facilitating the resumption of normal brain activity
[Paus 2001, Fuggetta 2005, Fuggetta 2008, Leuchter 2013] (Figure 3.10 B). How-
ever, as [Leuchter 2013] wrote, to maintain the resetting eﬀect, multiple treatments
over time are crucial. As they showed, rTMS seems to work in the entire spec-
trum of frequency oscillations, consisting in beta and gamma activity in the frontal
cortex, beta in parietal cortex, and alpha in the occipital cortex (Figure 3.10 C).
Figure 3.10: Effects of rTMS on the brain activity (description in the text) [Leuchter 2013].
3.7.2 TMS in the treatment of BP depression
Bipolar disorder is a chronic, severe and often life-threatening disorder which
aﬀects approximately 1-3% of the population causing substantial psychosocial mor-
bidity [Goodwin 1990]. The therapy of BP depression consists mainly of antide-
pressants during the depressive phase of the illness. Moreover, pharmacological
treatment is not eﬃcient for many patients.
Although rTMS has been widely tested as a treatment of MDD, it has been
poorly investigated in BP. Two small randomized controlled trials [Dolberg 2002,
Nahas 2003] and one open study [Dell’Osso 2009] have tested the eﬃcacy of rTMS
in BP depression therapy.
The study on Nahas et al. [Nahas 2003] was a 2-week study on 23 subjects
assigned to either sham treatment or rTMS (left prefrontal stimulation at 5 Hz,
110% motor threshold for 8 s, with an oﬀ period of 22 s, and a 20-min session
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duration). They did not manage to ﬁnd statistically signiﬁcant TMS clinical an-
tidepressant eﬀects greater than sham. However, the results of the active TMS
indicated a trend towards an improvement in mood-related symptoms. Another
sham-controlled research of Dolberg and coworkers [Dolberg 2002] included 20 pa-
tients, where 10 patients received 20 sessions of active rTMS (real group) and 10
patients received 10 sessions of sham-rTMS followed by 20 sessions of rTMS (con-
trol group). The results showed statistically signiﬁcant improvement in depression
rating scales in the real-group compared with the control group at week 2.
A more recent paper studying rTMS as the depression treatment was published
by [Dell’Osso 2009]. They investigated the eﬃcacy of 1-Hz navigation-guided rTMS
of right DLPFC as a supplement to mood stabilizers in eleven subjects with bipolar I
or bipolar II disorder and major depressive episode who did not respond to previous
pharmacological treatment. The results showed that rTMS was eﬀective and well
tolerated in this small sample of drug-resistant bipolar depressive patients.
Additionally, Harel and coworkers [Harel 2011] analysed the usefulness of H1-
Coil rTMS as an adjuvant treatment to mood stabilizers and antidepressants for
BP disorder. A signiﬁcant mean decrease from baseline in the Hamilton depression
rating scale (HDRS) score was observed a week after the last treatment session.
They suggested that add-on H1-coil rTMS treatment protocol in BP subjects can
help to improve bipolar depression symptoms.
3.8 Conclusions
Although some studies have shown that rTMS has very little advantage over
sham stimulation, there is convincing statistical evidence for rTMS as the antide-
pressant treatment with a substantial proportion of patients achieving a treatment
response. Numerous researchers have provided several plausible hypotheses for the
antidepressant eﬀects of rTMS. Furthermore, clinical trials have proved rTMS to
be safe when delivered within recommended parameter guidelines [Groppa 2012].
Interestingly, the most optimal combination of rTMS parameters to maximize the
therapeutic eﬀects is still not established and leaves a wide scope of research for
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further studies.
It should also be noted that the lack of minor therapeutic eﬀects reported
in some of reviewed papers [George 1999, Loo 1999, Padberg 1999, Martin 2003,
Miniussi 2005] might be explained by not having stimulated the intended area of
the DLPFC. These studies used standard procedure for coil placement and rTMS
could be performed at cortical sites that were not involved in the pathologic pro-
cesses of depression [Herwig 2001a].
Re´sume´ du Chapitre 4
Dans le dernier chapitre de l’introduction, je pre´senterai un re´sume´ de la rTMS,
de l’EEG et de la de´pression. Je de´crirai les de´ﬁs que repre´sente l’enregistrement
simultane´ de l’EEG et de la rTMS, les changements d’EEG lie´s aux troubles de
l’humeur et l’utilite´ des mesures d’EEG comme potentiel biomarqueur d’eﬃcacite´
the´rapeutique.
Chapter 4
rTMS, EEG and depression
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4.1 Introduction
In 1997, Ilmoniemi with coworkers [Ilmoniemi 1997] ﬁrst introduced measure-
ments of complete scalp distribution of event-related potentials (ERPs) following
TMS with an EEG ampliﬁer specially designed to work in the presence of huge gra-
dients of magnetic ﬁeld, such as those produced by TMS. Since then, EEG-TMS co-
registration is used to assess local and distant response of the brain to the stimula-
tion. Moreover, EEG allows to investigate the pathophysiology of neuropsychiatric
disorders and, additionally, short- and long-term rTMS-after-eﬀects can be evalu-
ated from EEG changes following TMS [Komssi 2006, Miniussi 2010]. Additionally,
thanks to EEG it is possible to study the TMS-evoked activity not only from motor
cortex but also from other brain regions. Theoretically complex brain networks can
be functionally and spatially characterised [Taylor 2008, Miniussi 2010]. However,
even after the introduction of EEG systems which do not saturate in the presence
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of high magnetic ﬁelds EEG-TMS co-registration remains technically challenging
[Bonato 2006]. The questions about the best technical conditions of recording and,
the most important about how long the rTMS-induced after-eﬀects lasts are still
unanswered.
4.2 Challenges of EEG-rTMS co-registration
In the ﬁrst studies of TMS-evoked EEG responses conducted by [Cracco 1989]
and [Amassian 1992], the induced currents produced large artefacts in the EEG
leads [Ilmoniemi 2010]. In addition, using standard EEG systems with TMS, one
need to be aware of ampliﬁers saturation. It takes hundreds of milliseconds for
the ampliﬁers to recover from large induced electric signals, and to go back to
the baseline. Furthermore, even after the recovery, recharging the capacitor of the
TMS device for the next pulse may cause a signiﬁcant artifact. In the ﬁrst type
of TMS-compatible EEG devices a delay circuit was inserted. A sample-and-hold
circuit is an analog device that grab and hold the voltages of a continuously varying
analog signal. A typical sample and hold circuit stores electric charge in a capacitor
[Horowitz 2001]. These ampliﬁers did not eliminate the TMS-artefacts, but they
remained operational and recorded clean EEG later, with a 30 to 1000 ms delay after
the pulse [Wassermann 2008]. Recently, most commonly available EEG for TMS are
modern direct current (DC) ampliﬁers that allow EEG recording at high sampling
frequencies [Bonato 2006, Daskalakis 2008, Fitzgerald 2008, Fitzgerald 2009a]. The
main point is that DC ampliﬁers do not have a high-pass ﬁlter, so they do not have
to recover after the artefact. They also allow for continuous EEG recording during
TMS without long-lasting or permanent ampliﬁer saturation [Taylor 2008].
The next issue for EEG-rTMS co-registration is the use of suitable electrodes.
These electrodes should be made from a suitable surface material, such as Ag/AgCl,
be small to avoid heating which is proportional to the square of electrode diameter
and to the square of TMS intensity. Also, the electrical contact with the scalp is
crucial for high-quality EEG-TMS recordings. This step requires cautious prepara-
tion of the skin surface, before inserting a conductive electrode paste. It is necessary
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to clean the skin with alcohol directly underneath the recording electrodes. Then,
the impedance must be checked for all of the electrodes, and kept as low as possible,
because the higher impedance the longer TMS-artefacts.
When studying TMS-evoked brain activity, like ERP, one must keep in mind
that a loud click sound from TMS and skin sensations produces auditory and so-
matosensory responses, respectively. These responses may mistakenly be inter-
preted as TMS-ERP [Wassermann 2008]. However, this is not an issue in the present
work, where only pre- and post-stimulus recordings where analysed.
The exact position of TMS coil is also very important. To be sure where ex-
actly the stimulation is delivered, it is worth of using a neuronavigation technique.
Targeting rTMS and neuronavigation system were described in section 3.3.
Although recording of TMS-evoked responses remains technically challenging,
it is possible to obtain interpretable data. EEG-TMS studies give novel insights
into underlying physiological TMS-after-eﬀects and allow to study the fundamental
aspects of brain network dynamics in healthy and diseased brain [Ilmoniemi 2010,
Thut 2010, Dayan 2013].
4.3 EEG changes correlated with mood disorders
4.3.1 Quantitative electroencephalography
Quantitative electroencephalography (qEEG) has been deﬁned as a numerical
analysis of raw EEG data. This method provides more detailed information about
brain activity than visual interpretation of EEG [Leuchter 1994].
The basic values which are calculated in qEEG analysis are total, absolute and
relative power of recorded signals. If as(f) represents the absolute power at single
electrode s in frequency band f, then a total power at the electrode s is deﬁned as
a summary of power across the frequency spectrum:
Ts =
∑
f
as(f) (4.1)
Then, relative power is calculated on the basis of the absolute and total power
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values:
rs(f) =
as(f)
Ts
(4.2)
In 1994, Leutcher with coworkers introduced a new measure called cordance. It
is a qEEG technique which combines absolute and relative power of EEG spectra,
characterizing both the magnitude of and the relationship between absolute and
relative power at each recording electrode [Leuchter 1994]. The ﬁrst step to compute
the cordance is calculation of relative power in each frequency band. Then, it is
necessary to relate power from one electrode to all recording sites. To do that we
need to deﬁned the maximum absolute and relative values AMAXf and RMAXf ,
respectively, in each frequency band. These maximum values are used to normalise
the absolute and relative power at each electrode for each frequency band:
aNORMs(f) =
as(f)
AMAXs
(4.3)
rNORMs(f) =
rs(f)
RMAXs
(4.4)
The next step is to subtract the half-maximal values on the normalised scale
from aNORM(s,f) and rNORM(s,f) (this half-maximal value is used to as an arbitrary
cutoﬀ). If aNORM(s,f) − 0.5 < 0 and rNORM(s,f) − 0.5 > 0, then this electrode s is
determined to show discordance in that frequency band. On contrary, if both abso-
lute and relative power are greater than the half-maximal value, then the recording
site is determined to represent concordance in that frequency. If rNORM(s,f) ≤ 0.5,
the electrode is neither concordant nor discordant and has a cordance value of zero.
The absolute values of explained above diﬀerences are summed to calculate the
cordance magnitude:
CORDANCEs,f = ±(|aNORM(s,f) − 0.5|+ |rNORM(s,f) − 0.5|) (4.5)
In this study Leuchter investigated MRI, PET and SPECT scans from groups
of subjects with brain diseases which cause cortical deaﬀerentation. On that ba-
sis they suggested that areas with high perfusion or metabolism are characterised
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by concordance, whereas discordance is found over areas with low perfusion or
metabolism [Leuchter 1994, Leuchter 1999]. Application of cordance as a predictor
of depression treatment will be mentioned in the following 4.3.3 section.
4.3.2 Depressed vs. healthy brain
A lot of brain areas are involved in emotion and mood disorders. The neural
pathways responsible for emotion include the dorsolateral and ventromedial pre-
frontal cortex, temporal and parietal cortex, nucleus accumbens, basal ganglia,
amygdala and hippocampus [Begic 2011, Deslandes 2008]. Although it is not typ-
ically used to diagnose depression, EEG has been used to study how depression
aﬀects brain’s function and to follow changes in the brain activity during antide-
pressant treatment.
The last twenty years of research resulted in many reports about the clinical use-
fulness of the EEG in the diagnosis of psychiatric disorders. Additionally, nowadays,
EEG is used to search for disease-speciﬁc biomarkers in MDD and BP disorders.
The aim is to ﬁnd objective biomarkers of treatment response, which could dis-
tinguish between responders and non-responders for a treatment, or identify those
at greater risk for relapse [Iosifescu 2011]. The ability to predict response to the
treatment before, or just after the new treatment is initiated, would signiﬁcantly
improve the therapy selection process and has important increase in the eﬃcacy of
the therapy (i.e. antidepressant therapy, rTMS or ECT).
EEG brought important information about depression. Diﬀerent studies have
found that typically 20% to 40% of depressed patients have EEG abnormalities, but
with several characteristics and controversial patterns [Coburn 2006]. Moreover, up
to 80% of psychiatric patients present various qEEG abnormalities on contrary to
only 10% of healthy subjects [Begic 2011, Coburn 2006].
Quantitative studies of resting EEG in elderly depressed patients with mild
cognitive deﬁcits found that the mean power of delta and theta waves was signif-
icantly higher than in the patients without cognitive impairment. Moreover, to-
tal delta power was negatively correlated with cognitive performance [Adler 1999].
Pollock and Schneider [Pollock 1990] used measures of the absolute and relative
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amplitude of EEG to compare elderly patients with major depression to healthy
control subjects. They observed signiﬁcantly higher absolute alpha amplitude in
patients than in controls, but without regional diﬀerences. Relative alpha ampli-
tudes, absolute and relative measures of beta, delta, and theta did not deﬁnitely
distinguish depressed and control subjects. A quantitative spectral analysis of EEG
was also performed by [Coutin-Churchman 2003] where diﬀerent psychiatric disor-
ders were tested. Importantly, this study took into account BP patients, and the
results showed decrease in absolute and relative power of slow bands with increase
in beta band. Unfortunately, EEG studies on bipolar depression are very limited
[Coutin-Churchman 2003, Micoulaud-Franchi 2012].
Sleep abnormalities occur in more than half of depressed patients. These
aberrations include polysomnographic features of sleep continuity disturbance, re-
duced non-REM (NREM) stages 3 and 4 sleep, decreased REM latency, increased
phasic REM activity and increased duration of REM sleep early in the night
[Pfurtsheller 1999].
Measuring absolute and relative power, inter- and intra-hemispheric power ra-
tios, mean frequency, and both inter and intra-hemispheric coherence indices of
resting EEG recordings of unipolar major depressive disorder male outpatients and
healthy controls, Knott and colleagues [Knott 2001] observed increased relative and
absolute beta power and higher mean frequency at bilateral frontal regions in de-
pressed patients than in controls. The inter-hemispheric alpha power asymmetry
was noted in controls, showing relative right anterior hemispheric hypoactivation.
Reduction of intra-hemispheric asymmetry of theta power was exhibited bilaterally
at all regions and beta power asymmetry was observed only in the right hemisphere
in patients. Moreover, in each band, patients exhibited reduced inter-hemispheric
coherence values for delta, theta, alpha and beta.
Moreover, recent studies reported asymmetry in EEG activity over frontal re-
gions in depression. Debener and coworkers [Debener 2000] studied resting EEG
alpha (8-13 Hz) asymmetry in 15 clinically depressed patients and 22 healthy adults
and observed diﬀerence between two groups in frontal EEG asymmetry. It was sug-
gested that increased frontal EEG asymmetry may be a characteristic feature for
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depression and be the marker for depression. They assumed that left hemisphere
activation is linked to positive emotion and right hemisphere activation to nega-
tive aﬀect. Although resting frontal EEG alpha asymmetry has been shown to be
a stable measure over time in nonclinical populations, its reliability and stability
in clinically depressed individuals has not been fully investigated. Decreased left
frontal activity, inferred by relatively higher left than right alpha band activity, ap-
peared to characterise individuals with major depression [Allen 2004]. This study
tested resting EEG alpha asymmetry in a group of 30 women diagnosed with major
depression at 4-week intervals for 8 or 16 weeks. Asymmetry scores displayed good
internal consistency and exhibited modest stability over the 8- and 16-week assess-
ment intervals. These ﬁndings suggest that resting EEG alpha asymmetry can be
reliably assessed in clinically depressed populations. In a study by [Vuga 2006],
resting EEG was recorded in 49 adults with a history of unipolar depression and
50 controls with no history of major psychopathology across a 1- to 3-year interval.
As in the previous studies, frontal EEG asymmetry in alpha range was observed
and moderately stable across time intervals. Likewise to , the magnitude of frontal
EEG asymmetry was uncorrelated with depressive symptom severity.
Both studies [Allen 2004, Vuga 2006] indicate that EEG activity in individuals
with MDD reveals left-right asymmetry of combined theta and alpha power, and
changes in frontal regions. In the following section I review ﬁndings regarding the
EEG as the predictor of depression treatment outcome.
4.3.3 EEG as the predictor of depression treatment
One of possible predictors of treatment outcome in MDD and BP are changes in
the alpha and theta bands. Almost 20 years ago, Ulrich with coworkers [Ulrich 1984]
observed diﬀerences between 20 responders and 20 non-responders after 4 weeks
of treatment with tricyclic antidepressants (TCAs). Left lateralization of alpha
power at baseline and decreased in absolute alpha power from baseline to week
4 was reported in responders with endogenous depression. The same group, in
a follow-up study, found that early changes in alpha oscillations after the ﬁrst
dose of antidepressants were associated with treatment response at three weeks
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[Ulrich 1988, Ulrich 1994]. Another group, Knott and colleagues [Knott 1996], stud-
ied 29 patients with unipolar depression treated with impramine (belongs to TCAs
group) for six weeks, discovered increased alpha power in responders compared to
non-responders, but the diﬀerences were not statistically signiﬁcant. In contrary,
baseline theta activity in responders was signiﬁcantly lower than in non-responders.
In another study [Knott 2000] of 70 MDD patients, responders showed increase in
baseline alpha power. Moreover responders showed greater theta activity and lower
beta activity at frontal recording sites. More recent study of Iosifescu and coworkers
[Iosifescu 2009] reported that frontal relative theta power at baseline and at week 1
were signiﬁcant predictors of treatment response to open-label SSRIs in major de-
pressive disorder. Baseline relative theta power was lower in responders, predicting
treatment response.
Alpha asymmetry between brain hemispheres recorded at baseline also diﬀer-
entiated responders from non-responders. Bruder and colleagues [Bruder 2001] no-
ticed that non-responders to ﬂuoxetine showed higher activation of alpha waves
over the right hemisphere, but responders did not. Alpha asymmetry was a signif-
icant predictor of treatment outcome. Seven years later the same group observed
that responders to ﬂuoxetine (antidepressant of the serotonin reuptake inhibitor
(SSRI) class) had greater alpha power compared with non-responders and healthy
control subjects, with largest diﬀerences at occipital sites where alpha was largest
[Bruder 2008]. There were also diﬀerences in alpha asymmetry between responders
and non-responders at occipital sites. Responders showed greater alpha (less activ-
ity) over right, versus left, hemisphere, whereas non-responders tended to show the
opposite pattern.
Hunter with colleagues [Hunter 2007] used qEEG to predict end-of-trial out-
comes within the ﬁrst week of a treatment. Early changes in prefrontal theta
cordance, in particular, have been associated with endpoint response and remis-
sion in double blind placebo-controlled trials [Cook 2002, Leuchter 2008] and have
been found to predict antidepressant response across independent research insti-
tutions [Bares 2007, Bares 2008]. Mentioned researches indicated that MDD sub-
jects treated with various antidepressant medications, decrease in prefrontal theta
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cordance one week after the beginning of the treatment. It has consistently pre-
dicted response to the treatment with overall accuracy ranging from 72% to 88%
[Iosifescu 2011].
As it was shown, there is a lot of studies of EEG as the predictor of pharma-
cological antidepressant treatment. Unfortunately, little is known on the predictive
value of EEG regarding the therapeutic response to rTMS in depression. Recently,
[Micoulaud-Franchi 2012] analysed 13 MDD and 8 BP patients to study the re-
sponses of depressed patients to the therapeutic rTMS. They investigated Spearman
correlations between pretreatment alpha band power in height regions of analysis
and absolute improvement in Beck Depression Inventory Short Form (∆BDI-SF). In
agreement with [Price 2008], they found that changes of alpha band power between
the baseline and the end of high frequency (10 Hz) rTMS therapy in the left DLPFC
negatively correlated in the left and right parieto-temporal regions with changes of
mood of MDD and BP patients, as assessed with ∆BDI-SF. To conclude, it was
suggested that alpha activity could be used as a marker of response to rTMS.
4.4 Conclusions
Although the reviewed studies showed the usefulness of EEG as a potential
predictor of antidepressant therapy response, there are only few about the corre-
lation between pretreatment brain oscillations and the outcome of rTMS therapy.
In the next chapter of this manuscript I will present the results of the EEG-rTMS
co-registration on healthy participants and depressed patients in the form of two
scientiﬁc reports. The aim was to ﬁnd what kind of perturbation rTMS induces on
healthy brain, and whether resting state EEG can be used to predict the response
to therapeutic rTMS stimulation. In addition, an analysis to distinguish BP and
MDD patients was performed.
The next chapter describes the methods used in these two studies.
Re´sume´ du Chapitre 5
Dans le dernier chapitre de l’introduction, je pre´senterai un re´sume´ de la rTMS,
de l’EEG et de la de´pression. Je de´crirai les de´ﬁs que repre´sente l’enregistrement
simultane´ de l’EEG et de la rTMS, les changements d’EEG lie´s aux troubles de
l’humeur et l’utilite´ des mesures d’EEG comme potentiel biomarqueur d’eﬃcacite´
the´rapeutique.
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In the following sections I will describe the experimental design used in this
study. I will characterize the groups of participant, both healthy and depressed
(with BP depression and MDD), who underwent the EEG-rTMS co-registration.
Although, I will not focus on detailed description of used rTMS parameters, because
it has already been explained in the previous section 3.5.
5.1 Participants, instrumentation and methodology
5.1.1 Participants
The study was approved by the regional ethical committee of Grenoble Univer-
sity Hospital (CPP Sud-Est I, ID RCB: 2011-A00114-37). All participants (patients
and healthy subjects, Table 5.1) were evaluated by a licensed psychiatrist (Dr David
Szekely) following an interview process. A written informed consent to participate
in the study was obtained from all subjects.
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In the ﬁrst experimental study, twenty healthy volunteers (10 males, 10 females),
aged 21 to 60 (mean 31.2 ± 10.3 years) were enrolled for ﬁve rTMS sessions with
concurrent EEG recordings. Two successive experimental sessions in the same sub-
ject were separated by at least 1 week and up to 10 days. All sessions for a given
subject were performed under identical conditions, at the same time of the day.
Three subjects were left-handed as assessed by the Edinburgh handedness inventory
[Oldﬁeld 1971]. None had neurological or psychological disorder or any contraindi-
cation for TMS. All subjects were familiarized with the TMS and the experimental
protocol, but none of them had received rTMS previously.
In the second experimental study, eighteen right-handed [Oldﬁeld 1971] patients
who met Diagnostic and Statistical Manual of Mental Disorder 4th ed. (DSM-IV)
criteria for Major Depressive Episode participated in the study. Eight MDD pa-
tients (6 females, age range 44-64, mean 52.1±7.8) and ten BP patients (6 females,
age range 32-69, mean 48.7 ± 12.6) according to the DSM-IV criteria [APA 2000]
were recruited from the Psychiatry Department of Grenoble University Hospital.
Inclusion criteria included nonresponse to pharmacological treatment of depression
using a minimum of two distinctly diﬀerent classes of antidepressant medications
for actual depressive episode (appropriate doses and duration) occurring at the time
of enrolment or earlier. Exclusion criteria included age under 18 years, drug abuse,
current comorbid major mental disorders assessed by clinical examination, neuro-
logical illness or convulsive disorders, and previous ECT treatments. All patients
were on a range of medications. For bipolar patients, mood stabilizer medication
has been unmodiﬁed for at least two weeks prior to the entry in the study, and
remained unchanged throughout the course of the study. No benzodiazepines were
administered two weeks before and during rTMS treatment. For MDD patients,
pre-treatment with an antidepressant and/or mood stabilizer medication has been
unmodiﬁed for at least four weeks prior to the entry in the study, and remained
unchanged throughout the course of the study. Only cyanemazine and hydroxyzine
were tolerated during the study.
Demographics characteristics (gender and age) and clinical characteristics (ill-
ness and episode duration, depression severity) using Montgomery Asberg De-
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pression Rate Scale (MADRS) [Montgomery 1979], 13-item Beck Depression In-
ventory (BDI-Short Form) [Collet 1986, Bouvard 1992, Beck 1996] and Clinical
Global Impression (CGI) were evaluated for each patient. For bipolar patients, ma-
niac or mixed symptoms were evaluated with Young Mania Rating Scale (YMRS)
[Young 1978]. All patients were assessed at inclusion, before the ﬁrst EEG record-
ing and after each 5 rTMS sessions by the same senior psychiatrist. The response
to rTMS treatment was deﬁned as at least 50% reduction of the baseline MADRS
scores. Patients were qualiﬁed as remitters when MADRS score was less than 8.
If YMRS was more than 15, at inclusion or during the course of rTMS treatment,
patients were excluded from the trial. The absolute changes in MADRS scores
(∆MADRS) between baseline and the end of rTMS (4 weeks after the ﬁrst evalu-
ation) were used to calculate clinical improvement and then, correlated with EEG
power in each frequency band.
Seventeen out of twenty healthy volunteers (9 females, 8 males), aged 21 to
60 (mean 31.2 ± 10.3 years), with no history of any neurological or psychological
disorder or any contraindication for TMS were choose to be used as controls. This
cohort of healthy controls was taken from the ﬁrst experimental study of this thesis.
EEG signals of control participants were recorded under the same conditions as in
patients, but with no TMS pulses actually delivered.
Demographic features of the three subject groups and the corresponding statis-
tical results are presented in Table 5.1
Table 5.1: Demographic features.
HC MDD BP
n=20 n=8 n=10
Mean age (years) 31.2± 10.3 52.1± 7.8 48.7± 12.6
Gender (male/female) 10/10 2/6 4/6
MADRS at baseline - 24.6± 9.3 23.6± 3.2
Duration of illness - 10.3± 6.4 18.9± 10.9
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5.1.2 rTMS methodology
At the ﬁrst rTMS/EEG session, the resting motor threshold (RMT) of the right
thumb abductor was determined by delivering single TMS pulses to the left motor
cortex with pre-gelled surface electrodes connected to an electromyographic (EMG)
ampliﬁer (MEP Monitor, Tonika Elektronic A/S, Denmark). The motor threshold
was deﬁned as the minimum stimulation intensity capable to induce at least 5
motor evoked potentials of at least 50 µV peak-to-peak amplitude in 10 single TMS
stimulations [Pascual-Leone 1996].
During rTMS treatment, the stimulation was guided by a neuronavigation sys-
tem (Premium Edition, Localite GmbH, Germany) to precisely deﬁne the neu-
roanatomical target of TMS from a T1-weighted magnetic resonance image (MRI)
of patient’s brain [Herwig 2001b] (the procedure has been described in the section
3.3). The TMS coil was then positioned in every session over the left DLPFC target
point, deﬁned as the intersection between Brodmann areas 9 and 46 along the middle
frontal gyrus. Active rTMS was performed using a MagPro X100 TMS stimulator
(Tonica Elektronik A/S, Denmark) with butterﬂy coil MCF-B65 for healthy par-
ticipants or MCF-B65-cooled coil for patients (Tonica Elektronik A/S, Denmark).
The coil was placed tangentially to the scalp to produce the highest level of the
stimulation on the cortical region parallel to the coil [Chen 2003]. The handle was
placed backward and laterally, approximately at 45o from the midline perpendicular
to the central sulcus. In case of head movement during the experiment, the coil was
manually repositioned to its initial position.
Healthy controls
In addition to active stimulation, healthy volunteers underwent sham-1 Hz stim-
ulation. In sham rTMS condition, a MCF-P-B65 Placebo coil (Tonica Elektronik
A/S, Denmark) was used to reduce the emitted magnetic ﬁeld by approximately
80% with identical sound level and mechanical outline as with active MCF-B65 coil.
Repetitive TMS protocols (1 Hz, 10 Hz, iTBS, cTBS, Sham-1 Hz) were con-
structed following the safety guidelines of the International Society of Transcranial
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Stimulation (ISTS) [Rossi 2009]. They all included between 792 and 800 pulses dis-
tributed into four periods for a total duration of 15 min. Inter-trains were included
in between stimulation periods to homogenise total duration of every protocol (Fig-
ure 5.1). Stimulation amplitude was 80% of RMT for cTBS and iTBS protocols,
120% of RMT for 1 Hz and 10 Hz protocols, and 24% (including coil attenuation)
for sham-1 Hz protocol. Protocol order was randomly distributed between subjects,
and subjects were not told about which protocol was used at the time of recording.
Figure 5.1: Description of rTMS protocols: 1 Hz and 10 Hz stimulations have identical intervals
between trains of pulses. In TBS protocols, three pulses of stimulation are given with 20 ms
interstimulus interval (ISI), repeated every 200 ms. In cTBS, 4 trains with 198 pulses each one
were given with 280 s interval between successive trains. In iTBS, a 2 s train was repeated every
8 s, which was then repeated 6 times for a total number of 198 pulses train with an interval of 229
s between successive long train.
Patients
Repetitive TMS was delivered using the standard procedure of depression treat-
ment at Grenoble University Hospital. Left DLPFC was stimulated at a frequency
of 10 Hz in 5-second trains at 120% of the estimated RMT. Forty trains were given in
each session (2000 pulses per session) with a 25-second intertrain interval. Twenty
72 Chapter 5. General methods
sessions were administrated within a 4-week period.
5.1.3 Self-evaluation of mood changes
A visual analogue scale (VAS) was used to proceed to a subjective assessment
of mood changes by every participant during the few hours following each rTMS
session, both for healthy volunteers and patients. The VAS consisted of 10 cm
horizontal lines with anchors at both poles and indicating mood changes from happy
/ unhappy, joyful / sad, relaxed / tense, calm / excited, vivid / gloomy, smiling /
serious. During the evening of the rTMS day, participants were asked to mark those
6 items between -5 and 5. The exact form used in these experiments is presented on
Figure 5.2. A positive/negative score reﬂected a positive/negative valence of mood
alteration. The sum over items was used to parsimoniously quantify mood changes
(score range from -30 to 30).
5.1.4 EEG acquisition and pre-processing
Subjects were seated in a reclining armchair with neck and back supported with a
pillow, arms relaxed and eyes closed. EEG was recorded before the ﬁrst TMS pulse,
then during stimulation and after the last pulse. Each of three recordings lasted 15
minutes. Healthy subjects underwent ﬁve separated rTMS-EEG sessions, whereas
patients underwent three EEG recordings performed at the ﬁrst TMS session, in
the middle TMS session (2 weeks after inclusion) and during the last, 4 weeks after
inclusion.
EEG signals were recorded with a 64-channel elastic cap with Ag/AgCl elec-
trodes positioned at the beginning of the experimental session according to the
10-20 system (Fast’n’Easy cap, Brain Products GmbH, Munich, Germany) and
connected to TMS-compatible DC ampliﬁers (BrainAmp, Brain Products GmbH,
Munich, Germany). Right eye vertical movements were recorded with one electro-
-oculogram (EOG) electrode. Electrode impedances were kept below 10 kΩ using
conduction gel. Recordings were made with a referential montage, where the refer-
ence electrode was placed just anterior to Fz, and the ground electrode just posterior
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Nom et prénom: 
Date de naissance: 
Date à laquelle le questionaire est rempli:
Echelle analogique visuelle (EVA)
Notez le point correspondant à la perception de votre état actuel. Zéro „0” signifie l'état qui 
n'a pas été modifié par TMS.
Ce formulaire doit être renseigné la journée qui suit la séance de rTMS.
Malheureux Heureux
-5 -4 -3 -2 -1 0 1 2 3 4 5
Triste Joyeux
-5 -4 -3 -2 -1 0 1 2 3 4 5
Mou Tonique
-5 -4 -3 -2 -1 0 1 2 3 4 5
Calme Agité
-5 -4 -3 -2 -1 0 1 2 3 4 5
Morne Vivant
-5 -4 -3 -2 -1 0 1 2 3 4 5
Sérieux Souriant
-5 -4 -3 -2 -1 0 1 2 3 4 5
Figure 5.2: Visual analogue scale.
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to Fz. The EEG ampliﬁer was used in DC mode with a high frequency cut oﬀ at
1000 Hz and no additional online ﬁltering. EEG data were digitized at 2500 Hz
sampling frequency with 16-bit resolution. Positions of the 64 EEG electrodes and
of the three ﬁducials (left and right tragus and nasion) were measured with the
TMS neuronavigation system.
Only pre- and post-rTMS EEG recordings, which did not contain any arte-
fact due the TMS pulses, were analysed. EEG data were pre-processed oﬀ-line in
EEGlab [Delorme 2004] and SPM8 (Wellcome Trust Centre for Neuroimaging, Uni-
versity College London, UK) running in Matlab (The MathWorks, USA). Continu-
ous recordings were ﬁrst band-pass ﬁltered between 1 and 45 Hz and down sampled
at 128 Hz to speed up subsequent analyses. Time periods that contained large
muscular and other non-stereotyped artefacts were then carefully pruned from the
signals. Up to 5 bad channels per session were visually identiﬁed. This data selec-
tion was followed by an independent component analysis (ICA) to remove eye blinks
and cardiac components from the EEG. After ﬁrst decomposition and elimination
of bad components, a second round of ICA ﬁltering was performed as proposed in
[Onton 2006]. The choice of bad components was based on visual inspection of the
spatial and temporal patterns of every component. Finally, 10-minute cleaned EEG
signals were re-referenced to the common average for scalp and source analyses, in
accordance with the assumption made for EEG forward modelling of SPM8.
5.1.5 EEG spectral analysis at the scalp and cortex levels
The ﬁrst 10 minutes of artefact-free signals for each condition were selected for
further processing. They were segmented into 20-second successive epochs onto
which fast Fourier transform (FFT) was applied to estimate spectral power for
each electrode. Power spectrum was then averaged over frequencies in separate
bands: delta (1-4 Hz), theta (3.5-7 Hz), alpha (7.5-13 Hz), low beta (14-22 Hz),
high beta (22-30 Hz) and gamma (30-45 Hz). To analyse patients data, only one
beta band was used (14-30 Hz). For statistical analyses in SPM8, spectral power of
each frequency band and each time bin was converted into a scalp map (128x128
pixels) using a two-dimensional (2D) spatial linear interpolation. Those maps were
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smoothed with a Gaussian kernel of 5 mm full width half maximum (FWHM) to
conform to assumptions of subsequent statistical analysis and to diminish inter-
subject variability.
To reconstruct cortical current source densities, the procedure proposed in Lit-
vak and Friston [Litvak 2008] was used. The canonical mesh at standard spatial
resolution (8196 sources) was warped to each subject’s anatomy. This step ensured
that cortical activity was reconstructed in the same source space over subjects
[Mattout 2007]. EEG electrodes were repositioned in subject’s MRI space with
rigid co-registration using the coordinates of the three ﬁducials (left ear, nasion,
right ear) and spatial projection of the electrode coordinates to the closest scalp
points. Then, a boundary element method (BEM) head model was used to compute
the forward operator that encodes the lead ﬁeld of each cortical source. Finally, an
image of cortical power was produced every 20 s of the 10 min selected scalp data
using the following steps:
1. Each 20 s time-window was epoched into ten successive time windows of 2 s
duration.
2. Induced cortical power was estimated from the 10 small time windows using
the inverse procedure of [Litvak 2008], based on a hierarchical model with
multiple sparse priors for EEG source reconstruction [Friston 2008] and em-
pirical priors that force uniformity of source reconstruction over epochs. The
“independent and identically distributed” (IID) option for spatial priors in
SPM8 was used, which corresponds to a minimum norm-like inverse solution
described in the section 2.4.2.
3. The image of cortical power for every frequency band of interest was created
using a contrast that did a band-pass ﬁltering.
4. Finally, images of cortical power were smoothed with an isotropic Gaussian
kernel of 8 mm FWHM.
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5.1.6 Statistical analyses
Statistical analyses of spectral power images were separated into ﬁrst level (sub-
ject level) and second level (group level) analyses. The statistical design of those
analyses was similar between scalp and cortical images for both, healthy controls
and patients. Subject level analysis consisted of a one sample t-test for each record-
ing session that allowed to obtain an image of the mean activity for recording session
applying the contrast “1” on the parameter estimates, as usual in SPM8. Those
images were used as input data to the second level analyses performed separately
in two following experimental designs.
Healthy controls
A 5x2 analysis of variance (ANOVA) over subject with 2 factors “rTMS proto-
col” (10Hz, 1Hz, iTBS, cTBS, sham) and “time condition” (pre- and post-rTMS)
was used as a second level analysis. To identify signiﬁcant eﬀects of each active
rTMS protocol as compared to sham stimulation, post hoc tests (Tukey HSD) were
used. Because the eﬀects of this 5x2 ANOVA were very much weighted by the
sham condition, a 4x2 ANOVA using only active protocols was also run, in order to
focus on interaction eﬀects that identify regions that responded diﬀerently between
active rTMS protocols. All ANOVAs were performed with adequate covariates to
remove the mean of the data of each experimental session. For scalp analysis, the
statistical threshold was set at p < 0.05, with correction for multiple comparisons
by controlling the family wise error (FWE). For cortical sources, a less stringent
threshold was applied (p < 0.001, uncorrected for multiple comparisons).
Patients
Firstly, a three-way analysis of variance (ANOVA) on baseline recordings over
patients was used to assess signiﬁcant changes during the treatment. The 3 factors
were “Session” (session 1, 10 and 20), “Response” to treatment (responders vs.
non-responders) and “Disease” (MDD vs. BP). Then, to be able to verify short-
term changes in the brain plasticity, another three-way ANOVA was applied, using
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baseline and post-stimulus recordings for MDD and BP patients separately. Here,
the factors were: “Session”, “Response” and “Time” (pre-rTMS vs post-rTMS). To
study the changes of oscillatory power after rTMS therapy, a three-way ANOVA
with three factors: “Response”, “Disease” and “Therapy” (ﬁrst pre-rTMS vs. last
post-rTMS) was used. In case of a signiﬁcant eﬀects, post hoc tests (Tukey HSD)
were performed. For scalp and cortical sources analysis, the statistical threshold
was set at p < 0.05, with correction for multiple comparisons by controlling the
family wise error (FWE).
Re´sume´ du Chapitre 6
Le chapitre suivant pre´sente les rsultats.
Dans un groupe de sujets sains, nous avons trouve´ pour chaque protocole actif
une diminution signiﬁcative des puissances delta et theˆta au niveau des e´lectrodes
pre´frontales, principalement localise´es dans le DLPFC gauche. Dans les bandes a`
plus haute frquence (beˆta et gamma), la diminution de la puissance dans le DLPFC
a e´galement e´te´ observe´e en controlate´ral et de´pendait du protocole de stimulation.
Puisqu’une importante activite´ delta et theˆta est ge´ne´ralement associe´e a` une inhi-
bition corticale, ces re´sultats sugge`rent que la SMTr au niveau du DLPFC diminue
de faon transitoire l’inhibition corticale locale. De plus, les oscillations EEG rapides
sont associe´es a` une excitabilite´ corticale et on peut en conclure que les diminutions
observe´es dans l’activite´ rapide localise´e au niveau du DLPFC sugge`rent e´galement
une excitabilite´ corticale re´duite, qui accompagne une diminution de l’inhibition
corticale.
Dans la seconde expe´rience, conduite sur des patients de´prime´s, la de´couverte
la plus importante est qu’il est possible de distinguer les sujets re´pondant au traite-
ment SMTr des non re´pondants. Les patients re´pondants montrent une puissance
signiﬁcativement plus haute dans les fre´quences basses. Par conse´quent, une aug-
mentation de la puissance alpha a e´te´ observe´e au niveau du cortex cingulaire ventral
pour les deux groupes.
La comparaison entre les patients et les sujets sains a mis en e´vidence une plus
haute activite´ des fre´quences basses au niveau du lobe occipital pour les sujets sains
que pour les patients. Les patients ont e´galement montre´ une puissance accrue des
bandes alpha dans les re´gions frontales et plus spe´cialement dans le DLPFC, de faon
bilate´rale. Une augmentation du rythme alpha peut s’expliquer par une association
de la bande alpha avec une dysfonction thalamique et une perturbation de l’activite´
corticale. La comparaison entre la de´pression majeure et les troubles bipolaires a
re´ve´le´ une activite´ plus importante dans les bandes theˆta et beˆta dans les patients
bipolaires, principalement localise´e au niveau du cortex pre´frontal.
5.1. Participants, instrumentation and methodology 79
Les re´sultats de l’analyse de re´gression multiple ont re´ve´le´ que la puissance de la
bande alpha au niveau des re´gions fronto-temporales gauches e´tait signiﬁcativement
et ne´gativement corre´le´e avec ∆MADRS. De plus, nous avons trouve´ une corre´lation
positive entre ∆MADRS et la puissance de la bande theˆta dans les zones de la ligne
me´diane poste´rieure. Ceci sugge`re que les deux caracte´ristiques de l’EEG pourraient
eˆtre utilise´es comme marqueurs aﬁn de pre´voir le re´sultat de la SMTr.
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6.1 Introduction
The aim of the ﬁrst experimental part of this thesis was to investigate the
modulations of healthy brain activity after diﬀerent rTMS protocols. To do that
there were four active rTMS protocols (1 Hz, 10 Hz, cTBS and iTBS) and sham
condition applied. The results are presented in the following manuscript of the ﬁrst
submitted paper, under the title “Changes of oscillatory brain activity induced by
repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex
in healthy subjects”.
6.2 Paper I
Changes of oscillatory brain activity induced by repetitive transcra-
nial magnetic stimulation of the left dorsolateral prefrontal cortex
in healthy subjects
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Changes of oscillatory brain activity induced by repetitive transcranial magnetic
stimulation of the left dorsolateral prefrontal cortex in healthy subjects
A. Woz´niak-Kwas´niewskaa,b, D. Szekelya,b,c, Pierre Aussedata, Thierry Bougerolc, O. Davida,b,∗
aFonctions Ce´re´brales et Neuromodulation, Universite´ Joseph Fourier, Grenoble, France
bInserm, U836, Grenoble Institut des Neurosciences, Grenoble, France
cClinique Universitaire de Psychiatrie, Poˆle Psychiatrie Neurologie, Centre Hospitalier Universitaire, Grenoble, France
Abstract
Repetitive transcranial magnetic stimulation (rTMS) modulates brain activity in different ways according to the stimulation
parameters. Although the after-effects of rTMS over motor cortex are well documented in healthy individuals, less is known about
the stimulation of dorso-lateral prefrontal cortex (DLPFC). Here, we studied in 20 healthy subjects how cortical oscillations are
modulated by four different active rTMS protocols (1 Hz, 10 Hz, continuous and intermittent theta bursts - cTBS and iTBS) of
the left DLPFC, and by a sham protocol used as a control condition, by comparing the spectral power of pre- and post-rTMS
electroencephalographic (EEG) recordings of 15 minutes duration. EEG spectrum was estimated with the Fast Fourier transform
(FFT) and partitioned using the common physiological frequency bands: delta (1-4 Hz), theta (3.5-7 Hz), alpha (7.5-13 Hz), low
beta (14-22 Hz), high beta (22-30 Hz) and gamma (30-45 Hz). Statistical analyses of EEG changes induced by rTMSwere computed
with Statistical Parametric Mapping (SPM) for EEG, in every frequency band, at the scalp level and at the cortex level. We found
for every active protocol a significant decrease of delta and theta power on left prefrontal electrodes, mainly localised in the left
DLPFC. In higher frequency bands (beta and gamma), the decrease of power in the DLPFC was also observed in the contralateral
DLFPC. Protocol-specific amplitude effects were also observed in the prefrontal cortex bilaterally in all frequency bands, but also
in parietal and temporal regions in low EEG frequencies. In high frequencies, EEG power in the prefrontal cortex increased after
rTMS for 10 Hz and iTBS protocols, but this effect did not survive the comparison to Sham responses. Because large delta and theta
activity is usually associated with cortical inhibition, observed rTMS-induced EEG changes in low frequencies suggest that rTMS
of DLPFC transiently decreases local cortical inhibition. Importantly, local responses take place in association with other unknown
mechanisms that modulate inter-hemispheric connectivity between homologous regions, resulting in the increase or decrease of fast
activity in each prefrontal lobe, depending on the stimulation protocol. Only decreases of fast activity following active rTMS could
be detected as significant when compared to Sham stimulation.
Keywords: EEG, rTMS, dorsolateral prefrontal cortex, methods
Introduction
Transcranial magnetic stimulation (TMS) uses a brief electric
current passing through a magnetic coil positioned on the scalp
to create a transient high-intensity magnetic field that focuses
on the cortex and induces neuronal responses (Di Lazzaro et al.,
2011; Hallett, 2007). The application of many pulses (repeti-
tive TMS, rTMS) can modulate brain’s activity during periods
that outlast the stimulation time and is thus of potential inter-
est for therapeutic applications, such as depression (Dell’Osso
et al., 2009; George, 2010; Richieri et al., 2011), schizophre-
nia with auditory hallucinations (Hasan et al., 2013; Homan
et al., 2012), migraines (Brigo et al., 2012; Magis et al., 2012)
or stroke (Hummel et al., 2008; Jung et al., 2012).
∗Corresponding author at:
Grenoble Institut des Neurosciences - Chemin Fortun Ferrini - Bt EJ Safra -
CHU 38700 La Tronche, France
Tel: +33 4 56 52 05 86
Fax: +33 4 56 52 05 98
Email address: odavid@ujf-grenoble.fr (O. David)
It is supposed that the inhibitory and excitatory properties of
rTMS protocols depend on the stimulation parameters, particu-
larly the frequency of stimulation and the temporal structure of
the paradigm, i.e. whether the series of pulses are applied con-
tinuously or not Classen and Stefan (2008). Those properties
can be efficiently estimated when stimulating the motor cortex
by recording motor evoked potentials on peripheral muscles.
From such electromyographic (EMG) recordings, it has been
shown that low-frequency stimulation (≤ 1Hz) produces lasting
decrease in motor cortex excitability, whereas high-frequency
stimulation (≥ 5Hz) induces facilitatory effects (Romero et al.,
2002; Hayashi et al., 2004; Houdayer et al., 2008; Di Lazzaro
et al., 2011; Noh et al., 2012). Similarly, theta burst stimulation
(TBS, burst of three 50 Hz pulses repeated every 200 ms) is
supposed to produce opposite neuronal after-effects depending
whether bursts are applied continuously (cTBS, inhibitory) or
intermittently (iTBS, excitatory) (Huang et al., 2005; Hoogen-
dam et al., 2010). When stimulating outside the motor cor-
tex, electroencephalographic (EEG) signals during or just fol-
lowing single pulse TMS provide similar valuable information
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about the changes in cortical activity, either locally or at re-
mote locations from the site of stimulation (Ilmoniemi et al.,
1997; Rosanova et al., 2009). Concerning rTMS, a recent re-
view and meta-analysis of EEG/rTMS studies pointed out that it
exists a certain degree of inter-study variability in the observed
EEG after-effects (Thut and Pascual-Leone, 2010). In addition,
the classical dichotomy between low vs. high frequency rTMS
and inhibition vs. excitation has been challenged by a series
of studies of EEG power changes following rTMS at differ-
ent frequencies (1 Hz, 5 Hz, 20 Hz) that all showed increases
of cortical motor oscillations in alpha and beta bands (Brig-
nani et al., 2008; Fuggetta et al., 2008; Veniero et al., 2011).
However, EEG oscillatory activity is only an indirect measure
of inhibitory and excitatory properties of underlying neuronal
networks. Still, from recordings in anesthetised animals com-
bining extracellular and EEG recordings (Contreras and Steri-
ade, 1995), it has been shown a direct correlation between low
frequencies of EEG and hyperpolarisation waves, suggesting
that amplitude of low frequency EEG positively correlate with
large-scale neuronal inhibition. Importantly, it has also been
shown that in the range of beta-gamma bands (20-80 Hz), os-
cillatory power was positively correlated with inhibitory trans-
mission of fast-spiking cells (Cardin et al., 2009), making this
band an indirect marker of local inhibition (see (Buzsaki and
Wang, 2012)) for a recent review on the mechanisms of gamma
oscillations).
Whereas rTMS of dorsolateral prefrontal cortex (DLPFC)
is commonly used for treating depression (Avery et al., 2006;
Fitzgerald et al., 2003; George et al., 2000, 1995; Pascual-
Leone et al., 1996), only a limited number of studies performed
in healthy subjects described brain’s responses to this type of
stimulation (Graf et al., 2001; Griskova et al., 2007; Grosshein-
rich et al., 2009; Okamura et al., 2001). While the responses
to motor cortex rTMS are relatively consistent across studies in
healthy controls, it is not the case for DLPFC rTMS because of
the heterogeneity of the population samples and of the experi-
mental design. The main experimental factors that introduced
variability in reported rTMS effects are the pulse parameters
(Arai et al., 2005; Classen and Stefan, 2008; Taylor and Loo,
2007), the different ways of targeting the DLPFC between ex-
perimenters and the different anatomy of the underlying gyri
between subjects (Thielscher et al., 2010).
In this study, we overcome these potential confounds by
studying the EEG after-effects of five rTMS protocols (sham,
1 Hz, 10 Hz, iTBS, cTBS) of the left DLPFC performed on
the same subjects by the same experimenter (A. W.-K.). In
contrast to the previous studies where only one or two active
protocols were compared to sham, the same subject under-
went here all five protocols. From such repeated measures, we
wanted to evaluate which rTMS protocol induces the most sig-
nificant after-effects and whether patterns of cortical responses
differ between rTMS protocols. To that end, statistical results
on modifications of EEG oscillatory activity by rTMS are pre-
sented below at the group level.
Methods
Participants
The study was approved by the regional ethical committee of
Grenoble University Hospital (CPP Sud-Est I, ID RCB: 2011-
A00114-37) and a written informed consent to participate in the
study was obtained from all participants. Twenty healthy volun-
teers (10 males, 10 females), aged 21 to 60 (mean 31.2 ± 10.3
years) were enrolled for five rTMS sessions with concurrent
EEG recordings. Two successive experimental sessions in the
same subject were separated by at least 1 week and up to 10
days. All sessions for a given subject were performed under
identical conditions, at the same time of the day. Three subjects
were left-handed as assessed by the Edinburgh handedness in-
ventory (Oldfield, 1971). The group was recruited after a pre-
liminary interview performed by a psychiatrist (D. S.). None
had neurological or psychological disorder or any contraindica-
tion for TMS. All subjects were familiarized with the TMS and
the experimental protocol, but none of them had received rTMS
previously.
rTMS protocols
During the first rTMS/EEG session, the resting motor thresh-
old (RMT) of the right thumb abductor was measured with pre-
gelled surface electrodes connected to an EMG amplifier (MEP
Monitor, Tonika Elektronic A/S, Denmark) when stimulating
the left primary motor cortex (Pascual-Leone et al., 1996). The
motor threshold was defined as the lowest stimulation intensity
that induced in 10 trials at least 5 motor evoked potentials of at
least 50µV peak-to-peak amplitude.
For all rTMS sessions, the stimulation was guided by a neu-
ronavigation system (Premium Edition, Localite GmbH, Ger-
many) to precisely define the neuroanatomical target of TMS
from a T1-weighted magnetic resonance image (MRI) of sub-
ject’s brain (Herwig et al., 2001). The TMS coil was then
positioned in every session over the left DLPFC target point,
defined as the intersection between Brodmann areas 9 and 46
along the middle frontal gyrus. Active rTMS was performed
using a MagPro X100 TMS stimulator (Tonica Elektronik A/S,
Denmark) with butterfly coil MCF-B65 (Tonica Elektronik A/S,
Denmark). In sham rTMS condition, a MCF-P-B65 Placebo
coil (Tonica Elektronik A/S, Denmark) was used to reduce the
emitted magnetic field by approximately 80% with identical
sound level and mechanical outline as with active MCF-B65
coil. The coil was placed tangentially to the scalp to produce
the highest level of the stimulation on the cortical region par-
allel to the coil (Chen et al., 2003). The handle was placed
backward and laterally, approximately at 45o from the midline
perpendicular to the central sulcus. In case of head movement
during the experiment, the coil was manually repositioned to its
initial position.
Repetitive TMS protocols (1 Hz, 10 Hz, iTBS, cTBS, Sham)
were constructed following the safety guidelines of the In-
ternational Society of Transcranial Stimulation (ISTS) (Rossi
et al., 2009). They all included between 792 and 800 pulses
distributed into four periods for a total duration of 15 min.
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Inter-trains were included in between stimulation periods to ho-
mogenise total duration of every protocol (Figure 1). Stimula-
tion amplitude was 80% of RMT for cTBS and iTBS protocols,
120% of RMT for 1 Hz and 10 Hz protocols, and 24% (in-
cluding coil attenuation) for Sham protocol. The pattern of the
Sham protocol was identical to the one used for 1 Hz stimula-
tion. Protocol order was randomly distributed between subjects,
and subjects were not told about which protocol was used at the
time of recording.
Self-evaluation of mood changes
A visual analogue scale (VAS) was used to proceed to a sub-
jective assessment of mood changes by every participants dur-
ing the few hours following each rTMS session. The VAS con-
sisted 10 cm horizontal lines with anchors at both poles and
indicating mood changes from happy / unhappy, joyful / sad,
relaxed / tense, calm / excited, vivid / gloomy, smiling / serious.
During the evening of the rTMS day, participants were asked
to mark those 6 items between -5 and 5. A positive/negative
score reflected a positive/negative valence of mood alteration.
The sum over items was used to parsimoniously quantify mood
changes (score range from -30 to 30).
EEG acquisition
Participants were seated in a reclining armchair with neck
and back supported with a pillow, arms relaxed and eyes closed.
They were asked to inhibit eye movements and blinks during
recordings. In case of drowsiness detected online from EEG
waves, the experimenter told the subject to open their eyes for
a short duration. These periods were noted and correspond-
ing signals removed from further analysis. EEG signals were
recorded before (at least during 15 min), during and after (at
least during 15 min) rTMS with a 64-channel elastic cap with
Ag/AgCl electrodes positioned at the beginning of the exper-
imental session according to the 10-20 system (Fast’n’Easy
cap, Brain Products GmbH, Munich, Germany) and connected
to TMS-compatible DC amplifiers (BrainAmp, Brain Products
GmbH, Munich, Germany). Right eye vertical movements
were recorded with one electro-oculogram (EOG) electrode.
Electrode impedances were kept below 10kΩ using conduction
gel. Recordings were made with a referential montage, where
the reference electrode was placed just anterior to Fz, and the
ground electrode just posterior to Fz. The EEG amplifier was
used in DC mode with a high frequency cut off at 1000 Hz and
no additional online filtering. EEG data were digitized at 2500
Hz sampling frequency with 16-bit resolution. Positions of the
64 EEG electrodes and of the three fiducials (left and right tra-
gus and nasion) were measured with the TMS neuronavigation
system.
EEG pre-processing
Only pre- and post-rTMS EEG recordings, which did not
contain any artefact due the TMS pulses, were analysed for the
study of rTMS after-effects. EEG data were pre-processed off-
line in EEGlab (Delorme and Makeig, 2004) and SPM8 (Well-
come Trust Centre for Neuroimaging, University College Lon-
don, UK) running in Matlab (The MathWorks, USA). Contin-
uous recordings were first band-pass filtered between 1 and 45
Hz and down sampled at 128 Hz to speed up subsequent analy-
ses. Time periods that contained large muscular and other non-
stereotyped artefacts were then carefully pruned from the sig-
nals. Up to 6 bad channels per session were visually identified.
This data selection was followed by an independent component
analysis (ICA) to remove eye blinks and cardiac components
from the EEG. After first decomposition and elimination of bad
components, a second round of ICA filtering was performed as
proposed in Onton et al. (2006). The choice of bad components
was based on visual inspection of the spatial and temporal pat-
terns of every component. Finally, cleaned EEG signals were
re-referenced to the common average for scalp and source anal-
yses, in accordance with the assumption made for EEG forward
modelling.
EEG spectral analysis at the scalp and cortical levels
The first 10 minutes of artefact-free signals for each condi-
tion were selected for further processing. They were segmented
into 20-second successive epochs onto which fast Fourier trans-
form (FFT) was applied to estimate spectral power for each
electrode. For each channel, peak frequency of the spectrum
within the band [4-14] Hz was extracted and power spectrum
was averaged over frequencies in separate bands: delta (1-4
Hz), theta (3.5-7 Hz), alpha (7.5-13 Hz), low beta (14-22 Hz),
high beta (22-30 Hz) and gamma (30-45 Hz). For statistical
analyses in SPM8, peak frequency and spectral power of each
frequency band and each time bin was converted into a scalp
map (128x128 pixels) using a two-dimensional (2D) spatial lin-
ear interpolation. Those maps were smoothed with a Gaussian
kernel of 5 mm full width half maximum (FWHM) to conform
to assumptions of subsequent statistical analysis and to dimin-
ish inter-subject variability.
To reconstruct cortical current source densities, we used the
procedure proposed in Litvak and Friston (2008). The canon-
ical mesh at standard spatial resolution (8196 sources) was
warped to each subject’s anatomy. This step ensured that cor-
tical activity was reconstructed in the same source space over
subjects (Mattout et al., 2007). EEG electrodes were reposi-
tioned in subject’s MRI space with rigid co-registration using
the coordinates of the three fiducials (left ear, nasion, right ear)
and spatial projection of the electrode coordinates to the closest
scalp points. Then, a boundary element method (BEM) head
model was used to compute the forward operator that encodes
the lead field of each cortical source. Finally, an image of corti-
cal power was produced every 20 s of the 10 min selected scalp
data using the following steps: 1) Each 20 s time-window was
epoched into ten successive time windows of 2 s duration. 2) In-
duced cortical power was estimated from the 10 small time win-
dows using the inverse procedure of Litvak and Friston (2008),
based on a hierarchical model with multiple sparse priors for
EEG source reconstruction (Friston et al., 2008) and empiri-
cal priors that force uniformity of source reconstruction over
3
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Figure 1: Description of rTMS protocols. 1 Hz and 10 Hz stimulations have identical intervals between trains of pulses. In TBS protocols, three pulses of
stimulation are given with 20 ms interstimulus interval (ISI), repeated every 200 ms. In cTBS, 4 trains with 198 pulses each one were given with 280 s interval
between successive trains. In iTBS, a 2 s train was repeated every 8 s (so called “small” train) which was then repeated 6 times for a total number of 198 pulses of
“long” train with an interval of 229 s between successive long train. All protocols were composed of 4 trains, except 10 Hz protocol that used 16 trains.
epochs. We used the “independent and identically distributed”
(IID) option for spatial priors in SPM8, which corresponds to a
minimum norm-like inverse solution. 3) The image of cortical
power for every frequency band of interest was created using a
contrast that did a band-pass filtering. 4) Finally, images of cor-
tical power were smoothed with an isotropic Gaussian kernel of
8 mm FWHM.
Statistical analyses
Statistical analyses of spectral power images were separated
into first level (subject level) and second level (group level)
analyses. The statistical design of those analyses was similar
between scalp and cortical images. First level analysis con-
sisted of a one sample t-test for each protocol (1 Hz, 10 Hz,
cTBS, iTBS, sham), time condition (pre- and post-rTMS), and
subject. It allowed to obtain an image of the mean activity
for each condition applying the contrast “1” on the parameter
estimates, as usual in SPM8. Those images were used as in-
put data to the second level analyses. Firstly, a 5x2 analysis
of variance (ANOVA) over subject was used. The 2 factors
were “rTMS protocol” (10Hz, 1Hz, iTBS, cTBS, sham) and
“time condition” (pre- and post-rTMS). To identify significant
effects of each active rTMS protocol as compared to sham stim-
ulation, post hoc tests (Tukey HSD) were used. Because the
effects of this 5x2 ANOVA were very much weighted by the
sham condition, we also run a 4x2 ANOVA using only active
protocols, in order to focus on interaction effects that identify
regions that responded differently between active rTMS proto-
cols. All ANOVAs were performed with covariates of no in-
terest introduced in the design matrix to remove the temporal
mean of the data during the pre- and post-rTMS periods for
each recording session. This was done in order to diminish the
confounding effects of any variations of electrode impedance
and/or of any sources of experimental noise between record-
ing sessions. Because EEG was continuously recorded during
pre-, per- and post-rTMS periods, we assumed in the statistical
model that confounds had the same amplitude between those
pre- and post-rTMS periods and were thus all contained in the
EEG power averaged over time, whereas effects of interest were
represented in variations around the mean. For scalp analy-
sis, the statistical threshold was set at p<0.05, with correction
for multiple comparisons by controlling the family wise error
(FWE) rate. For cortical sources, a less stringent threshold was
applied (p<0.001, uncorrected for multiple comparisons).
Results
Experimental events
Three out of 20 subjects had to be excluded from the entire
analysis because of very bad quality of EEG signals or because
4
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Table 1: Summed scores of self-evaluated mood changes after rTMS session of
subjects showing the score different from zero (no change).
Subject No 1 Hz 10 Hz cTBS iTBS Sham
S3 0 0 5 12 0
S7 0 0 0 2 0
S8 0 0 1 2 0
S11 0 5 0 1 -1
S13 0 0 1 -1 1
S16 0 4 0 0 0
S17 1 5 -1 0 5
S18 -3 1 2 -1 0
S19 5 6 1 -7 0
S20 0 2 0 9 0
Total 3 23 9 17 5
of drowsiness. One additional subject had to also be removed
from 10 Hz and 1 Hz analyses because of too short artefact free
periods. Additionally, the coil position was slightly adapted in
3 subjects who experienced pain in the left eye or in the trigem-
inal nerve when stimulated on the target defined a priori. Two
subjects reported headache after 10 Hz rTMS and one subject
had nausea after cTBS. Those uncomfortable sensations disap-
peared in all subjects few hours after rTMS sessions.
Self-evaluation of mood changes
Half of subjects (n = 10) did not notice any mood change on
the VAS for any type of rTMS protocol. The summed scores
of the 10 other subjects are shown in Table 1, where posi-
tive/negative values mean positive/negative mood alterations.
Reports varied a lot between subjects. No negative score was
reported for 10 Hz rTMS. Positive and negative scores were
equally reported for sham, 1 Hz, cTBS and iTBS. Total score
after summation over subjects was positive for all protocols,
including sham (Total score = 5), and was the largest for 10
Hz stimulation (Total score = 23). Regression analysis of VAS
scores and EEG spectral power changes induced by rTMS on
every sessions pooled together did not reveal any significant
correlation in every frequency band.
Modulation of EEG spectral power - Active vs. Sham stimula-
tion
No significant changes in EEG peak frequency were found to
be induced by any active rTMS protocol as compared to sham.
All active rTMS protocols induced significant decrease of
delta power as compared to sham (Figure 2). On the scalp, the
most significant responses were clearly observed on left pre-
frontal electrodes, i.e. close to the stimulated site as confirmed
by source localisation. Continuous TBS showed the least dif-
fuse activation, with only the left DLPFC significantly deacti-
vated, whereas the other conditions showed more diffuse scalp
activity which translated in the presence of significant decrease
of power mainly in bilateral central and parietal regions while
the most significant decrease was always observed in the left
DLPFC. Figure 3 shows pre- and post-rTMS absolute power in
electrode AF3, which was the closest to the stimulation target,
to illustrate how reproducible was the reduction in scalp delta
power across protocols and subjects. Despite one outlier (blue
circle, S1), the decrease in power is clearly visible across sub-
jects.
Figure 2: Group analysis of EEG after effects in the delta band. Colours code
for post-hoc t-test comparing active rTMS to Sham. Cortical maps are thresh-
olded at p<0.001, uncorrected (t = 3.09). Significance threshold (p<0.05 FWE)
is at t = 2.91 on scalp maps (light blue). Electrodes showing significant differ-
ences are marked with bigger black dots. Yellow cross on the scalp and cortex
indicate the cortical target.
In the theta band, EEG after-effects induced by rTMS were
found very similar to those observed in the delta band, but
slightly less significant (Figure 4). The only decreases of theta
power that survived outside the DLPFC were located in pari-
etal regions, at the parietal-occipital and parietal-temporal junc-
tions.
No after-effect was found to be significant in the alpha band.
In higher frequency bands (low beta, high beta, gamma), a
decrease of power was also detected on prefrontal electrodes
(Figures 5, 6 and 7). The main difference with low frequen-
cies was that this decrease could be left-sided, right sided or
bilateral on the scalp electrodes, depending on the stimulation
protocol. Source localisation confirmed the deactivation of the
DLFPC, but it was never significant on the left hemisphere
alone. DLPFC deactivation was bilateral (in low beta for 1 Hz
and iTBS; in high beta for 1 Hz, iTBS and cTBS; in gamma
for iTBS) or right sided (in low beta for 10 Hz and cTBS; in
high beta for 10 Hz; in gamma for 10 Hz, 1 Hz and cTBS).
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Figure 3: Pre- and post-rTMS absolute delta power on electrode AF3. Each subject is represented using a specific marker.
In addition, an increase of EEG power induced by rTMS was
also observed in central and posterior electrodes, particularly
for iTBS and cTBS protocols. On the cortex it corresponded to
small clusters in occipital and left opercular cortices.
Figure 4: Group analysis of EEG after effects in the theta band. See Figure 2
for details. Significance thresholds: t = 3.56 (cortex) and t = 2.82 (scalp).
Modulation of EEG spectral power - Interaction effects between
active protocols
Interaction effects between active protocols were found in
all frequency bands, except in the alpha band (Figure 8). In
the delta band, significant interactions were distributed in pari-
etal and temporal regions, also including left prefrontal cor-
tex (PFC). The most significant activations were at the right
temporo-parieto-occipital junction as a consequence of the
strong decrease of power observed only for 10 Hz and 1 Hz
stimulation (Figure 2). In the theta band, the interaction effect
in the right parietal cortex was still there (specific response to
10 Hz and 1Hz stimulation, Figure 4), but the DLPFC was also
bilaterally activated. In higher frequency, interactions were al-
ways significant bilaterally in the DLPFC, suggesting specific
lateralisation effect depending on stimulation parameters (see
Figures 5, 6 and 7).
To get a full picture of interaction effects in the PFC, we ex-
tracted the amplitude of relative changes of power between pre-
and post-rTMS. This was done by constructing a symmetrical
mask from PFC regions showing significant interactions (Fig-
ure 8 middle) that was used to extract values of relative power in
every subject from left (Figure 8 left) and right (Figure 8 right)
PFC. Pair-wise comparisons of relative changes were then per-
formed to detect significant differences in the modulatory ef-
fects of rTMS protocols (Figure 8). We found that in low fre-
quency bands (delta, theta), all protocols induced a decreased
of EEG power and that interaction effects thus concerned only
amplitude of this effect, with the smallest changes occurring
for 10 Hz protocol. However, in high frequency bands (beta
and gamma), the sign of the modulatory effect of 10 Hz proto-
col was inverted bilaterally. This inversion of effect was also
detected for iTBS, but only in the right hemisphere and for the
highest frequencies (high beta and gamma). It is important to
note that the interactions showing an inversion of the sign of
the effects were observed more anterior and more inferior in
the PFC than the main effects (decrease of power) corrected by
Sham (Figures 2, 4, 5, 6 and 7). It indicates that the inversion
of effects observed for 10 Hz and iTBS did not actually survive
the correction by Sham recordings.
Discussion
The aim of this research was to investigate the EEG after-
effects of different rTMS protocols of the left DLPFC in
6
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Figure 5: Group analysis of EEG after effects in the low beta band. See Figure
2 for details. Significance thresholds: t = 3.47 (cortex) and t = 3.05 (scalp).
healthy controls maintained at rest and awake. From scalp and
source localisation analyses, the largest responses were iden-
tified around the anatomical target of rTMS, but also distant
responses could be observed, particularly in the homologous
region in high frequency bands.
Review of the literature
To our knowledge, only five studies of EEG changes after
DLPFC rTMS were performed in healthy subjects (Okamura
et al., 2001; Schutter et al., 2001; Graf et al., 2001; Griskova
et al., 2007; Grossheinrich et al., 2009). Described methods and
results are extremely variable. In the study by Okamura et al.
(2001) (10 Hz vs. sham, 60 pulses, 100% MT, left DLPFC,
32 healthy subjects), no spectral analysis was performed but it
was shown that rTMS increased the maximal absolute power
of EEG within 2 minutes after stimulation, which was then de-
creased after 3 minutes, whereas the mean absolute power in-
creased only after 4 minutes. In contrast, Graf et al. (2001)
noticed a decrease of delta and theta power induced by rTMS
(20 Hz, 1600 pulses, 90% MT, left DLPFC, 8 healthy sub-
jects). However, they concluded that observed effects were
small, and may thus be related to non-specific effects. Schut-
ter et al. (2001) (1 Hz, 1200 pulses, 130% MT, right DLPFC,
12 healthy subjects) found different results as these authors re-
vealed a “stimulation x hemisphere” interaction in theta band
Figure 6: Group analysis of EEG after effects in the high beta band. See Figure
2 for details. Significance thresholds: t = 3.46 (cortex) and t = 3.21 (scalp).
power and a significant increase in left prefrontal theta activ-
ity between 25-35 min and 55-65 min after rTMS. More re-
cent studies by Griskova et al. (2007) and Grossheinrich et al.
(2009) reported an overall increase in delta power after 10 Hz
rTMS and significant effect in the alpha2 band (8.5-10 Hz) af-
ter iTBS. In the study by Griskova et al. (2007), the rTMS
after-effects in the other frequency bands were highly variable,
whereas Grossheinrich et al. (2009) did not find any effects for
cTBS and shamTBS comparing each TBS condition with base-
line.
Because all the parameters influencing rTMS after-effects -
stimulus intensity and frequency, total number of delivered im-
pulses, duration of stimulation period, the shape of the magnetic
pulse (Arai et al., 2005, 2007; Taylor and Loo, 2007; Classen
and Stefan, 2008) - were different between studies, and because
most of experiments were not performed with a neuronaviga-
tion system, it is difficult to interpret on solid ground the re-
sults of those different studies. This is the main reason why we
performed an additional study in which several protocols were
tested in the same subjects with up-to-date EEG-TMS method-
ology based on distributed EEG source localisation and neuron-
avigated TMS to minimise inter-subject variability.
EEG after-effects
The most robust finding of this study, which was observed for
every active protocol, was a decrease of delta and theta power
7
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Figure 7: Group analysis of EEG after effects in the gamma band. See Figure 2
for details. Significance thresholds: t = 3.31 (cortex) and t = 3.26 (scalp).
on left prefrontal electrodes, which was localised mainly in the
DLPFC (superior, middle and inferior frontal gyri). In healthy
adults, delta and theta bands are usually observed during rest-
ing state in frontal brain regions and they are correlated with
the deepest stages of sleep (delta) and drowsiness or arousal
(theta) (Buzsaki, 2006). Under pathological conditions, delta
and theta waves are considered as markers of cortical inhibition,
which leads to suppression of neural activities, and are associ-
ated with frontal hypo-activation (Angrilli et al., 2009; Gasser
et al., 1988; Spironelli et al., 2011). According to this assump-
tion, the observed decrease of frontal delta and theta oscillatory
power after active rTMS could be interpreted as a decrease of
DLPFC inhibition induced by all tested rTMS protocols. Un-
der the same line of thinking, because fast EEG oscillations
(20-80 Hz) are positively correlated with local inhibitory trans-
mission of fast spiking cells onto excitatory pyramidal cells
(Benali et al., 2011; Cardin et al., 2009), unspecific observed
decreases in fast activity localised in the DLPFC also advocate
for reduced cortical inhibition. This is apparently in contrast
with the effects that would have been observed on motor cor-
tex stimulation where half of the protocols were assumed to be
inhibitory and the other half excitatory. However, this compar-
ison falls short because we did not directly measure cortical
excitability with an additional paired-pulse paradigm. Inter-
estingly though, it has been demonstrated by others using the
long interval cortical inhibition (LICI) paradigm that cortical
excitability of DLPFC and motor cortex are different, which
strongly suggests different excitatory/inhibitory local mecha-
nisms induced by rTMS (Farzan et al., 2009).
No significant effects of active rTMS were observed in the
alpha band, whereas the beta and gamma bands exhibited sig-
nificant responses but with distinct patterns from that in low
frequencies. Critically, probably because EEG signal to noise
ratio decreases with frequency, more variability was observed
between responses to the different protocols in the higher fre-
quency bands. Interestingly, significant responses obtained on
prefrontal electrodes or cortical regions always corresponded
to a decrease of post-rTMS power as compared to pre-rTMS
state, similarly to results obtained in low frequencies. In ad-
dition, negative effects on DLPFC were extended to the right
side in contrast to responses in low frequencies, which were
more exclusively left-sided. This very interesting, and quite
unexpected, finding appeared to be robust as it was obtained
with several protocols. If one assumes that low frequency os-
cillations are carrier frequencies used to synchronise high fre-
quency oscillations that would support computational processes
between remote regions (Fries, 2005), then one could interpret
the bilateral desynchronisation of high frequencies by DLPFC
rTMS as if locally inhibiting low frequencies decreases syn-
chronisation of fast activity not only locally but also in the ho-
mologous region by the means of strong transcallosal connec-
tivity.
Overall, we did not find that a change in rTMS protocol in-
duced fundamentally different EEG after-effects, though some
interaction effects were detected (Figure 8). This is in line with
the series of studies of EEG responses to rTMS of motor cortex
performed at different frequencies (1 Hz, 5 Hz, 20 Hz) (Brig-
nani et al., 2008; Fuggetta et al., 2008; Veniero et al., 2011).
These authors showed increases of EEG power over parietal
and central regions in the alpha and beta bands, which were the
only bands of interest of those studies. Taken together, these
results and ours suggest a rather unspecific effect of rTMS fre-
quency on the modulation of cortical oscillations.
Finally, it is important to remind that we chose to keep the
duration of rTMS delivery and the number of stimuli constant
across protocols, but to reproduce standard clinical protocols,
stimulation amplitude varied from 80% of RMT for cTBS and
iTBS protocols to 120% of RMT for 1 Hz and 10 Hz protocols.
The slightly less diffused effects obtained in low frequencies
for cTBS and iTBS, as compared to 1 Hz and 10 Hz protocols
(Figures 2 and 4), may thus be due to less powerful stimulation
used for theta burst protocols.
Transposition to patient studies
All participants were asked to fill the self-evaluation psycho-
logical test to evaluate the mood and behaviour changes 3 hours
after each rTMS session. Though the change of mood was pos-
itive for all protocols on average, it is important to note that no
significant correlations were found between EEG after-effects
and mood changes. Since the goal of DLPFC rTMS is to im-
prove mood in bipolar or unipolar patients (Avery et al., 2006;
Fitzgerald et al., 2009), we cannot predict from our data what
8
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Figure 8: Significant interaction effects in the different EEG bands between the two factors “active rTMS protocol” x “time condition” (p<0.001 uncorrected). Bar
plots show the relative changes of power (arbitrary units) in the prefrontal cortex, averaged over subjects (vertical lines indicate standard errors). Stars indicate
significant pairwise comparison between protocols of the change of power between pre- and post-rTMS (p<0.001 uncorrected).
would be the optimal protocol to test first in patients and what
would be the EEG biomarker that would indicate an early ther-
apeutic response to successive rTMS sessions. Only EEG data
gathered in patients being treated by rTMS will be likely to pro-
vide pieces of information regarding this issue.
Improvements and limitations of the study
This study significantly consolidates DLPFC rTMS research
for several reasons. First, the definition of the anatomical tar-
get and the repositioning of the coil between protocols were
very much improved using the neuronavigation system (Herwig
et al., 2001). Most studies performed so far used a limited em-
pirical approach proposed in the early days of rTMS to place the
coil above Brodman area (BA) 9 and 46 (George et al., 1995;
Pascual-Leone et al., 1996). We can thus suggest that, addi-
tionally to the dissimilarities between stimulation parameters,
the discrepancies of the stimulus precision can produce oppo-
site (or negative) results between our work and cited literature.
Second, to our knowledge, there is still no available EEG source
localisation study of resting state recordings in healthy subjects
after rTMS, so that it has not been yet clarified what generators
are modulated by rTMS of DLPFC. Last but not at least, this
is the first research performing analysis of changes of neural
activity as a response to five different rTMS protocols over left
DLPFC applied in the same subjects. In particular, the litera-
ture suffers from a lack of direct comparison between 1 Hz and
10 Hz on the one hand, and cTBS and iTBS on the other hand.
However, our study has some limitations. First, changes over
time of spectral power were not analysed, as in Okamura et al.
(2001).The main reason for that is that many contaminated pe-
riods were cut differently between subjects to increase the like-
lihood of capturing neuronal signatures. As a consequence, it
was difficult to reach a sufficient statistical power over every
successive time period when concatenating data from the dif-
ferent subjects. Second, the post-EEG recording period was
limited to 15 minutes, because of the lengthy experimental pro-
cedure duration (preparation and recordings) that made subjects
to easily become drowsy or asleep. Ideally, it would have been
interesting to record longer but this was already difficult to ob-
tain this kind of data five times in the same subjects. Third,
only 64 electrodes were used, which makes spatial precision of
source analysis more limited than if the number of electrodes
was doubled. Fourth, there was no control of subjects’ mental
state and this would have been interesting to compare this pas-
sive condition to an active, as proposed in Noh et al. (2012) for
rTMS of motor cortex. However, this would have again doubled
the duration of the recordings. Finally, as mentioned above,
no measure of cortical excitability has been performed and this
9
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would have been relevant to relate the sign of EEG after-effects
to direct measures of cortical excitability from brain potentials
evoked by paired-pulse TMS for every session. Unfortunately,
we did not anticipate this step. To go further in the understand-
ing of our data, it would also be relevant to develop neuronal
models of EEG after-effects, as already proposed for motor cor-
tex Bey et al. (2012). This is out of the scope of this report but
is an interesting avenue to explore.
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6.3 Paper II
Distinct neural oscillatory activity patterns between responders and
non-responders with bipolar and major depressive disorder to repet-
itive transcranial magnetic stimulation treatment
In the second part, the results from an open study on depressed patients are
presented. The question was whether it is possible to distinguish BP from MDD
patients, and responders from non-responders to 10 Hz rTMS by studying EEG
biomarkers of resting state brain activity. These ﬁndings are presented in the second
paper which is going to be submitted, under the title “Distinct neural oscillatory
activity patterns between responders and non-responders with bipolar and major
depressive disorder to repetitive transcranial magnetic stimulation treatment”.
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The influence of 10 Hz repetitive Transcranial Magnetic Stimulation treatment on resting
EEG activity in patients with Bipolar Depression and Major Depressive Disorder
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Abstract
Major depressive disorder (MDD) and bipolar disorder (BP) are the main cause of disability among adults around the world.
On a physiopathological point of view, these two types of depression are due to distinct neuropathologies, though it is sometimes
difficult to distinguish between depressive clinical symptoms. In this perspective, the possibility to predict treatment response in
mental health disorders with biomarkers is an important clinical issue. This open study aimed to examine whether it is possible
to distinguish BP from MDD patients, and responders from non-responders to 10 Hz repetitive transcranial magnetic stimulation
(rTMS) by studying EEG features of resting brain activity.
Eight MDD (6 females) and 10 BP patients (6 females) were enrolled to navigated rTMS therapy. Stimulation consisted of
from 10 up to 20 sessions of continuous 10 Hz stimulation of the left DLPFC (2000 pulses, 120% motor threshold). We studied the
different patterns of EEG activity in both depressive disorders, by comparing spectral power of pre- and post-rTMS EEG recordings
throughout the therapeutic sessions in responders and non-responders. As a reference, we used EEG recordings at rest performed
in the same conditions in 17 healthy subjects (HS, 9 females).
EEG spectrum was estimated with the Fast Fourier transform (FFT) and partitioned using the common physiological frequency
bands: delta (1-4 Hz), theta (3.5-7 Hz), alpha (7.5-13 Hz) and beta (14-30 Hz). Statistical analyses of induced diseases-specific EEG
patterns were computed with Statistical Parametric Mapping (SPM) for EEG, in every frequency band at the scalp level, and at the
cortex level using a distributed source model with a minimum norm-like inverse solution. Furthermore, multiple regression analysis
of all frequency bands and absolute improvement in Montgomery Asberg Depression Rate Scale (∆MADRS) was performed.
The comparison of MDD and BP disorders revealed significantly higher activity in theta and beta bands power in bipolar patients,
mainly localised in prefrontal cortex. Next, responders showed increased activity in low frequencies and decreased power of
alpha band, when compared to non-responders. The results of multiple regression analysis revealed that alpha band power on the
left fronto-temporo-parietal regions was significantly (p<0.05) and negatively correlated with ∆MADRS. Additionally, we found
positive correlation of ∆MADRS and theta band power in the posterior midline areas (p<0.01). We suggest that both EEG features
could be used as biomarkers to predict rTMS outcome.
Keywords: rTMS, EEG, MDD, BP, resting state
Introduction
Nowadays depression is a leading cause of disability world-
wide among adults. As long as mental health disorders are
associated with lost productivity, high risk of mortality and
family burden, rapid and effective discrimination of respon-
ders and non-responders could potentially help in more tar-
geted and more focused clinical treatment (Disner et al., 2011).
The review by Pigott et al. (2010) of recent meta- and re-
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CHU 38700 La Tronche, France
Tel: +33 4 56 52 05 86
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analyses of sequenced treatment alternatives to relieve depres-
sion (STAR*D) suggests that the rate of success of antidepres-
sant treatments is below 30%. To date, many different predic-
tors of treatment response such as clinical manifestations, phys-
iological indices or neuroimaging markers have been developed
(Kemp et al., 2008). Unfortunately, the sensitivity and speci-
ficity of these biomarkers are still not properly determined.
For the last two decades, repetitive transcranial magnetic
stimulation (rTMS) has been demonstrated to be an effective
therapeutic treatment for major depressive disorder (MDD)
(George et al., 1995; Pascual-Leone et al., 1996; Fitzgerald
et al., 2006; George et al., 2000; Carpenter et al., 2012). Studies
on bipolar depression (BP) (Dolberg et al., 2002; Tamas et al.,
2007; Dell’Osso et al., 2009) are, however, very limited. The
effects of rTMS outlast the period of the stimulation, and can
Preprint submitted to NeuroImage October 22, 2013
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last for minutes after one session, and if repeated, some days
or weeks after the end of the treatment. Moreover, the effects
depending on intensity of stimulation spread to brain areas re-
mote from the targeted site, altering oscillatory activity, plas-
ticity and connectivity of neural networks. Here, we will focus
on the potential EEG biomarkers for predicting the response to
rTMS treatment of MDD and BP disorders.
Unfortunately, the actual knowledge about antidepressant
mechanisms of rTMS is still unclear. The limbic-cortical net-
work is supposed to have a crucial role in depression and be cor-
related emotional dysregulation (Drevets et al., 2008; Mayberg,
2003). This neuronal network consists from cortical (dorso-
lateral, medial and ventral prefrontal cortices) and limbic (hip-
pocampus and amygdala) structures (Li et al., 2010).
EEG brought important information about depression and
various studies have found that typically 20% to 40% of de-
pressed patients have EEG abnormalities, with several charac-
teristics and controversial patterns (Coburn et al., 2006). More-
over, up to 80% of psychiatric patients present various quanti-
tative EEG (qEEG) abnormalities on contrary to only 10% of
healthy subjects (Begic et al., 2011; Coburn et al., 2006).
In short, the strongest evidence in this field is that when
different pre-treatment EEG parameters were tested as possi-
ble biomarkers, alpha and theta bands were reported as the
most valuable indices to differentiate responders from non-
responders.
Increased frontal EEG asymmetry, as measured by relatively
higher left than right alpha band activity, appears to charac-
terise depressed individuals (Debener et al., 2000; Allen et al.,
2004; Vuga et al., 2006) and to be a state-marker of depression.
Interestingly, alpha asymmetry between brains hemispheres
recorded at baseline also differentiates responders from non-
responders to pharmacological treatment (Ulrich et al., 1984;
Knott et al., 1996; Bruder et al., 2001, 2008; Tenke et al., 2011).
Responders showed greater alpha power over right, versus left,
hemisphere, whereas non-responders tended to show the op-
posite pattern. Micoulaud-Franchi et al. (2012)studied the ab-
solute alpha power as a predictive value of responses to high
frequency (10 Hz) rTMS in the left DLPFC. They observed sig-
nificant and negative correlation of absolute variations in BDI-
Short Form (∆BDI-SF) scores between baseline and the end of
rTMS with alpha band power in left and right parieto-temporal
regions.
Frontal theta band modulations have been interpreted as re-
flecting altered activity in the anterior cingulate cortex impli-
cated in emotional regulations (Iosifescu, 2011). Many studies
have shown the association of theta alternations with treatment
response to antidepressants, although these findings are incon-
sistent across studies (Knott et al., 1996, 2000; Heikman et al.,
2001; Iosifescu et al., 2009). However, recently Schulman et al.
(2011) proposed that a perturbation of the thalamo-cortical res-
onance known as thalamo-cortical dysrhythmia (TCD) might be
an underlying process of many psychiatric disorders. Thalamo-
cortical dysrhythmia can be described as persistent abnor-
mal internally-generated delta and theta oscillations in thala-
mic neurons which disrupt the normal, state-dependent, flow
of information within the thalamo-cortico-thalamic networks
(Fuggetta and Noh, 2013). Increased low-frequency oscilla-
tions registered during awake and at rest can lead to perturba-
tion of cognition and sensory-motor performance observed in
many disorders, including major depression.
Regarding possibilities to distinguish MDD from BP pa-
tients, a recent study by Ford et al. (2013) showed differences in
bipolarity index (BI) of youth patients in this resting-state fMRI
scans. This group observed higher activation in putamen, claus-
trum and insula in BP patients, whereas activation in postcentral
and posterior cingulate gyrus was higher in MDD patients Ford
et al. (2013).
In this open study, we aimed to distinguish rTMS after-
effects between responders and non-responders by analysing
resting state EEG with fast Fourier transformation (FFT) us-
ing normalised power and source localisation technique. We
suggest that it is also possible to differentiate MDD from BP
patients using EEG power analysis as a marker.
Methods
Participants
This study has been approved by the regional ethical commit-
tee of Grenoble University Hospital (ID RCB: 2011-A00114-
37). All participants (patients and healthy subjects, Table 1)
were evaluated by a licensed psychiatrist (D.S.) following an
interview process. A written informed consent to participate in
the study was obtained from all participants. All patients were
on a range of medications.
Eighteen right-handed (Oldfield, 1971) patients who met Di-
agnostic and Statistical Manual of Mental Disorder 4th ed.
(DSM-IV) criteria for major depressive episode or bipolar de-
pressive episode participated in the study. Eight MDD patients
(6 females, age range 44-64, mean 52.1 ± 7.8) and ten BP pa-
tients (6 females, age range 32-69, mean 48.7 ± 12:6) accord-
ing to the DSM-IV criteria (APA, 2000) were recruited from
the Psychiatry Department of Grenoble University Hospital. If
bipolar patients met mixed characteristic, they were excluded
from the study. Inclusion criteria for MDD included nonre-
sponse to pharmacological treatment of depression level of re-
sistance 3 on Thase and Rush (1997) criteria using a minimum
of two distinctly different classes of antidepressant medications
for actual depressive episode (appropriate doses and duration)
occurring at the time of enrolment or earlier. For MDD pa-
tients, pre-treatment with an antidepressant and/or mood stabi-
lizer medication has been unmodified for at least four weeks
prior to entry in the study, and remained unchanged throughout
the course of the study.
For bipolar patients, mood stabilizer medication has been
optimized according to recent recommendation (Frances et al.
1998), then maintained at an unmodified dosage for at least two
weeks prior to the entry in the study, and remained unchanged
throughout the course of the study.
For all patients, exclusion criteria included age under 18
years, drug abuse, current comorbid major mental disorders as-
sessed by clinical examination in axe II (DSM IV-TR), neuro-
logical illness or convulsive disorders, and previous treatment
with electro-convulsive therapy (ECT).
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No benzodiazepines were administered two weeks before
and during rTMS treatment. Only cyanemazine and hydrox-
yzine were tolerated during the study.
Demographics characteristics (gender and age) and clini-
cal characteristics (illness and episode duration, depression
severity) using Montgomery Asberg Depression Rate Scale
(MADRS) (Montgomery and Asberg, 1979), 13-item Beck De-
pression Inventory (BDI-Short Form) (Collet and Cottraux,
1986; Beck et al., 1996; Bouvard et al., 1992) and Clinical
Global Impression (CGI) were evaluated for each patient. For
bipolar patients, maniac or mixed symptoms were evaluated
on clinical examination. During the study, maniac or mixed
symptoms have been evaluated with Young Mania Rating Scale
(YMRS) (Young et al., 1978). All patients were assessed at in-
clusion, before the first EEG recording and after each of the 5
rTMS sessions by the same senior psychiatrist. The response
to rTMS treatment was defined as at least 50% reduction of the
baseline MADRS scores. Patients were qualified as remitters
when MADRS score was less than 10. If YMRS was more than
15, at inclusion or during the course of rTMS treatment, patients
were excluded from the trial. The absolute changes in MADRS
scores (∆MADRS) between baseline and the end of rTMS (4
weeks after the first evaluation) were used to calculate clinical
improvement and then, correlated with power in different EEG
frequency bands.
Seventeen healthy volunteers (9 females), aged 21 to 60
(mean 31.2 ± 10.3 years), with no history of any neurological
or psychological disorder or any contraindication for TMSwere
recruited to be used as controls. EEG signals of control partic-
ipants were recorded under the same conditions as in patients,
but with no TMS pulses actually delivered.
Table 1: Demographic features.
HC MDD BP
n=17 n=8 n=10
Mean age (years) 31.2 ± 10.3 52.1 ± 7.8 48.7 ± 12.6
Gender (male/female) 9/8 2/6 4/6
MADRS at baseline - 24.6 ± 9.3 23.6 ± 3.2
Duration of illness - 10.3 ± 6.4 18.9 ± 10.9
Repetitive transcranial magnetic stimulation (rTMS)
At the first rTMS/EEG session, resting motor threshold
(RMT) of the right thumb abductor was determined by deliver-
ing single TMS pulses to the left motor cortex with pre-gelled
surface electrodes connected to an electromyographic (EMG)
amplifier (MEP Monitor, Tonika Elektronic A/S, Denmark).
The motor threshold was defined as the minimum stimulation
intensity capable to induce at least 5 motor evoked potentials of
at least 50 µV peak-to-peak amplitude in 10 single TMS stimu-
lations (Pascual-Leone et al., 1996).
During rTMS treatment, the stimulation was guided by a neu-
ronavigation system (Premium Edition, Localite GmbH, Ger-
many) to precisely define the neuroanatomical target of TMS
from a T1-weighted magnetic resonance image (MRI) of pa-
tient’s brain (Herwig et al., 2001). The TMS coil was then
positioned in every session over the left DLPFC target point,
defined as the intersection between Brodmann areas 9 and 46
along the middle frontal gyrus. Active rTMS was performed
using a MagPro X100 TMS stimulator (Tonica Elektronik A/S,
Denmark) with butterfly MCF-B65-cooled coil (Tonica Elek-
tronik A/S, Denmark). The coil was placed tangentially to the
scalp to produce the highest level of the stimulation on the cor-
tical region parallel to the coil (Chen et al., 2003). The handle
was placed backward and laterally, approximately at 45o from
the midline perpendicular to the central sulcus. In case of head
movement during the experiment, stimulation was stopped tran-
siently and the coil was manually repositioned to its initial po-
sition.
Repetitive TMS was delivered using standard procedure of
depression treatment. Left DLPFC was stimulated at a fre-
quency of 10 Hz in 5-second trains at 120% of the estimated
RMT. Forty trains were given in each session (2000 pulses per
session) with a 25-second intertrain interval. Twenty sessions
were administrated within a 4-week period.
EEG acquisition
Patients were seated in a reclining armchair with neck and
back supported with a pillow, arms relaxed and eyes closed.
EEG was recorded before the first rTMS, then during stimula-
tion and after stimuli. The following two recordings were taken
in the middle session (2 weeks after inclusion) and during the
last one, 4 weeks after inclusion. EEG signals were recorded
with a 64-channel elastic cap with Ag/AgCl electrodes posi-
tioned at the beginning of the experimental session according
to the 10-20 system (Fast’n’Easy cap, Brain Products GmbH,
Munich, Germany) and connected to TMS-compatible DC am-
plifiers (BrainAmp, Brain Products GmbH, Munich, Germany).
Right eye vertical movements were recorded with one elec-
trooculogram (EOG) electrode. Electrode impedances were
maintained below 10 kΩ using conduction gel. Data were
recorded with a referential montage, where the reference elec-
trode was placed just anterior to Fz, and the ground electrode
just posterior to Fz. The EEG amplifier was used in DC mode
with a high frequency cut off at 1000 Hz and no additional on-
line filtering. Recordings were digitized at 2500 Hz sampling
frequency with 16-bit resolution. Positions of the 64 EEG elec-
trodes and of the three fiducials (left and right tragus and na-
sion) were measured with the TMS neuronavigation system.
EEG processing
Fifteen-minutes resting state pre- and post-rTMS EEG
recordings, which did not contain any artefact due the TMS
pulses, were analysed for this study. EEG data were pre-
processed off-line in EEGlab (Delorme and Makeig, 2004) and
SPM8 (Wellcome Trust Centre for Neuroimaging, University
College London, UK) running in Matlab (The MathWorks,
USA). Continuous recordings were first band-pass filtered be-
tween 1 and 45 Hz and down sampled at 128 Hz to speed up
subsequent analyses. Time periods that contained large mus-
cular and other non-stereotyped artefacts were then carefully
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pruned from the signals. Up to 5 bad channels per session were
visually identified. This data selection was followed by an in-
dependent component analysis (ICA) to remove eye blinks and
cardiac components from the EEG. After first decomposition
and elimination of bad components, a second round of ICA fil-
tering was performed as proposed in Onton et al. (2006). The
choice of bad components was based on visual inspection of the
spatial and temporal patterns of every component. Finally, 10-
minute cleaned EEG signals were re-referenced to the common
average for scalp and source analyses, in accordance with the
assumption made for EEG forward modelling.
EEG spectral analysis at the scalp and cortex levels
The artefact-free signals were selected for further process-
ing. In order to remove the impedance bias between record-
ings, EEG signals of each channel and each recording was di-
vided by its square root of variance over all channels during the
recording. Normalized EEG recordings were segmented into
20-second successive epochs. A fast Fourier transform (FFT)
was applied to estimate spectral power for each electrode and
epoch. Then, the normalized spectral power was averaged over
frequencies in separate bands: delta (1-4 Hz), theta (3.5-7 Hz),
alpha (7.5-13 Hz), beta (14-30 Hz) and gamma (30-45 Hz). For
statistical analyses in SPM8, the normalized spectral power of
each frequency band and each time bin was converted into a
scalp map (128x128 pixels) using a two-dimensional (2D) spa-
tial linear interpolation. Those maps were smoothed with a
Gaussian kernel of 5 mm full width half maximum (FWHM) to
conform to assumptions of subsequent statistical analysis and
to diminish inter-subject variability.
Source reconstruction was performed on normalized EEG
recordings using the procedure proposed in Litvak and Fris-
ton (2008). The canonical mesh at standard spatial resolution
(8196 sources) was warped to each subject’s anatomy. This
step ensured that cortical activity was reconstructed in the same
source space over subjects (Mattout et al., 2007). EEG elec-
trodes were repositioned in subject’s MRI space with rigid co-
registration using the coordinates of the three fiducials (left ear,
nasion, right ear) and spatial projection of the electrode coor-
dinates to the closest scalp points. Then, a boundary element
method (BEM) head model was used to compute the forward
operator that encodes the lead field of each cortical source. Fi-
nally, an image of cortical power was produced every 20 s of
the 10 min selected scalp data using the following steps: 1)
Every 20 s time-window was epoched into ten successive time
windows of 2 s duration. 2) Induced cortical power was esti-
mated from the 10 small time windows using the inverse pro-
cedure of (Litvak and Friston, 2008), based on a hierarchical
model with multiple sparse priors for EEG source reconstruc-
tion (Friston et al., 2008) and empirical priors that force uni-
formity of source reconstruction over epochs. We used the “in-
dependent and identically distributed” (IID) option for spatial
priors in SPM8, which corresponds to a minimum norm-like
inverse solution. 3) The image of cortical power for every fre-
quency band of interest was created using a contrast that did a
band-pass filtering. 4) Finally, images of cortical power were
smoothed with an isotropic Gaussian kernel of 8 mm FWHM.
EEG asymmetry analysis
To analyse the asymmetry in EEG signal we created a new
image of EEG Asymmetry according to the following formula:
Asymmetry map = Recorded EEG map Left/Right Flipped
Image of Recorded EEG
Using this formula we can calculate the differences between
original and flipped images.
Statistical analyses
Statistical analyses of spectral power and asymmetry images
were separated into first level (subject level) and second level
(group level) analyses. The statistical design of those analyses
was similar between scalp and cortical images. Subject level
analysis consisted of a one sample t-test for each recording ses-
sion that allowed to obtain an image of the mean activity for
recording session applying the contrast “1” on the parameter
estimates, as usual in SPM8. Those images were used as in-
put data to the second level analyses. To assess potential group
differences in power of different frequency waves, factorial and
regression analysis with age as covariates of no interest was
used between-group comparisons. Firstly, a three-way analysis
of variance (ANOVA) on baseline recordings over patients was
used to assess significant changes during the treatment. The
3 factors were “Session” (session 1, 10 and 20), “Response”
to treatment (responders vs. non-responders) and “Disease”
(MDD vs. BP). Then, to be able to verify short-term changes
in the brain plasticity, we run another three-way ANOVA, using
baseline and post-stimulus recordings for MDD and BP patients
separately. Here, the factors were: “Session”, “Response” and
“Time” (pre-rTMS vs post-rTMS). To study the changes of os-
cillatory power after rTMS therapy, we used next three-way
ANOVA with three factors: “Response”, “Disease” and “Ther-
apy” (first pre-rTMS vs. last post-rTMS). In case of significant
effects, post hoc tests (Tukey HSD) were performed. For scalp
and cortical sources analysis, the statistical threshold was set at
p<0.05, with correction for multiple comparisons by control-
ling the family wise error (FWE).
Results
Clinical outcome
Two out of 20 recruited patients had to be excluded after the
first session. The first one declined to continue to participate to
the study, while the second one was not manageable for EEG
recordings because of very severe depression. Four out of 18
remaining patients stopped rTMS treatment after 10 sessions
(second EEG-rTMS recording, 2 weeks after inclusion) because
of lack of the response to the rTMS therapy. Four out of 8 MDD
and 6 out of 10 BP patients were responders to rTMS. Overall,
we were able to analysed 18 patients in sessions 1 and 2, and
14 patients in session 3.
Fast modulation of EEG spectral power
At the group level, we did not find any significant short-term
changes between pre-rTMS and post-rTMS EEG recorded dur-
ing the same session in all frequency bands.
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Comparison of responders and non-responders
The analysis of responders and non-responders (Figure 1) re-
vealed larger delta and theta power in responders, while alpha
oscillations were higher in non-responders (p<0.05 FWE). In
responders, higher delta activity was observed bilaterally in a
distributed network, with largest effects in the left hemisphere.
Theta band showed the same pattern as delta, but more signifi-
cant and thus more spread. The most significant changes were
observed in the temporo-parietal lobes, reaching supramarginal
gyri and right temporal lobe, up to bilateral prefrontal cortex,
including DLPFC. Interestingly, non-responders to rTMS treat-
ment showed higher alpha activity than responders. Significant
difference in alpha was observed in left and right frontal lobes
(most significant), ventral cingulate gyrus and lateral visual cor-
tex (Figure 1).
To detect disease specific responses, we plotted MDD and
BP groups separately (Figures 2 and 3). This revealed that beta
band was significantly higher in posterior and inferior parietal
lobes, bilaterally, reaching left DLPFC in responders than non-
responders only in a group of MDD patients. Delta activity in
BP responders was much more focused comparing to MDD pa-
tients. The highest activation was observed in the right and left
supramarginal gyri, inferior occipital lobes, and in prefrontal
cortex. Theta oscillations demonstrated the same pattern of ac-
tivity as in MDD patients, however with higher amplitude than
in MDD responders. In two groups of patients non-responders
showed increased alpha power. In BP non-responders, power of
alpha oscillations was significantly increased in frontal and oc-
cipital lobes. In MDD nonresponders the most significant dif-
ferences were observed bilaterally in superior parietal cortex,
and to a less extent in the visual cortex.
Figure 1: Group analysis of responders and non-responders in a group of
patients. Blue colour indicates higher activity in non-responders, red colour
higher activity in responders. Scalp and cortical maps are thresholded at p<0.05
FWE (T = 3.2). Yellow cross on the scalp and cortex indicates the target of
stimulation.
Figure 2: Group analysis of responders and non-responders in a group of MDD
patients. Scalp and cortical maps are thresholded at p<0.05 FWE (T = 3.1).
See Figure 1 for details.
Comparison of healthy controls with patients
One way ANOVA of patients (responders and non-
responders) and healthy controls baseline recordings showed
significantly higher delta and theta power in non-responders,
where alpha oscillations were clearly increased (p<0.05 FWE,
4 Differences in beta band were not significant.
Most significant differences for delta band were found in
parieto-occipital lobes with higher power in healthy controls.
Regarding theta band, in the left posterior temporal and parieto-
occipital lobes we observed higher absolute power in HC group
than non-responders to the treatment. In non-responders an in-
crease of alpha power was found in the left middle frontal gyri
and right inferior frontal lobe with additional higher activity in
ventral and posterior cingulate cortex.
Regarding comparison of HC with responders, we did not
observed any significant differences between these two groups.
MDD and BP
A comparison of all MDD and BP patients revealed that BP
patients demonstrate higher theta and beta band oscillations
than MDD patients (p<0.05 FWE, Figure 5). In theta range,
BP patients showed higher activity in the left and right ante-
rior dorsolateral frontal gyri and bilaterally in the ventral cin-
gulate cortex. Additionally, we observed more activity in the
left than right rostral section of temporal gyrus. However, in
beta range higher power in bipolar patients was observed in the
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Figure 3: Group analysis of responders and non-responders in a group of BP
patients. Significance threshold p<0.05 FWE (T= 3.1). See Figure 1 for details.
right frontal gyri, left and right temporal pole and interestingly,
in the right rostral section of temporal gyrus. In addition, pa-
tients suffering from bipolar depression showed higher activity
in the right primary motor cortex in both frequencies.
First baseline compared with last post-rTMS
Post-hoc comparison for the significant interaction of “Resp-
Non x Pre-Post” on the scalp level showed that there was
slightly higher, however not significant, theta activity in respon-
ders after the rTMS therapy than in non-responders (p<0.05
unc.). The highest activity was observed in the right and left
parieto-temporal areas. The same analysis on the cortex level
did not reveal any significant changes.
Regression analysis
Ten out of eighteen studied patients responded to the 10 Hz
rTMS therapy. They showed more than 50% reduction in the
initial MADRS score after 4 weeks of the treatment. The scores
are presented in Table 2.
Multiple regression analysis implemented in SPM8 allowed
to study the correlation of the EEG power and ∆MADRS
scores not only on the scalp, but also on the cortex. The re-
sults revealed that ∆MADRS was significantly and positively
correlated with posterior midline theta band power (p<0.01
unc.), while alpha band power on the fronto-temporal regions,
around post central and precentral gyri, was correlated nega-
tively (p<0.05 unc., Figure 6). Right anterior temporal lobe pre-
sented high pre-treatment theta activity in responders, seen on
scalp and cortex level. Additionally, using the source analysis,
higher baseline activity in theta band power in ventral section
of cingulate cortex was observed in responders to rTMS ther-
apy. Correlation, however, was not highly significant, probably
because of only 10 patients who were recorded for the third
Figure 4: Group analysis of differences between healthy controls and non-
responding patients. Red colour indicates higher power in healthy controls,
blue colour higher power in non-responders. Scalp maps are thresholded at
p<0.05 FWE (t = 3.1) and on cortical level p<0.001 uncorrected, (t = 3.35).
See Figure 1 for details.
time and had measured the third MADRS score. The regres-
sion analysis between MADRS changes and power in other fre-
quency bands did not show any significant correlation.
Asymmetry of baseline EEG
No statistically significant differences in EEG asymmetry
were reported in the group of examined patients.
Discussion
The main objectives were to investigate the short and long-
lasting changes in cortical activity induced by 10 Hz rTMS
treatment and to study the possible EEG biomarkers to dis-
tinguish a priori responders and non-responders to rTMS ther-
apy. Additionally, we studied EEG differences between BP and
MDD patients. Different patterns of oscillatory activity were
analysed and demonstrated significant dissimilarities, despite
the small number of participants. The results of the present
study also indicate that pre-treatment EEG baseline analysis re-
veals important information about the treated patients, and the
further possible treatment course.
EEG after-effects
The most robust finding of this study is that it is possi-
ble to distinguish non-responders to the treatment from re-
sponders and healthy controls. Significantly lower power of
low frequency oscillations was observed in non-responding pa-
tients. Next, in both groups of patients (responders and non-
responders) increase of alpha power was observed in ventral
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Figure 5: Group analysis of differences between MDD and BP patients, respon-
ders and non-responders put together. Blue colour indicates higher activity in
BP, red colour higher activity in MDD. Scalp and cortical maps are thresholded
at p<0.05 FWE (T = 3.4). See Figure 1 for details.
Table 2: Scores of MADRS scale of depressed patients during the rTMS ther-
apy. (- indicates missing data)
Patient Baseline 2 weeks 4 weeks
P1 15 - -
P2 15 11 -
P3 36 33 -
P5 23 - -
P7 32 18 5
P9 32 23 13
P10 26 15 5
P11 25 28 8
P12 23 26 21
P13 28 28 15
P14 21 23 1
P15 15 22 -
P16 27 17 36
P17 24 10 5
P18 18 4 -
P19 27 24 -
cingulate cortex. In addition, non-responders showed higher
alpha activity in prefrontal cortex.
Schulman et al. (2011) and Fuggetta and Noh (2013) demon-
strated opposite results to the present analysis of HC and pa-
tients group. They observed increased low-frequencies oscilla-
tions, caused by constant thalamic delta or theta bands activ-
ity, registered during awake and at rest in depressed patients,
when compared to healthy controls. However, our findings are
in line with a study by Coutin-Churchman et al. (2003), where
more activity in low frequencies in occipital lobe in the group
of healthy participants than in non-responding patients was reg-
istered. Also, patients demonstrated increased power of alpha
band in the frontal regions, especially in DLPFC, bilaterally.
Increased alpha rhythm can be explained as an association of al-
pha band with thalamic dysfunction and cortical activity pertur-
bation (Begic et al., 2011). As it was indicated in previous stud-
Figure 6: Regression analysis of theta and alpha power and ∆MADRS score
changes. Theta band is thresholded at p<0.01, uncorrected (T = 2.9) and alpha
band at p<0.05, uncorrected (T = 1.9). Yellow dots on the scalp indicate elec-
trodes near rTMS coil and yellow cross shows the cortical target. The higher
alpha power at baseline in posterior fronto-temporal regions and the lower theta
power at baseline in posterior frontal regions, the lower was the rTMS-treatment
response. See Figure 1 for details.
ies (Cook et al., 1998; Pollock and Schneider, 1990), reduced
left frontal activity is followed by increased activity of alpha
oscillations. Researches using functional magnetic resonance
imaging (fMRI) of resting-state blood oxygen level-dependent
(BOLD) signal in MDD have shown lower relative blood flow
in the left DLPFC areas and what come along, decreased cor-
tical excitability. 10 Hz rTMS is then suggested to boost the
activity not only in the stimulated region, but also in other areas
including anterior cingulate cortex (Paus et al., 2001; Rossini
et al., 2010).
Analysis of responders and non-responders in a group of
MDD and BP patients also revealed similar results (Figure 1).
Non-responders tend to show decreased activity in low frequen-
cies, and increased power in alpha band. Interestingly, when
this test was performed separately on two types of depression,
higher beta power was observed only in MDD responders than
non-responders.
Interestingly, group analysis of different oscillatory patterns
in MDD and BP patients demonstrated increased power in theta
and beta bands in BP patients (see Figure 5). Higher beta
rhythm observed in patients with bipolar disorder can be impli-
cated by high sensitivity of emotional context and may be as-
sociated with increased vulnerability in bipolar disease model
(Phillips et al., 2003). Furthermore, increased power in theta
and beta bands in motor areas in BP patients can suggest that
psychomotor activation and thoughts acceleration might be a
potential marker for bipolar type of depression. Our findings
are in line with a study by Cassano et al. (2012), where the
psychomotor activation factor was determined for patients with
unipolar and bipolar disorder.
Long-lasting rTMS treatment effects
The analysis of long-lasting rTMS-after-effects (comparing
baseline with last post-rTMS) revealed that increased theta ac-
tivity outlasted the rTMS treatment in responders to the stimula-
7
100 Chapter 6. Results
tion. However, this result did not reach significant level (p<0.05
unc.). It can be partially explained by small number of patients
recorded for the third time. Right and left parieto-temporal and
frontal midline areas showed increase of theta power in MDD
and BP group of responders, which can suggest that decreased
theta band power in non-responders is associated with higher
level of anxiety (Gold et al., 2013).
Regression analysis
Importantly, we observed a negative correlation between al-
pha power at baseline and ∆MADRS amelioration, ameliora-
tion, which is in line with Price et al. (2008) and Micoulaud-
Franchi et al. (2012). However, in cited studies depression
severity were recorded with 13-item Beck Depression Inventory
(BDI-Short Form) whereas here, we used MADRS scores. Fur-
thermore, we also observed significant positive correlation be-
tween ∆MADRS and theta band power. However, researchers
analysing the predictive value of alpha band power at baseline
to different antidepressant pharmacological treatment outcome
showed an opposite results to ours (Ulrich et al., 1984; Knott
et al., 1996; Bruder et al., 2001, 2008; Tenke et al., 2011). These
reversed results between rTMS and pharmacological treatment
may indicate on two different mechanisms of action underling
the antidepressant drugs and magnetic stimulation effects. Ac-
cording to Leuchter et al. (2013), rTMS seems to act trough en-
training pathological brain activity to the frequency of delivered
stimulation, facilitating the re-emergence of normal, intrinsic
oscillatory activity by resetting cortical and thalamo-cortical os-
cillators (Paus et al., 2001; Fuggetta et al., 2005, 2008; Leuchter
et al., 2013).
Advances and limitations of the study
To our knowledge, no study compares unipolar and bipolar
depression and responders and non-responders in one study, us-
ing also source localisation analysis. However, several lim-
itations should be considered in this study. First of all, pa-
tients were not drug-naive or drug-free, which could have an
influence on the brain oscillatory activity and be different com-
pared to drug-free patients (Itil et al., 1983). Second, here we
studied only pharmacoresistant patients whose brain activity
can vary from depressed patients in general, especially non-
pharmacoresistant. Regarding the signal analysis, changes over
time of spectral power were not analysed. The main reason for
that is that many contaminated periods were cut differently be-
tween subjects to increase the likelihood of capturing neuronal
signatures. Second, the post-EEG recording period was limited
to 15 minutes, because of the lengthy experimental procedure
duration (preparation and recordings) that made patients very
tired.
Future studies with similar design, with more homogeneous
cohort of patients and with bigger number of participants are re-
quired to confirm these results. Nevertheless, the presented re-
sults demonstrate that neurophysiological EEG biomarkers can
be useful as a tool to distinguish MDD from BP patients, and
the most important, responders from non-responders to rTMS
treatment. Additionally, we can suggest that lateral parietal
cortex can be a potential rTMS target in future works. Re-
sults presented on figures 1-3 shows inhibited activity in the left
and right parietal cortex in non-responders to rTMS, suggesting
that these patients suffer from stronger inhibition of emotion-
regulating regions (Downar and Daskalakis, 2013). However
this approach should be based on pre-treatment EEG analysis
of each individual patient.
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7.1 Conclusions
This thesis presents the results from concurrent EEG-rTMS on healthy par-
ticipants and depressed patients. This project was introduced in context of the
development of EEG for rTMS treatment in Psychiatry Department in CHU in
Grenoble. This is the ﬁrst thesis on this subject and the method used here is still
being improved. Recently, the rTMS robot was bought, which allows to have precise
coil placement during the entire stimulation period.
Using two cohorts of participants we aimed: 1) to ﬁnd the rTMS after-eﬀects on
healthy brain when stimulated over left DLPFC, 2) to verify if resting state EEG
can be used as a prediction of the response to therapeutic rTMS stimulation. Also,
the analysis to distinguish BP and MDD patients was performed.
Study I
The ﬁrst experiment studied the changes in cortical oscillatory activities in
response to ﬁve diﬀerent rTMS protocols (1 Hz, 10 Hz, iTBS, cTBS and sham-
-1 Hz) using 64-channel EEG-rTMS compatible. To be able to compare between-
protocols eﬀect, stimulation duration and approximately the same number of pulses
104 Chapter 7. Conclusions and future works
were applied over left DLPFC. Absolute power of six frequency bands (delta, theta,
alpha, low and high beta, and gamma) was examined on the scalp and cortex levels.
The most important result is the demonstration that rTMS induced a decrease in
low and high frequencies mainly in frontal areas. Although, the signiﬁcant changes
were also observed in distant areas, particularly in the homologous region in high
frequency bands. Signiﬁcant after-eﬀects in delta and theta oscillations were found
over the left stimulation sites, whereas beta and gamma oscillations’ changes were
bilateral or in remote regions, including right DLPFC. Interestingly, there was no
signiﬁcant eﬀect in the alpha band oscillations, even after 10 Hz stimulation. More-
over, regression analysis of visual analogue scale (VAS) scores and EEG spectral
power changes induced by rTMS on every sessions pooled together did not reveal
any signiﬁcant correlation in every frequency band. Based on these results, we
can suggest that tested active rTMS protocols may generally induce a transient
reduction in local cortical inhibition and excitation when applied on the DLPFC.
According to the literature, it is the ﬁrst study investigating various rTMS pro-
tocols within-subject, allowing for comprehensible between-protocols comparison.
To our knowledge, this was not done before and all previous EEG-rTMS stud-
ies on DLPFC only tested a subset of these protocols [Graf 2001, Okamura 2001,
Griskova 2007, Grossheinrich 2009]. Next, by using the neuronavigation system we
improved the deﬁnition of the anatomical target and the repositioning of the coil
between protocols [Herwig 2001a]. Most studies performed so far used a limited
empirical approach proposed in the early days of rTMS to place the coil above
Brodman area (BA) 9 and 46 [George 1995, Pascual-Leone 1996]. We may sug-
gest that, additionally to the dissimilarities between stimulation parameters, the
discrepancies of the stimulus precision can produce opposite (or negative) results
between our work and above mentioned literature. Additionally, to our knowledge,
there is still no available EEG source localisation study of resting state recordings
in healthy subjects after rTMS.
However, this work still has some limitations. First of all, we did not analyse
changes over time of spectral power as it was done in [Okamura 2001]. There are
two reasons why we did not perform this test. Many contaminated periods were
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cut diﬀerently between subjects and second, post-EEG recording period was limited
only to 15 minutes. The preparation and recordings were already long (minimum 2
hours), which made subjects drowsy or sleepy. Next, used 64-electrodes EEG makes
spatial precision of source analysis more limited than if higher number of electrodes
was used.
Study II
In the second part of this project, we performed EEG-rTMS co-registration
on depressed patients undergoing 10 Hz rTMS treatment. Although some studies
showed usefulness of EEG as a potential predictor of antidepressant therapy out-
come [Knott 1996, Knott 2000, Heikman 2001, Iosifescu 2009], there are only few
about the correlation between pretreatment brain oscillations and the response to
rTMS treatment [Price 2008, Micoulaud-Franchi 2012].
The main goal was to distinguish neural oscillatory activity patterns between
responders and non-responders with BP and MDD to standard 10 Hz rTMS treat-
ment. As in previous experiment, we used 64-electrode EEG-rTMS compatible cap,
although with a diﬀerent protocol design (2000 pulses). To study changes in EEG
during antidepressant treatment, each patient underwent three EEG-rTMS sessions
which took place at the beginning of the treatment (day 1), in the middle (day 10)
and at the last (20th) day of the treatment. To study diﬀerent patterns of EEG ac-
tivity in both depressive disorders, the spectral power of standard frequency bands
was examined on the scalp and cortex levels. Furthermore, multiple regression
analysis of all frequency bands and absolute improvement in Montgomery Asberg
Depression Rate Scale (∆MADRS) was performed.
Here, the most important ﬁnding is an observation of negative correlation be-
tween alpha power at baseline and ∆MADRS amelioration, which is in line with
[Price 2008] and [Micoulaud-Franchi 2012]. Furthermore, we also observed signif-
icant positive correlation between ∆MADRS and theta band power. However,
researchers analysing the predictive value of alpha band power at baseline to diﬀer-
ent antidepressant pharmacological treatment outcome showed an opposite results
to ours [Ulrich 1984, Knott 1996, Bruder 2001, Bruder 2008, Tenke 2011]. These
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reversed results between rTMS and pharmacological treatment may indicate two
diﬀerent mechanisms of action underlying the eﬀects of antidepressant drugs and
of magnetic stimulation. According to [Thut 2011, Leuchter 2013], rTMS seems
to act trough entraining pathological brain activity to the frequency of delivered
stimulation, facilitating the re-emergence of normal, intrinsic oscillatory activity
by resetting cortical and thalamo-cortical oscillators [Paus 2001, Fuggetta 2005,
Fuggetta 2008, Leuchter 2013].
Next, we showed that it possible to distinguish non-responders to the treat-
ment from responders and healthy controls. Signiﬁcantly lower power of low fre-
quency oscillations was observed in non-responding patients, which can be explained
by deﬁcit in inhibitory mechanisms. Although studies of [Schulman 2011] and
[Fuggetta 2013] demonstrated opposite results, our ﬁndings are in line with a study
by [Coutin-Churchman 2003], where more activity in low frequencies in occipital
lobe in the group of healthy participants than in patients was registered.
Next, in both groups of patients (responders and non-responders) increase of
alpha power was observed in ventral cingulate cortex. In addition, non-responders
also showed higher alpha activity in prefrontal cortex. Increased alpha rhythm
can be explained as an association of alpha band with thalamic dysfunction and
cortical activity perturbation [Begic 2011]. As it was indicated in previous stud-
ies [Cook 1998, Pollock 1990], reduced left frontal activity is followed by increased
activity of alpha oscillations. Researches using fMRI of resting-state blood oxygen
level-dependent (BOLD) signal in MDD have shown lower relative blood ﬂow in
the left DLPFC areas and what come along, decreased cortical excitability. 10 Hz
rTMS is thus suggested to boost the activity not only in the stimulated region, but
also in other areas including anterior cingulate cortex [Paus 2001, Rossini 2010].
Importantly, analysis of responders and non-responders in a group of MDD and BP
patients also revealed similar results.
Interestingly, group analysis of diﬀerent oscillatory patterns in MDD and BP
patients demonstrated increased power in theta and beta bands in BP patients.
Higher beta rhythm observed in patients with bipolar disorder can be implicated
by high sensitivity of emotional context and may be associated with increased vul-
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nerability in bipolar disease according to the model of [Phillips 2003].
To our knowledge, no study compares unipolar and bipolar depression and re-
sponders and non-responders in one study, using also source localisation analysis.
However, several limitations should be considered in this study. First of all, pa-
tients were not drug-naive or drug-free, which could have an inﬂuence on the brain
oscillatory activity and be diﬀerent compared to drug-free patients [Itil 1983]. Sec-
ond, here we studied only pharmacoresistant patients whose brain activity can vary
from depressed patients in general, especially non-pharmacoresistant. Regarding
the signal analysis, changes over time of spectral power were not analysed. The
main reason for that is that many contaminated periods were cut diﬀerently be-
tween subjects to increase the likelihood of capturing neuronal signatures. Second,
the post-EEG recording period was limited to 15 minutes, because of the lengthy
experimental procedure duration (preparation and recordings) that made patients
very tired.
Future studies with similar design, with more homogeneous cohort of patients
and with bigger number of participants are required to conﬁrm these results. Never-
theless, the presented results demonstrate that neurophysiological EEG biomarkers
can be useful as a tool to distinguish MDD from BP patients, and the most impor-
tant, responders from non-responders to rTMS treatment.
7.2 Future works
To go further in the understanding of our data, it would also be relevant to
develop neuronal models of EEG after-eﬀects, as already proposed for motor cortex
[Bey 2012]. This was out of the scope of this thesis but is an interesting avenue to
explore. To do that I will work on rTMS-evoked responses and on the functional
connectivity analysis of the same recordings using dynamic causal modeling (DCM)
[Friston 2003, David 2006]. These method is based on Bayesian model comparison
procedure that rests on comparing models of how data were generated. The basic
idea is to construct reasonably realistic models of functionally connected cortical
regions and then, to select the best model which can be identiﬁed from observed
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data based on the model evidences.
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Abstract
Evaluation of cortical excitability with electroencephalography recordings for optimizing
the repetitive transcranial magnetic stimulation in patients with mood disorders.
Transcranial magnetic stimulation (TMS) is a non-invasive technique for stimulating the brain. Repeti-
tive TMS, application of many magnetic pulses, is able to induce relatively long-lasting excitability changes
and nowadays is being developed for various therapeutic and scientiﬁc purposes. The aim of this PhD thesis
was to compare diﬀerent rTMS protocols in healthy subjects and to ﬁnd neurophysiological EEG biomarkers
characteristic for response or not to rTMS therapy in major and bipolar depression. The main originality
of presented method is within-subject comparison of between-protocols eﬀects. Additionally, source locali-
sation was performed in both analyses. Here, we studied in 20 healthy subjects how cortical oscillations are
modulated by four diﬀerent active rTMS protocols of the left DLPFC, and by a sham-1Hz protocol used
as a control condition, by comparing the spectral power of pre- and post-rTMS electroencephalographic
(EEG) recordings. We found for every active protocol a signiﬁcant decrease of delta and theta power on left
prefrontal electrodes, mainly localised in the left DLPFC. In higher frequency bands (beta and gamma), the
decrease of power in the DLPFC was also observed additionally in the contralateral DLFPC and depended
on the stimulation protocol. In the second experiment we worked on two subgroups of patients, with major
depressive disorder (MDD) and bipolar disorder (BP). In this open study we aimed to examine whether
there are EEG diﬀerences in resting brain activity between BP and MADD patients, and between respon-
ders and non-responders to 10 Hz repetitive transcranial magnetic stimulation (rTMS) by studying EEG
biomarkers. The most important ﬁnding is that it is possible to distinguish responders from non-responders
to the rTMS treatment.
Keywords: EEG, rTMS, dorso-lateral prefrontal cortex, depression.
Re´sume´
Evaluation de l’excitabilite´ corticale par e´lectroence´phalographie pour l’optimisation de
la stimulation magne´tique transcraˆnienne re´pe´te´e chez les patients souffrant de troubles de
l’humeur
La stimulation magne´tique transcranienne (SMT) est une technique non invasive qui permet de stimuler
le cerveau. Les SMT re´pe´titives (SMTr), c’est-a`-dire l’application de nombreuses impulsions magne´tiques,
sont capable d’induire des modiﬁcations de longue dure´e de l’excitabilite´ neuronale. La SMT s’est de´veloppe´e
dans un but the´rapeutique et scientiﬁque. L’objectif de cette the`se e´tait de comparer diﬀe´rents protocoles
SMTr sur des sujets sains et de trouver des marqueurs e´lectroence´phalograpiques (EEG) de la re´ponse ou pas
a` la the´rapie SMTr dans la de´pression majeure et bipolaire. La principale originalite´ de la me´thode pre´sente´e
est la comparaison intra-sujet d’eﬀets entre-protocoles et le de´veloppement de techniques de localisation de
sources. Ceci e´tait la premie`re the`se d’EEG-SMTr dans notre groupe et la me´thode a e´te´ de´veloppe´e pour
la premie`re fois tant pour les deux mode`les expe´rimentaux et d’autres analyses EEG. Cette the`se pre´sente
les re´sultats de deux expe´riences se´pare´ment conduites, sur des sujets sains et des patients de´prime´s. Dans
la deuxie`me expe´rience, nous avons travaille´ sur deux groupes de patients, souﬀrant de trouble de´pressif
majeur (MDD) et de trouble bipolaire (BP). Dans cette e´tude ouverte, nous avons cherche´ a` de´terminer
s’il existe des diﬀe´rences d’EEG de repos dans l’activite´ ce´re´brale entre patients BP et MDD, et entre les
re´pondeurs et non-re´pondeurs a` la SMTr a` 10 Hz en e´tudiant des biomarqueurs d’EEG. La conclusion la
plus importante est qu’il est possible de distinguer les re´pondeurs des non-re´pondeurs au traitement SMTr.
Les mots cle´s: EEG, rTMS, cortex pre´frontal dorso-late´ral (DLPFC), la depression.

